合成路线1
该中间体在本合成路线中的序号:
(B) The metal-ammonia reduction of 4,6-dimethoxy-m-xylene (I) gives 1,5-dimethyl-2,4-dimethoxy-1,4-cyclohexadiene (II), which by treatment with potassium tert-butoxide in DMSO is converted into the conjugated diene (III). The Dies-Alder reaction of (III) with dimethyl acetylenedicarboxylate (A), and subsequent elimination of the bridge affords dimethyl 3-methyl-4,6-dimethoxyphthalate (IV), which is selectively monodemethylated with BCl3 yielding the o-hydroxyphthalic ester (V). The hydrolysis and anhydrization of (V) gives 3-hydroxy-5-methoxy-6-methylphthalic anhydride (VI), which is reduced with Zn and HCl in acetic acid affording 4-methyl-5-methoxy-7-hydroxyphthalide (VII). The reaction of (VII) with allyl bromide (B) by means of K2CO3 in ether gives the allylic ether (VIII), which undergoes thermal rearrangement into 4-methyl-5-methoxy-7-hydroxy-6-allyl-phthalide (IX). The ozonolysis of (IX) affords the aldehyde (X), which by a Wittig condensation with 1-formylethylydenetriphenylphosphorane (XI) is converted into the new aldehyde (XII). A new Wittig reaction of (XII) with the phosphorane (XIII) gives the ethyl ester (XIV), which is finally hydrolyzed and partially reduced with diimide.
【1】
Castaner, J.; Hillier, K.; Mycophenolic acid. Drugs Fut 1978, 3, 8, 594.
|
【2】
Wright, J.J.; Birch, A.J.; A total synthesis of mycophenolic acid. J Chem Soc 1969, 14, 788-789.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(A) |
24551 |
Dimethyl acetylenedicarboxylate; Dimethyl 2-butynedioate;Acetylenedicarboxylic acid dimethyl ester |
762-42-5 |
C6H6O4 |
详情 | 详情
|
(I) |
39930 |
1,5-dimethoxy-2,4-dimethylbenzene; 5-methoxy-2,4-dimethylphenyl methyl ether
|
|
C10H14O2 |
详情 |
详情
|
(II) |
39931 |
1,5-dimethoxy-2,4-dimethyl-1,4-cyclohexadiene; 5-methoxy-2,4-dimethyl-1,4-cyclohexadien-1-yl methyl ether
|
|
C10H16O2 |
详情 |
详情
|
(III) |
39932 |
3-methoxy-4,6-dimethyl-1,3-cyclohexadien-1-yl methyl ether; 2,4-dimethoxy-1,5-dimethyl-1,3-cyclohexadiene
|
|
C10H16O2 |
详情 |
详情
|
(IV) |
39933 |
dimethyl 4,6-dimethoxy-3-methylphthalate
|
|
C13H16O6 |
详情 |
详情
|
(V) |
39934 |
dimethyl 6-hydroxy-4-methoxy-3-methylphthalate
|
|
C12H14O6 |
详情 |
详情
|
(VI) |
39935 |
7-hydroxy-5-methoxy-4-methyl-2-benzofuran-1,3-dione
|
|
C10H8O5 |
详情 |
详情
|
(VII) |
39936 |
7-hydroxy-5-methoxy-4-methyl-2-benzofuran-1(3H)-one
|
|
C10H10O4 |
详情 |
详情
|
(VIII) |
39937 |
7-(allyloxy)-5-methoxy-4-methyl-2-benzofuran-1(3H)-one
|
|
C13H14O4 |
详情 |
详情
|
(IX) |
39938 |
6-allyl-7-hydroxy-5-methoxy-4-methyl-2-benzofuran-1(3H)-one
|
|
C13H14O4 |
详情 |
详情
|
(X) |
39939 |
2-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)acetaldehyde
|
|
C12H12O5 |
详情 |
详情
|
(XI) |
39940 |
2-(triphenylphosphoranylidene)propanal
|
|
C21H19OP |
详情 |
详情
|
(XII) |
39941 |
(E)-4-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-2-methyl-2-butenal
|
|
C15H16O5 |
详情 |
详情
|
(XIII) |
39942 |
ethyl 2-(triethylphosphoranylidene)acetate
|
|
C10H21O2P |
详情 |
详情
|
(XIV) |
39943 |
ethyl (2E,4E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4-methyl-2,4-hexadienoate
|
|
C19H22O6 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By condensation of 2'-hydroxy-5,9-dimethyl-6,7-benzomorphan (I) with allyl bromide (II) by means of NaHCO3 in refluxing ethanol.
【1】
Gordon, M.; Lafferty, J.J. (SmithKline Beecham Corp.); Novel N-allyl and N-propargyl benzmorphan derivs.. US 4048178 .
|
【2】
Serradell, M.N.; Castaner, J.; Paton, D.M.; Blancafort, P.; SKF-10,047. Drugs Fut 1983, 8, 5, 439.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36016 |
(1R,9R,13R)-1,13-dimethyl-10-azatricyclo[7.3.1.0(2,7)]trideca-2,4,6-trien-4-ol
|
|
C14H19NO |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(II) The alkylation of 4-(N-acetyl-N-ethylamino)-2-hydroxyacetophenone (I) with allyl bromide (II) by means of K2CO3 in DMF gives the allyl ether (III), which is isomerized by refluxing in diethylaniline to 4-(N-acetyl-N-ethylamino)-3-allyl-2-hydroxyacetophenone (IV) The reduction of (IV) with H2 over Pd/C in ethanol affords the corresponding propyl derivative (V), which is deacetylated with HBr in refluxing acetic acid water to 4-(ethylamino)-3-propyl-2-hydroxyacetophenone (VI). The addition of (VI) dimethyl acetylenedicarboxylate (VII) in refluxing ethanol affords the aminomaleate (VIII), which by cyclization witn polyphosphoric acid at 100 C gives methyl 1-ethyl-6-acetyl-7-hydroxy-4 oxo-8-propyl-4H-quinoline-2-carboxylate (IX). The condensation of (IX) with diethyl oxalate in DMF by means of NaH results in the ester of the final product (X), which is then hydrolyzed with NaHCO3 iin refluxing ethanol.
【1】
Wilkinson, D.J.; Lockley, W.J.S.; Synthesis of nedocromil sodium labelled with tritium, deuterium and carbon-14. J Label Compd Radiopharm 1985, 22, 9, 883.
|
【2】
Caims, H.; Cox, D. (Rhone-Poulenc Rorer Ltd.); Nouvelles pyranoquinoleinones et leurs compositions pharmaceutiques. DE 2819215; ES 469391; JP 1199909; JP 53137969 .
|
【3】
Cairns, H.; Cox, D. (Rhone-Poulenc Rorer Ltd.); 4,6-Dioxo-4H,6H-pyrano[3,2-g]quinoline-2,8-dicarbocyclic acids. GB 2022078 .
|
【4】
Prous, J.; Castaner, J.; Nedocromil sodium. Drugs Fut 1986, 11, 9, 756.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(I) |
24545 |
N-(4-acetyl-3-hydroxyphenyl)-N-ethylacetamide
|
|
C12H15NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
24547 |
3-[4-acetyl-3-(allyloxy)phenyl]-2-pentanone
|
|
C16H20O3 |
详情 |
详情
|
(IV) |
24548 |
N-(4-acetyl-2-allyl-3-hydroxyphenyl)-N-ethylacetamide
|
69049-64-5 |
C15H19NO3 |
详情 | 详情
|
(V) |
24549 |
N-(4-acetyl-3-hydroxy-2-propylphenyl)-N-ethylacetamide
|
|
C15H21NO3 |
详情 |
详情
|
(VI) |
24550 |
1-[4-(ethylamino)-2-hydroxy-3-propylphenyl]-1-ethanone
|
69049-68-9 |
C13H19NO2 |
详情 | 详情
|
(VII) |
24551 |
Dimethyl acetylenedicarboxylate; Dimethyl 2-butynedioate;Acetylenedicarboxylic acid dimethyl ester |
762-42-5 |
C6H6O4 |
详情 | 详情
|
(VIII) |
24552 |
dimethyl (Z)-2-[4-acetyl(ethyl)-3-hydroxy-2-propylanilino]-2-butenedioate
|
77941-04-9 |
C19H25NO6 |
详情 | 详情
|
(IX) |
24553 |
methyl 6-acetyl-1-ethyl-7-hydroxy-4-oxo-8-propyl-1,4-dihydro-2-quinolinecarboxylate
|
69049-70-3 |
C18H21NO5 |
详情 | 详情
|
(X) |
24554 |
diethyl 9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylate
|
69049-72-5 |
C23H25NO7 |
详情 | 详情
|
合成路线4
该中间体在本合成路线中的序号:
(II) By condensation of 2-(2,6-dichloroanilino)-2-imidazoline (I) with allyl bromide (II) by means of pyridine in refluxing methanol.
【1】
Staehle, H.; et al.; US 3708485 .
|
【2】
Castaner, J.; Hopkins, S.J.; Alinidine. Drugs Fut 1980, 5, 1, 11.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39118 |
N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine; N-(2,6-dichlorophenyl)-N-(4,5-dihydro-1H-imidazol-2-yl)amine
|
|
C9H9Cl2N3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VII) The condensation of 7-amino-3-bromomethyl-3-cephem-4-carboxylic acid tert-butyl ester 1-oxide (I) with 2-(2-tritylamino-4-thiazolyl)-2-[2-(tert-butoxycarbonyl)-2-propyloxyimino]acetic acid (II) by means of dicyclohexylcarbodiimide in CH2Cl2 gives the corresponding amide (III), which is treated with N-allyl-pyridine-2-thione (IV) in dimethylacetamide yielding the pyridinium salt (V). Finally, this compound is deprotected by a treatment with HCl in formic acid.
The thione (IV) is prepared as follows: The reaction of 2-bromopyridine (VI) with allyl bromide (VII) in acetone gives N-allyl-2-bromopyridinium bromide (VIII), which is then treated with potassium hydrosulfide in water.
【1】
Labeeuw, B.; Salhi, A. (Sanofi-Synthelabo); Derivatives of pyridinium thiomethyl cephalosporins. EP 0088853; FR 2516515; JP 58090590; US 4593022 .
|
【2】
Serradell, M.N.; Matthews, R.; Castaner, J.; Burnie, J.; CM-40874. Drugs Fut 1985, 10, 3, 193.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29048 |
tert-butyl 7-amino-3-(bromomethyl)-5,8-dioxo-5lambda(4)-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C12H17BrN2O4S |
详情 |
详情
|
(II) |
29047 |
2-[[2-(tert-butoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetic acid
|
|
C32H33N3O5S |
详情 |
详情
|
(III) |
29049 |
tert-butyl 3-(bromomethyl)-7-([2-[[2-(tert-butoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetyl]amino)-5,8-dioxo-5lambda(4)-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
|
|
C44H48BrN5O8S2 |
详情 |
详情
|
(IV) |
29050 |
1-allyl-2(1H)-pyridinethione
|
|
C8H9NS |
详情 |
详情
|
(V) |
29051 |
1-allyl-2-([[2-(tert-butoxycarbonyl)-7-([2-[[2-(tert-butoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-[2-(tritylamino)-1,3-thiazol-4-yl]acetyl]amino)-5,8-dioxo-5lambda(4)-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]sulfanyl)pyridinium bromide
|
|
C52H57BrN6O8S3 |
详情 |
详情
|
(VI) |
29052 |
2-Bromopyridine;α-bromopyridine;α-bromoazine |
109-04-6 |
C5H4BrN |
详情 | 详情
|
(VII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VIII) |
29053 |
1-allyl-2-bromopyridinium bromide
|
|
C8H9Br2N |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) The Keck's enantioselective allylation of dodecanal (I) with allyl bromide (II) employing a catalytic amount of (R)-BINOL and titanium tetraisopropoxide furnishes the chiral alcohol (III), which is esterified with acryloyl chloride (IV), TEA and DMAP to give the acrylate (V). The olefin metathesis of (V) by means of Grubbs' catalyst and Ti(O-iPr)4 in refluxing dichloromethane yields the dihydropyranone (VI), which is epoxidized with H2O2 and NaOH to afford the chiral epoxide (VII). The reductive cleavage of (VII) with diphenyl diselenide and NaBH4 gives the chiral tetrahydropyranone (VIII), which is silylated with Tbdms-Cl and DIEA, yielding the silyl ether (IX). Opening of the lactone ring of (IX) with TEA and methanol affords the hydroxyester (X), which is treated with dihydropyran and PPTS to provide the tetrahydropyranyl ether (XI). The desilylation of (XI) with TBAF in THF gives the beta-hydroxyester (XII), which is alkylated with hexyl iodide and LDA in THF, yielding the adduct (XIII). The cyclization of (XIII) by hydrolysis with LiOH, followed by treatment with Ph-SO2-Cl, affords the beta-lactone (XIV), which is treated with PPTS to eliminate the tetrahydropyranyl-protecting group and yield the secondary alcohol (XV). The esterification of (XV) with N-(benzyloxycarbonyl)-L-leucine (XVI) by means of DCC and DMAP affords the leucinate (XVII), which is deprotected with H2 over Pd/C, affording (XVIII) with a free amino group that is formylated with acetic formic mixed anhydride to furnish the target (-)-tetrahydrolipstatin.
【1】
Ghosh, A.K.; Liu, C.; A stereoselective synthesis of (-)-tetrahydrolipstatin. Chem Commun (London) 1999, 1743.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11082 |
Lauraldehyde; Dodecanal
|
112-54-9 |
C12H24O |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
11089 |
(4S)-1-Pentadecen-4-ol
|
|
C15H30O |
详情 |
详情
|
(IV) |
11577 |
Acryloyl chloride; Acrylyl chloride;2-Propenoyl chloride |
814-68-6 |
C3H3ClO |
详情 | 详情
|
(V) |
49595 |
(1S)-1-undecyl-3-butenyl acrylate
|
|
C18H32O2 |
详情 |
详情
|
(VI) |
49596 |
(6S)-6-undecyl-5,6-dihydro-2H-pyran-2-one
|
|
C16H28O2 |
详情 |
详情
|
(VII) |
49597 |
(1S,4S,6S)-4-undecyl-3,7-dioxabicyclo[4.1.0]heptan-2-one
|
|
C16H28O3 |
详情 |
详情
|
(VIII) |
49598 |
(4S,6S)-4-hydroxy-6-undecyltetrahydro-2H-pyran-2-one
|
|
C16H30O3 |
详情 |
详情
|
(IX) |
49599 |
(4S,6S)-4-[[tert-butyl(dimethyl)silyl]oxy]-6-undecyltetrahydro-2H-pyran-2-one
|
|
C22H44O3Si |
详情 |
详情
|
(X) |
49600 |
methyl (3S,5S)-3-[[tert-butyl(dimethyl)silyl]oxy]-5-hydroxyhexadecanoate
|
|
C23H48O4Si |
详情 |
详情
|
(XI) |
49601 |
methyl (3S,5S)-3-[[tert-butyl(dimethyl)silyl]oxy]-5-(tetrahydro-2H-pyran-2-yloxy)hexadecanoate
|
|
C28H56O5Si |
详情 |
详情
|
(XII) |
49602 |
methyl (3S,5S)-3-hydroxy-5-(tetrahydro-2H-pyran-2-yloxy)hexadecanoate
|
|
C22H42O5 |
详情 |
详情
|
(XIII) |
49603 |
methyl (2S,3S,5S)-2-hexyl-3-hydroxy-5-(tetrahydro-2H-pyran-2-yloxy)hexadecanoate
|
|
C28H54O5 |
详情 |
详情
|
(XIV) |
49604 |
(3S,4S)-3-hexyl-4-[(2S)-2-(tetrahydro-2H-pyran-2-yloxy)tridecyl]-2-oxetanone
|
|
C27H50O4 |
详情 |
详情
|
(XV) |
49605 |
(3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone
|
|
C22H42O3 |
详情 |
详情
|
(XVI) |
22838 |
(2S)-2-[[(benzyloxy)carbonyl]amino]-4-methylpentanoic acid
|
|
C14H19NO4 |
详情 |
详情
|
(XVII) |
49606 |
(1S)-1-[[(2S,3S)-3-hexyl-4-oxooxetanyl]methyl]dodecyl (2S)-2-[[(benzyloxy)carbonyl]amino]-4-methylpentanoate
|
|
C36H59NO6 |
详情 |
详情
|
(XVIII) |
49607 |
(1S)-1-[[(2S,3S)-3-hexyl-4-oxooxetanyl]methyl]dodecyl (2S)-2-amino-4-methylpentanoate
|
|
C28H53NO4 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The chiral amine intermediate (XV) has been obtained as follows: The alkylation of 4-fluorophenol (I) with allyl bromide (II) and K2CO3 gives the allyl ether (III), which by thermal rearrangement at 210 C yields 2-allyl-4-fluorophenol (IV). The silylation of (IV) with TBDMS-Cl and imidazole affords the silyl ether (V), which is submitted to hydroboration with BH3 and H2O2 to provide the propanol (VI). The oxidation of (VI) with Dess Martin periodinane (DMP) gives the aldehyde (VII), which is condensed with the phosphorane (VIII) to yield the pentenoic ester (IX). The reduction of (IX) with DIBAL affords the unsaturated alcohol, which is desilylated with TBAF in THF furnishing the diol (XI). The treatment of (XI) under the Sharpless asymmetric epoxidation conditions ((-)-DET and titanium tetraisopropoxide) gives, after cyclization with NaOH, 1(R)-(6-fluoro-3,4-dihydro-2H-1-benzopyran-2(S)-yl)-1,2-ethanediol (XII), which is selectively tosylated with TsCl and pyridine yielding the monotosylate (XIII). The reaction of (XIII) with sodium azide in DMF affords the azide (XIV), which is reduced to the corresponding amine (XV) with H2 over Pd/C in ethanol.
【1】
Chandrasekhar, S.; Reddy, M.V.; Enantioselective total synthesis of the antihypertensive agent (S,R,R,R)-nebivolol. Tetrahedron 2000, 56, 34, 6339.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19639 |
4-fluorophenol
|
371-41-5 |
C6H5FO |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
40848 |
1-(allyloxy)-4-fluorobenzene; allyl 4-fluorophenyl ether
|
|
C9H9FO |
详情 |
详情
|
(IV) |
40849 |
2-allyl-4-fluorophenol
|
|
C9H9FO |
详情 |
详情
|
(V) |
40850 |
(2-allyl-4-fluorophenoxy)(tert-butyl)dimethylsilane; 2-allyl-4-fluorophenyl tert-butyl(dimethyl)silyl ether
|
|
C15H23FOSi |
详情 |
详情
|
(VI) |
40851 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-1-propanol
|
|
C15H25FO2Si |
详情 |
详情
|
(VII) |
40852 |
3-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)propanal
|
|
C15H23FO2Si |
详情 |
详情
|
(VIII) |
14182 |
ethyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate; (Carbethoxymethylene)triphenylphosphorane
|
1099-45-2 |
C22H21O2P |
详情 | 详情
|
(IX) |
40853 |
ethyl (E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-pentenoate
|
|
C19H29FO3Si |
详情 |
详情
|
(X) |
40854 |
(E)-5-(2-[[tert-butyl(dimethyl)silyl]oxy]-5-fluorophenyl)-2-penten-1-ol
|
|
C17H27FO2Si |
详情 |
详情
|
(XI) |
40855 |
4-fluoro-2-[(E)-5-hydroxy-3-pentenyl]phenol
|
|
C11H13FO2 |
详情 |
详情
|
(XII) |
40856 |
(1R)-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1,2-ethanediol
|
|
C11H13FO3 |
详情 |
详情
|
(XIII) |
40857 |
(2R)-2-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-2-hydroxyethyl 4-methylbenzenesulfonate
|
|
C18H19FO5S |
详情 |
详情
|
(XIV) |
40858 |
(1R)-2-azido-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H12FN3O2 |
详情 |
详情
|
(XV) |
40859 |
(1R)-2-amino-1-[(2S)-6-fluoro-3,4-dihydro-2H-chromen-2-yl]-1-ethanol
|
|
C11H14FNO2 |
详情 |
详情
|
合成路线8
该中间体在本合成路线中的序号:
(XIX) Synthesis of the aromatic intermediate (XXXIII): The esterification of the 5-hydroxyisophthalic acid (XVII) with SOCl2 and methanol gives the dimethyl ester (XVIII), which is treated with allyl bromide (XIX) and K2CO3 in refluxing acetone to yield the allyl ether (XX). The thermal isomerization of (XX) affords 4-allyl-5-hydroxyisophthalic acid dimethyl ester (XXI), which is treated with Bn-Br and K2CO3 in refluxing acetone to provide the benzyl ether (XXII). The hydrolysis of the ester groups of (XXII) with NaOH in THF gives the isophthalic acid (XXIII), which by reaction with Br2 and NaHCO3 yields the lactone (XXIV). The reduction of the carboxyl group of (XXIV) with isopropyl chloroformate and NaBH4 in THF/water affords the carbinol (XXV), which is protected with Bom-Cl and DIEA, providing compound (XXVI). The debromination of (XXVI) with Zn and NH4Cl in ethanol/water gives the 2-allylbenzoic acid (XXVII), which by a Curtius rearrangement with DPPA and TEA in refluxing tert-butanol yields the aryl carbamate (XXVIII). The reaction of (XXVIII) with OsO4 and NaIO4 in dioxane/water affords the indoline derivative (XXIX), which is treated with NaBH4 in EtOH to afford the 2-phenylethanol derivative (XXX). The reaction of (XXX) with Tbdms-Cl, TEA and DMAP provides the silyl ether (XXXI), which is treated with Tbdms-OTf and pyridine to give the aniline derivative (XXXII). Finally, this amine is reprotected with Alloc-Cl and NaHCO3 to yield the desired intermediate (XXXIII).
【1】
Katoh, T.; Terashima, S.; Total synthesis of antitumor antibiotic FR900482. Yuki Gosei Kagaku Kyokaishi 1997, 55, 11, 946.
|
【2】
Yoshino, T.; et al.; Total synthesis of an enantiomeric pair of FR900482. 2. Syntheses of the aromatic and the optically active aliphatic segments. Tetrahedron 1997, 53, 30, 10239.
|
【3】
Yoshino, T.; et al.; Total synthesis of natural (+)-FR900482. 2. Efficient syntheses of the aromatic and the optically active aliphatic fragments. Tetrahedron Lett 1996, 37, 20, 3475.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVII) |
47387 |
5-hydroxyisophthalic acid
|
618-83-7 |
C8H6O5 |
详情 | 详情
|
(XVIII) |
31197 |
dimethyl 5-hydroxyisophthalate
|
13036-02-7 |
C10H10O5 |
详情 | 详情
|
(XIX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XX) |
47388 |
dimethyl 5-(allyloxy)isophthalate
|
|
C13H14O5 |
详情 |
详情
|
(XXI) |
47389 |
dimethyl 4-allyl-5-hydroxyisophthalate
|
|
C13H14O5 |
详情 |
详情
|
(XXII) |
47390 |
dimethyl 4-allyl-5-(benzyloxy)isophthalate
|
|
C20H20O5 |
详情 |
详情
|
(XXIII) |
47391 |
4-allyl-5-(benzyloxy)isophthalic acid
|
|
C18H16O5 |
详情 |
详情
|
(XXIV) |
47392 |
5-(benzyloxy)-3-(bromomethyl)-1-oxo-3,4-dihydro-1H-isochromene-7-carboxylic acid
|
|
C18H15BrO5 |
详情 |
详情
|
(XXV) |
47393 |
5-(benzyloxy)-3-(bromomethyl)-7-(hydroxymethyl)-3,4-dihydro-1H-isochromen-1-one
|
|
C18H17BrO4 |
详情 |
详情
|
(XXVI) |
47394 |
5-(benzyloxy)-7-[[(benzyloxy)methoxy]methyl]-3-(bromomethyl)-3,4-dihydro-1H-isochromen-1-one
|
|
C26H25BrO5 |
详情 |
详情
|
(XXVII) |
47395 |
2-allyl-3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]benzoic acid
|
|
C26H26O5 |
详情 |
详情
|
(XXVIII) |
47396 |
tert-butyl 2-allyl-3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]phenylcarbamate
|
|
C30H35NO5 |
详情 |
详情
|
(XXIX) |
47397 |
tert-butyl 4-(benzyloxy)-6-[[(benzyloxy)methoxy]methyl]-2-hydroxy-1-indolinecarboxylate
|
|
C29H33NO6 |
详情 |
详情
|
(XXX) |
47398 |
tert-butyl 3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-2-(2-hydroxyethyl)phenylcarbamate
|
|
C29H35NO6 |
详情 |
详情
|
(XXXI) |
47399 |
tert-butyl 3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-2-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)phenylcarbamate
|
|
C35H49NO6Si |
详情 |
详情
|
(XXXII) |
47400 |
3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-2-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)phenylamine; 3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-2-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)aniline
|
|
C30H41NO4Si |
详情 |
详情
|
(XXXIII) |
47401 |
allyl 3-(benzyloxy)-5-[[(benzyloxy)methoxy]methyl]-2-(2-[[tert-butyl(dimethyl)silyl]oxy]ethyl)phenylcarbamate
|
|
C34H45NO6Si |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(II) The reaction of N-isopropylethanolamine (I) with allyl bromide (II) in THF gives the secondary amine (III), which is treated with SOCl2 in dichloromethane to yield the chloroethylamine (IV). The condensation of (IV) with 2-(2-chlorophenyl)-4-(1-piperidinyl)butyronitrile (V) by means of KOH in DMSO affords the adduct (VI), whose nitrile group is hydrolyzed with H2SO4 to provide the corresponding amide (VII). The elimination of the allyl group of (VII) by means of a Rh catalyst and 1,4-diazabicyclo[2,2,2]octane (DABCO) in refluxing aqueous ethanol gives the secondary amine (VIII), which is finally acetylated with Ac2O in ethyl acetate to yield the target diamide.
【1】
Awasthi, A.K.; Paul, K.; A new and improved synthesis of bidisomide. Org Process Res Dev 2001, 5, 5, 528.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
51925 |
2-(Isopropylamino)ethanol; 2-(iso-Propylamino)ethanol; N-Isopropylethanolamine
|
109-56-8 |
C5H13NO |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
51926 |
2-[allyl(isopropyl)amino]-1-ethanol
|
|
C8H17NO |
详情 |
详情
|
(IV) |
51927 |
N-(2-chloroethyl)-N-isopropyl-2-propen-1-amine; N-allyl-N-(2-chloroethyl)-N-isopropylamine
|
|
C8H16ClN |
详情 |
详情
|
(V) |
11434 |
2-(2-Chlorophenyl)-4-piperidinobutanenitrile
|
|
C15H19ClN2 |
详情 |
详情
|
(VI) |
51928 |
4-[allyl(isopropyl)amino]-2-(2-chlorophenyl)-2-[2-(1-piperidinyl)ethyl]butanenitrile
|
|
C23H34ClN3 |
详情 |
详情
|
(VII) |
51929 |
4-[allyl(isopropyl)amino]-2-(2-chlorophenyl)-2-[2-(1-piperidinyl)ethyl]butanamide
|
|
C23H36ClN3O |
详情 |
详情
|
(VIII) |
11438 |
2-(2-Chlorophenyl)-4-(isopropylamino)-2-(2-piperidinoethyl)butanamide
|
|
C20H32ClN3O |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(XXIII) 2) (2R,3S,5S(2'S,4'R))-5-(2-(iodomethyl)tetrahydrofuran-4-yl)-5-(4-methoxy benzyloxy)-2-methyl-3-(triisopropylsilyloxy)pentanal (XXXII). The regioselective reduction of methyl 5-(4-methoxybenzyloxy)-3-oxopentanoate (XXI) with H2 over Ru2Cl4((S)-BINAP)2(C2H5)3N in methanol gives the 3(S)-hydroxy derivative (XXII), which is condensed with ally bromide (XXIII) by means of lithium diisopropylamide THF-HMPA to yield the ally derivative (XXIV). The reduction of (XXIV) with LiAlH4 in THF affords the diol (XXV), which is cyclized to the ketal (XXVI) by means of DDQ in dichloromethane. The reaction of (XXVI) first with N-iodosuccinimide (NIS) and then with diisobutylaluminum hydride affords (3S(2'S,4'R))-3-(2-iodomethyl)tetrahydrofuran-4-yl)-3-(4-methoxybenzyl)-1-propanol (XXVII), which is oxidized to the corresponding aldehyde (XXVIII) by means of oxalyl chloride in dichloromethane. The condensation of (XXVIII) with 2(E)-butenyltriphenylstannane (XXIX) by means of boron trifluoride ethearate in dichloromethane gives the alcohol (XXX), which is protected with TIPS trifluoromethanesulfonate in dichloromethane yielding the fully protected diol (XXXI). Finally, the double bond of (XXXI) is oxidized with ozone in methanol - dichloromethane yielding the second building fragment (XXXII).
【1】
Smith, D.B.; Schreiber, S.L.; Ragan, J.A.; Uehling, D.E.; Nakatsuka, M.; Sammakia, T.; Total synthesis of FK506 and an FKBP probe reagent, (C8,C9-13C2)-FK5. J Am Chem Soc 1990, 112, 14, 5583.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXI) |
11461 |
methyl 6-(4-methoxyphenyl)-3-oxohexanoate
|
|
C14H18O4 |
详情 |
详情
|
(XXII) |
11462 |
methyl (3S)-3-hydroxy-6-(4-methoxyphenyl)hexanoate
|
|
C14H20O4 |
详情 |
详情
|
(XXIII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXIV) |
11464 |
methyl (2S)-2-[(1S)-1-hydroxy-4-(4-methoxyphenyl)butyl]-4-pentenoate
|
|
C17H24O4 |
详情 |
详情
|
(XXV) |
11465 |
(2R,3S)-2-Allyl-5-[(4-methoxybenzyl)oxy]-1,3-pentanediol
|
|
C16H24O4 |
详情 |
详情
|
(XXVI) |
11466 |
(2R)-2-[(2S,4S)-2-(4-Methoxyphenyl)-1,3-dioxan-4-yl]-4-penten-1-ol
|
|
C16H22O4 |
详情 |
详情
|
(XXVII) |
11467 |
(3S)-3-[(3S,5S)-5-(Iodomethyl)tetrahydro-3-furanyl]-4-(4-methoxyphenyl)-1-butanol
|
|
C16H23IO3 |
详情 |
详情
|
(XXVIII) |
11468 |
(3S)-3-[(3S,5S)-5-(Iodomethyl)tetrahydro-3-furanyl]-4-(4-methoxyphenyl)butanal
|
|
C16H21IO3 |
详情 |
详情
|
(XXIX) |
11469 |
(E)-2-Butenyl(triphenyl)stannane
|
|
C22H22Sn |
详情 |
详情
|
(XXX) |
11470 |
(3S,4S,6S)-6-[(3S,5S)-5-(Iodomethyl)tetrahydro-3-furanyl]-7-(4-methoxyphenyl)-3-methyl-1-hepten-4-ol
|
|
C20H29IO3 |
详情 |
详情
|
(XXXI) |
11481 |
([(1S,2S)-1-[(2S)-2-[(3S,5S)-5-(Iodomethyl)tetrahydro-3-furanyl]-3-(4-methoxyphenyl)propyl]-2-methyl-3-butenyl]oxy)(triisopropyl)silane; (1S,2S)-1-[(2S)-2-[(3S,5S)-5-(Iodomethyl)tetrahydro-3-furanyl]-3-(4-methoxyphenyl)propyl]-2-methyl-3-butenyl triisopropylsilyl ether |
|
C29H49IO3Si |
详情 |
详情
|
(XXXIII) |
11471 |
1,4-Pentadien-3-ol
|
922-65-6 |
C5H8O |
详情 | 详情
|
(XXXIV) |
11472 |
(1S)-1-[(2R)Oxiranyl]-2-propen-1-ol
|
|
C5H8O2 |
详情 |
详情
|
(XXXV) |
11473 |
(2S)-2-[(1S)-1-(4-Methoxybenzyl)-2-propenyl]oxirane; Methyl 4-[(2S)-2-[(2S)oxiranyl]-3-butenyl]phenyl ether
|
|
C13H16O2 |
详情 |
详情
|
(XXXVI) |
11474 |
(3S,4R)-7-Ethoxy-4-methoxy-3-(4-methoxybenzyl)-1-hepten-6-yne; 4-[(2S,3R)-6-Ethoxy-3-methoxy-2-vinyl-5-hexynyl]phenyl methyl ether
|
|
C18H24O3 |
详情 |
详情
|
(XXXVII) |
11475 |
ethyl (4R,5S)-5-hydroxy-4-methoxy-6-heptenoate
|
|
C10H18O4 |
详情 |
详情
|
(XXXVIII) |
11476 |
(5R,6S)-5-Methoxy-6-vinyltetrahydro-2H-pyran-2-one
|
|
C8H12O3 |
详情 |
详情
|
(XXXIX) |
11585 |
methyl (1R,5R)-5-methoxy-3-cyclohexene-1-carboxylate
|
|
C9H14O3 |
详情 |
详情
|
(XL) |
11586 |
methyl (1R,3R,4R)-4-hydroxy-3-methoxycyclohexanecarboxylate
|
|
C9H16O4 |
详情 |
详情
|
(XLI) |
11588 |
methyl (1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexanecarboxylate
|
|
C18H36O4Si |
详情 |
详情
|
(XLII) |
11480 |
[(1R,3R,4R)-3-Methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl]methanol
|
|
C17H36O3Si |
详情 |
详情
|
(XLIII) |
11532 |
(1R,3R,4R)-3-Methoxy-4-[(triisopropylsilyl)oxy]cyclohexanecarbaldehyde
|
|
C17H34O3Si |
详情 |
详情
|
合成路线11
该中间体在本合成路线中的序号:
(XXXV) The asymmetric reduction of 5-(4-methoxybenzyloxy)-3-oxopentanoic acid methyl ester (XXXIII) with H2 over a chiral Ru catalyst gives the chiral hydroxyester (XXXIV), which is alkylated by means of allyl bromide (XXXV) and LDA to yield the chiral 2-allyl-3-hydroxypentanoic ester (XXXVI). The reduction of (XXXVI) with LiAlH4, and then with DDQ affords the 1,3-dioxan-4-ylethanol (XXXVII), which is treated with NIS, NaHCO3 and reduced with DIBAL to afford the iodomethyl tetrahydrofuran (XXXVIII). The oxidation of the primary OH group of (XXXVIII) with oxalyl chloride provides the carbaldehyde (XXXIX), which is condensed with the propenylstannane (XL) by means of BF3/Et2O in dichloromethane to give the unsaturated alcohol (XLI). The protection of the OH group of (XLI) with TipsOTf yields the unsaturated silyl ether (XLII), which is ozonolyzed by means of O3, pyridine and Me2S to afford the carbaldehyde (XLIII). The condensation of (XLIII) with the chiral intermediate 2-bromovinyl cyclohexane (XVIII) by means of tBuLi and MgBr2 provides the alcohol (XLIV), which is esterified with 1-(tert-butoxycarbonyl)piperidine-2(S)-carboxylic acid (XLV) by means of DCC to give the expected ester (XLVI). The reaction of (XLVI) with Zn and NH4Cl yields the chiral alpha-allyl alcohol (XLVII), which is oxidized by means of oxalyl chloride to afford the corresponding carbaldehyde (XLVIII).
【1】
Ragan, J.A.; The total synthesis of FK506 and an FKBP probe reagent, (C8,C9-13C2)-FK506. Diss Abstr Int B - Sci Eng 1991, 51, 8, 3849.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XVIII) |
11485 |
([(1R,2R,4R)-4-[(E)-2-Bromo-1-propenyl]-2-methoxycyclohexyl]oxy)(triisopropyl)silane; (1R,2R,4R)-4-[(E)-2-Bromo-1-propenyl]-2-methoxycyclohexyl triisopropylsilyl ether
|
|
C19H37BrO2Si |
详情 |
详情
|
(XXXIII) |
57260 |
methyl 5-[(4-methoxybenzyl)oxy]-3-oxopentanoate
|
|
C14H18O5 |
详情 |
详情
|
(XXXIV) |
57261 |
methyl (3S)-3-hydroxy-5-[(4-methoxybenzyl)oxy]pentanoate
|
|
C14H20O5 |
详情 |
详情
|
(XXXV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXXVI) |
57262 |
methyl (2S)-2-{(1S)-1-hydroxy-3-[(4-methoxybenzyl)oxy]propyl}-4-pentenoate
|
|
C17H24O5 |
详情 |
详情
|
(XXXVII) |
11466 |
(2R)-2-[(2S,4S)-2-(4-Methoxyphenyl)-1,3-dioxan-4-yl]-4-penten-1-ol
|
|
C16H22O4 |
详情 |
详情
|
(XXXVIII) |
57263 |
(3S)-3-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-3-[(4-methoxybenzyl)oxy]-1-propanol
|
|
C16H23IO4 |
详情 |
详情
|
(XXXIX) |
57264 |
(3S)-3-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-3-[(4-methoxybenzyl)oxy]propanal
|
|
C16H21IO4 |
详情 |
详情
|
(XL) |
11469 |
(E)-2-Butenyl(triphenyl)stannane
|
|
C22H22Sn |
详情 |
详情
|
(XLI) |
57265 |
(1S,3S,4S)-1-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-1-[(4-methoxybenzyl)oxy]-4-methyl-5-hexen-3-ol
|
|
C20H29IO4 |
详情 |
详情
|
(XLII) |
57266 |
(1S,2S)-1-{(2S)-2-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-2-[(4-methoxybenzyl)oxy]ethyl}-2-methyl-3-butenyl triisopropylsilyl ether; [((1S,2S)-1-{(2S)-2-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-2-[(4-methoxybenzyl)oxy]ethyl}-2-methyl-3-butenyl)oxy](triisopropyl)silane |
|
C29H49IO4Si |
详情 |
详情
|
(XLIII) |
57267 |
(2R,3S,5S)-5-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-5-[(4-methoxybenzyl)oxy]-2-methyl-3-[(triisopropylsilyl)oxy]pentanal
|
|
C28H47IO5Si |
详情 |
详情
|
(XLIV) |
57268 |
(E,3S,4S,5S,7S)-7-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-7-[(4-methoxybenzyl)oxy]-1-{(1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2,4-dimethyl-5-[(triisopropylsilyl)oxy]-1-hepten-3-ol
|
|
C47H85IO7Si2 |
详情 |
详情
|
(XLV) |
11487 |
(2S)-1-(tert-Butoxycarbonyl)hexahydro-2-pyridinecarboxylic acid
|
|
C11H19NO4 |
详情 |
详情
|
(XLVI) |
57269 |
1-(tert-butyl) 2-((1S,2E)-1-{(1S,2S,4S)-4-[(3R,5S)-5-(iodomethyl)tetrahydro-3-furanyl]-4-[(4-methoxybenzyl)oxy]-1-methyl-2-[(triisopropylsilyl)oxy]butyl}-3-{(1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-2-methyl-2-propenyl) (2S)-1,2-piperidinedicarboxylate |
|
C58H102INO10Si2 |
详情 |
详情
|
(XLVII) |
57270 |
1-(tert-butyl) 2-{(1S,2S,3S,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxybenzyl)oxy]-1-((E)-2-{(1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-1-methylethenyl)-2-methyl-3-[(triisopropylsilyl)oxy]-8-nonenyl} (2S)-1,2-piperidinedicarboxylate
|
|
C58H103NO10Si2 |
详情 |
详情
|
(XLVIII) |
57271 |
1-(tert-butyl) 2-{(1S,2S,3S,5S,6S)-6-formyl-5-[(4-methoxybenzyl)oxy]-1-((E)-2-{(1R,3R,4R)-3-methoxy-4-[(triisopropylsilyl)oxy]cyclohexyl}-1-methylethenyl)-2-methyl-3-[(triisopropylsilyl)oxy]-8-nonenyl} (2S)-1,2-piperidinedicarboxylate
|
|
C58H101NO10Si2 |
详情 |
详情
|
合成路线12
该中间体在本合成路线中的序号:
(IV) A formal total synthesis of vancomycin has been reported. The known aglycon of vancomycin (I) was protected at the amino group as the allyloxy- carbonyl derivative (III) using allyloxycarbonyl succinimide (II). Then, carboxylate group was converted to allyl ester (V) with allyl bromide (IV) and KHCO3.
【1】
Thompson, C.; et al.; Synthesis of vancomycin from the aglycon. J Am Chem Soc 1999, 121, 6, 1237.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25729 |
(1S,2R,18R,19R,22S,25R,28R,40R)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,50-hexahydroxy-19-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylic acid |
|
C53H52Cl2N8O17 |
详情 |
详情
|
(II) |
25730 |
allyl 2,5-dioxo-1-pyrrolidinecarboxylate
|
|
C8H9NO4 |
详情 |
详情
|
(III) |
25731 |
(1S,2R,18R,19R,22S,25R,28R,40R)-19-([(2R)-2-[[(allyloxy)carbonyl](methyl)amino]-4-methylpentanoyl]amino)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,50-hexahydroxy-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylic acid |
|
C57H56Cl2N8O19 |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
25732 |
allyl (1S,2R,18R,19R,22S,25R,28R,40R)-19-([(2R)-2-[[(allyloxy)carbonyl](methyl)amino]-4-methylpentanoyl]amino)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,50-hexahydroxy-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylate |
|
C60H60Cl2N8O19 |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(IV) Selective protection of the phenol group of (V) with p-methoxybenzyl chloride (VI) gave benzyl ether (VII), and the remaining phenol groups of (VII) were further alkylated with allyl bromide to afford (VIII).
【1】
Thompson, C.; et al.; Synthesis of vancomycin from the aglycon. J Am Chem Soc 1999, 121, 6, 1237.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
25732 |
allyl (1S,2R,18R,19R,22S,25R,28R,40R)-19-([(2R)-2-[[(allyloxy)carbonyl](methyl)amino]-4-methylpentanoyl]amino)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37,50-hexahydroxy-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylate |
|
C60H60Cl2N8O19 |
详情 |
详情
|
(VI) |
11910 |
4-Methoxybenzyl chloride; 1-(Chloromethyl)-4-methoxybenzene; alpha-Chloro-4-methoxytoluene; 4-(Chloromethyl)phenyl methyl ether
|
824-94-2 |
C8H9ClO |
详情 | 详情
|
(VII) |
25733 |
allyl (1S,2R,18R,19R,22S,25R,28R,40R)-19-([(2R)-2-[[(allyloxy)carbonyl](methyl)amino]-4-methylpentanoyl]amino)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-50-[(4-methoxybenzyl)oxy]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylate |
|
C68H68Cl2N8O20 |
详情 |
详情
|
(VIII) |
25734 |
allyl (1S,2R,18R,19R,22S,25R,28R,40R)-32,37-bis(allyloxy)-19-([(2R)-2-[[(allyloxy)carbonyl](methyl)amino]-4-methylpentanoyl]amino)-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18-dihydroxy-50-[(4-methoxybenzyl)oxy]-20,23,26,42,44-pentaoxo-35-(vinyloxy)-7,13-dioxa-21,24,27,41,43-pentaazaoctacyclo[26.14.2.2(3,6).2(14,17).1(8,12).1(29,33).0(10,25).0(34,39)]pentaconta-3,5,8(50),9,11,14,16,29(49),30,32,34,36,38,45,47-pentadecaene-40-carboxylate |
|
C76H78Cl2N8O20 |
详情 |
详情
|
合成路线14
该中间体在本合成路线中的序号:
(V) Several related syntheses for AA-193 have been reported:
1) The Friedel-Crafts' condensation of 2,5-dichlorophenol (I) with benzoyl chloride (II) by means of AlCl3 gives 2,5-dichloro-4-hydroxybenzophenone (III), which by reaction with hydroxylamine and KOH is converted to 5-chloro-6-hydroxy-3-phenylbenzisoxazole (IV). The condensation of (IV) with allyl bromide (V) by means of K2CO3 affords the 7-allyl derivative (VI), which is cyclized by means of N-bromosuccinimide and NaOH to 5-chloro-7-(hydroxymethyl)-3-phenyl-7,8-dihydrofuro[2,3-g]-1,2-benzisox azole (VII). Finally, this compound is oxidized to the final product with KMnO4 in refluxing dichloromethane.
2) The chlorination of 1,3-dimethoxybenzene (VIII) with SO2Cl2 gives 1-chloro-2,4-dimethoxybenzene (IX), which is condensed with benzoyl chloride (II) as before, yielding 5-chloro-2,4-dihydroxybenzophenone (X). Tosylation of (X) with tosyl chloride gives the corresponding ditosyl derivative (XI), which by reaction with hydroxylamine is converted to the oxime (XII). Finally, this compound is treated with KOH in order to cyclize to the benzisoxazole (IV).
3) The reaction of the benzisoxazole (IV) with formaldehyde and dimethylamine gives 5-chloro-7-(dimethylaminomethyl)-6-hydroxy-3-phenylbenzisoxazole (XIII), which is condensed and cyclized with the ylide (XIV) to yield the ethyl ester of the desired product (XV). Finally, this compound is hydrolyzed with NaOH.
【1】
Koga, H.; Kuromaru, K.; Ishizawa, T.; Aoki, B.; Sato, H.; Studies on uricosuric diuretics. V. Convenient and efficient synthesis of 2,3-dihydrobenzofuran derivatives. Chem Pharm Bull 1992, 40, 10, 2597.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11953 |
2,5-Dichlorophenol
|
583-78-8 |
C6H4Cl2O |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
11955 |
(2,5-Dichloro-4-hydroxyphenyl)(phenyl)methanone
|
|
C13H8Cl2O2 |
详情 |
详情
|
(IV) |
11945 |
5-Chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C13H8ClNO2 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
11950 |
7-Allyl-5-chloro-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H12ClNO2 |
详情 |
详情
|
(VII) |
11941 |
(5-Chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazol-7-yl)methanol
|
|
C16H12ClNO3 |
详情 |
详情
|
(VIII) |
11934 |
m-Dimethoxybenzene; 1,3-Dimethoxybenzene; 3-Methoxyphenyl methyl ether
|
151-10-0 |
C8H10O2 |
详情 | 详情
|
(IX) |
11942 |
1-Chloro-2,4-dimethoxybenzene; 2-Chloro-5-methoxyphenyl methyl ether
|
7051-13-0 |
C8H9ClO2 |
详情 | 详情
|
(X) |
11962 |
(5-Chloro-2,4-dihydroxyphenyl)(phenyl)methanone
|
|
C13H9ClO3 |
详情 |
详情
|
(XI) |
11963 |
2-benzoyl-4-chloro-5-[[(4-methylphenyl)sulfonyl]oxy]phenyl 4-methylbenzenesulfonate
|
|
C27H21ClO7S2 |
详情 |
详情
|
(XII) |
11964 |
4-chloro-2-[(hydroxyimino)(phenyl)methyl]-5-[[(4-methylphenyl)sulfonyl]oxy]phenyl 4-methylbenzenesulfonate
|
|
C27H22ClNO7S2 |
详情 |
详情
|
(XIII) |
11946 |
5-Chloro-7-[(dimethylamino)methyl]-3-phenyl-1,2-benzisoxazol-6-ol
|
|
C16H15ClN2O2 |
详情 |
详情
|
(XIV) |
11966 |
2-(Dimethylsulfonium)acetic acid ethyl ester inner salt
|
|
C6H12O2S |
详情 |
详情
|
(XV) |
11948 |
ethyl 5-chloro-3-phenyl-7,8-dihydrofuro[2,3-g][1,2]benzisoxazole-7-carboxylate
|
|
C18H14ClNO4 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
The condensation of benzaldehyde (I) with malonic ester (II) by means of piperidine and acetic acid in benzene gives the unsaturated malonate (III), which by a selective ester cleavage and a Curtius rearrangement by means of N3-PO(OPh)2 and Et3N in toluene yields the unsaturated aminoester (IV). The reduction of (IV) with a chiral rhodium catalyst affords the chiral protected aminoester (V), which is cyclized to the bridged lactone (VI) by means of BF3 ethearate in dichloromethane. Reductive cleavage of the benzyloxycarbonyl benzyl ether groups of (VI) with H2 over Pd/C affords the free aminophenol (VII). The condensation of (VII) with aldehyde (VIII) (obtained by reduction of ester (IX) with DIBAL in dichloromethane) by means of KCN and AcOH, and after allylation of the aromatic OH group with allyl bromide, the intermediate (X) is obtained. The reduction of the lactone group of (X) with DIBAL, followed by desilylation with KF and cyclization with CH3SO3H affords the polycyclic compound (XI).
【1】
Gin, D.Y.; Corey, E.J.; Kania, R.S.; Enantioselective total synthesis of Ecteinascidin 743. J Am Chem Soc 1996, 118, 38, 9202-03.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
36449 |
6-(benzyloxy)-7-methyl-1,3-benzodioxole-5-carbaldehyde
|
|
C16H14O4 |
详情 |
详情
|
(II) |
36450 |
1-(2,2-dimethoxyethyl) 3-isobutyl malonate
|
|
C10H16O6 |
详情 |
详情
|
(III) |
36451 |
1-(2,2-dimethoxyethyl) 3-isobutyl 2-[(E)-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-5-yl]methylidene]malonate
|
|
C26H28O9 |
详情 |
详情
|
(IV) |
36452 |
2,2-dimethoxyethyl (Z)-2-[[(benzyloxy)carbonyl]amino]-3-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-5-yl]-2-propenoate
|
|
C30H31NO9 |
详情 |
详情
|
(V) |
36453 |
2,2-dimethoxyethyl (2S)-2-[[(benzyloxy)carbonyl]amino]-3-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-5-yl]propanoate
|
|
C30H33NO9 |
详情 |
详情
|
(VI) |
35454 |
2-phenyl-1H-imidazole-4-carbaldehyde
|
|
C10H8N2O |
详情 |
详情
|
(VII) |
36455 |
(1R,12S)-9-hydroxy-8-methyl-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-13-one
|
|
C13H13NO5 |
详情 |
详情
|
(VIII) |
36456 |
allyl (1S)-1-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)-2-oxoethylcarbamate
|
|
C26H45NO6Si2 |
详情 |
详情
|
(IX) |
36457 |
methyl (2S)-2-[[(allyloxy)carbonyl]amino]-3-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)propanoate
|
|
C27H47NO7Si2 |
详情 |
详情
|
(X) |
36458 |
allyl (1S,2R)-2-[(1R,12S)-9-(allyloxy)-8-methyl-13-oxo-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-16-yl]-1-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)-2-cyanoethylcarbamate
|
|
C43H61N3O10Si2 |
详情 |
详情
|
(XI) |
36459 |
allyl (1R,2S,13R,15R,16S)-5-(allyloxy)-15-cyano-20,22-dihydroxy-13-(hydroxymethyl)-21-methoxy-6-methyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C31H33N3O9 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(XLIV) The previously reported synthesis of 139221 (scheme 13922101a) has been investigated in order to find a more efficient, reproducible and economical route to work in the mutikilogram scale. Herein it is reported a new process which is simpler and proceeds with an overall yield of 54% (the original process, 35%).
The condensation of intermediate aminolactone (I) (scheme 13922101a, intermediate (VII)) with acid (XLII) (the acid derived from scheme 13922101a, intermediate ester (IX)) by means of 2-chloro-1,3-dimethylimidazolidinium hexafluorophosphate (CIP), and 1-hydroxy-7-azabenzotriazole (HOAt) in THF/dichloromethane gives the coupling product (XLIII), which is allylated with allyl bromide (XLIV) and Cs2CO3 in DMF yielding the allyl ether (XLV). The reduction of the lactone group of (XLV) with LiAlH2(OEt)2 in ethyl ether affords the lactol (XLVI), which is desilylated with KF in methanol to provide the phenolic compound (XLVII). The opening of the lactol ring of (XLVII) with simultaneous cyclization by means of Tf-OH in water/trifluoroethanol gives the hexacyclic intermediate (XLVIII), which is finally reductocondensed with KCN by means of LiAlH2(OEt)2 in THF to furnish the previously reported pentacyclic intermediate (XI) (scheme 13922101a, intermediate (XI)).
【1】
Martinez, E.J.; Corey, E.J.; A new, more efficient, and effective process for the synthesis of a key pentacyclic intermediate for production of ecteinascidin and phthalascidin antitumor agents. Org Lett 2000, 2, 7, 993.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VII) |
36455 |
(1R,12S)-9-hydroxy-8-methyl-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-13-one
|
|
C13H13NO5 |
详情 |
详情
|
(XI) |
36459 |
allyl (1R,2S,13R,15R,16S)-5-(allyloxy)-15-cyano-20,22-dihydroxy-13-(hydroxymethyl)-21-methoxy-6-methyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C31H33N3O9 |
详情 |
详情
|
(XLII) |
38116 |
(2S)-2-[[(allyloxy)carbonyl]amino]-3-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxyphenyl)propionic acid
|
|
C26H45NO7Si2 |
详情 |
详情
|
(XLIII) |
38117 |
allyl (1S)-1-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)-2-[(1R,12S)-9-hydroxy-8-methyl-13-oxo-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-16-yl]-2-oxoethylcarbamate
|
|
C39H56N2O11Si2 |
详情 |
详情
|
(XLIV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XLV) |
38118 |
allyl (1S)-2-[(1R,12S)-9-(allyloxy)-8-methyl-13-oxo-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-16-yl]-1-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)-2-oxoethylcarbamate
|
|
C42H60N2O11Si2 |
详情 |
详情
|
(XLVI) |
38119 |
allyl (1S)-2-[(1R,12S,13S)-9-(allyloxy)-13-hydroxy-8-methyl-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-16-yl]-1-(3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-4-methoxybenzyl)-2-oxoethylcarbamate
|
|
C42H62N2O11Si2 |
详情 |
详情
|
(XLVII) |
38120 |
allyl (1S)-2-[(1R,12S,13S)-9-(allyloxy)-13-hydroxy-8-methyl-4,6,14-trioxa-16-azatetracyclo[10.3.1.0(2,10).0(3,7)]hexadeca-2,7,9-trien-16-yl]-1-(3,5-dihydroxy-4-methoxybenzyl)-2-oxoethylcarbamate
|
|
C30H34N2O11 |
详情 |
详情
|
(XLVIII) |
38121 |
allyl (1R,2S,13R,16S)-5-(allyloxy)-20,22-dihydroxy-13-(hydroxymethyl)-21-methoxy-6-methyl-15-oxo-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C30H32N2O10 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(VI) Reaction of cyanosafracin B (I) with Boc2O in ethanol gives the amino-protected compound (II), which is treated with methoxymethyl bromide (MOM-Br), DIEA and DMAP in acetonitrile yielding the O-protected compound (III). The demethylation of (III) with NaOH in methanol affords the hydroxyquinone (IV), which is reduced with H2 over Pd/C and cyclized with bromochloromethane and Cs2CO3 in hot DMF to provide compound (V). Reaction of (V) with allyl bromide (VI) and Cs2CO3 in DMF gives the allyl ether (VII), which first is treated with TFA, phenyl isothiocyanate and HCl to yield the primary amine (VIII) and then protected at the free NH2 group with Troc-Cl and pyridine, to afford the amino protected compound (IX).
【1】
Cuevas, C.; Martin, M.J.; Perez, M.; et al.; Synthesis of ecteinascidin ET-743 and phathalascidin Pt-650 from cyanosafracin B. Org Lett 2000, 2, 16, 2545.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41775 |
(2S)-2-amino-N-[[(1S,2S,10R,12R,13R)-12-cyano-19-hydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0(2,11).0(4,9).0(15,20)]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl]propanamide
|
|
C29H35N5O6 |
详情 |
详情
|
(II) |
41776 |
tert-butyl (1S)-2-([[(1S,2S,10R,12R,13R)-12-cyano-19-hydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0(2,11).0(4,9).0(15,20)]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl]amino)-1-methyl-2-oxoethylcarbamate
|
|
C34H43N5O8 |
详情 |
详情
|
(III) |
41777 |
tert-butyl (1S)-2-([[(1S,2S,10R,12R,13R)-12-cyano-7,18-dimethoxy-19-(methoxymethoxy)-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0(2,11).0(4,9).0(15,20)]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl]amino)-1-methyl-2-oxoethylcarbamate
|
|
C36H47N5O9 |
详情 |
详情
|
(IV) |
41778 |
tert-butyl (1S)-2-([[(1S,2S,10R,12R,13R)-12-cyano-7-hydroxy-18-methoxy-19-(methoxymethoxy)-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.0(2,11).0(4,9).0(15,20)]henicosa-4(9),6,15,17,19-pentaen-10-yl]methyl]amino)-1-methyl-2-oxoethylcarba
|
|
C35H45N5O9 |
详情 |
详情
|
(V) |
41779 |
tert-butyl (1S)-2-([[(1S,2S,13R,15R,16R)-15-cyano-5-hydroxy-21-methoxy-22-(methoxymethoxy)-6,20,24-trimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaen-13-yl]methyl]amino)-1-methyl-2-oxoe
|
|
C36H47N5O9 |
详情 |
详情
|
(VI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VII) |
41780 |
tert-butyl (1S)-2-([[(1S,2S,13R,15R,16R)-5-(allyloxy)-15-cyano-21-methoxy-22-(methoxymethoxy)-6,20,24-trimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaen-13-yl]methyl]amino)-1-methyl-2-o
|
|
C39H51N5O9 |
详情 |
详情
|
(VIII) |
41781 |
(1S,2S,13R,15R,16R)-5-(allyloxy)-13-(aminomethyl)-22-hydroxy-21-methoxy-6,20,24-trimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaene-15-carbonitrile
|
|
C29H34N4O5 |
详情 |
详情
|
(IX) |
41782 |
2,2,2-trichloroethyl [(1S,2S,13R,15R,16R)-5-(allyloxy)-15-cyano-22-hydroxy-21-methoxy-6,20,24-trimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0(2,14).0(4,12).0(7,11).0(18,23)]tetracosa-4,6,11,18,20,22-hexaen-13-yl]methylcarbamate
|
|
C32H35Cl3N4O7 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(XL) The selective protection of the phenolic OH of (XXXIII) by means of benzyl bromide and K2CO3 in refluxing acetonitrile gives the benzyl ether (XXXIV), which is reductocyclized by means of Red-Al in THF to yield the oxazolidine (XXXV). The cleavage of the oxazolidine ring of (XXXV) by means of Tms-CN and BF3/Et2O in dichloromethane affords the hydroxy nitrile (XXXVI), which is treated with Ac2O and pyridine to provide the acetate (XXXVII). The desilylation of (XXXVII) with HF in acetonitrile, followed by oxidation with DMP gives the carbaldehyde (XXXVIII), which is submitted to hydrogenolysis of the benzyl ethers by means of H2 over Pd/C in THF, performing a simultaneous cyclization to yield the pentacyclic compound (XXXIX). The reaction of (XXXIX) with allyl bromide (XL) and DIEA affords the allyl ether (XLI), which is treated with K2CO3 in methanol to provide the carbinol (XLII). The reaction of (XLII) with L-cysteine derivative (XLIII) by means of WSCD and DMAP in dichloromethane gives the corresponding ester (XLIV).
【1】
Abe, M.; Yanagisawa, A.; Tohma, S.; Kan, T.; Fukuyama, T.; Endo, A.; Total synthesis of ecteinascidin 743. J Am Chem Soc 2002, 124, 23, 6552.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXIX) |
58637 |
2,2,2-trichloroethyl (1R,2R,3S,13R,15R,16S)-13-[(acetyloxy)methyl]-15-cyano-3,5,22-trihydroxy-21-methoxy-6,20-dimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0~2,14~.0~4,12~.0~7,11~.0~18,23~]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C30H30Cl3N3O10 |
详情 |
详情
|
(XXXIII) |
58631 |
2,2,2-trichloroethyl (1R,9S,12R)-3-(benzyloxy)-12-({[tert-butyl(dimethyl)silyl]oxy}methyl)-11-[(1R)-2-hydroxy-1-(6-hydroxy-7-methyl-1,3-benzodioxol-4-yl)ethyl]-4-methoxy-5-methyl-10-oxo-11,13-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-triene-13-carbox
|
|
C40H49Cl3N2O10Si |
详情 |
详情
|
(XXXIV) |
58632 |
2,2,2-trichloroethyl (1R,9S,12R)-3-(benzyloxy)-11-{(1R)-1-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-4-yl]-2-hydroxyethyl}-12-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4-methoxy-5-methyl-10-oxo-11,13-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-triene-13-ca
|
|
C47H55Cl3N2O10Si |
详情 |
详情
|
(XXXV) |
58633 |
2,2,2-trichloroethyl (1R,9S,10S,13R,15R)-3-(benzyloxy)-13-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-4-yl]-15-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4-methoxy-5-methyl-11-oxa-14,16-diazatetracyclo[7.6.1.0~2,7~.0~10,14~]hexadeca-2,4,6-triene-16-carbox
|
|
C47H55Cl3N2O9Si |
详情 |
详情
|
(XXXVI) |
58634 |
2,2,2-trichloroethyl (1R,9S,10R,12R)-3-(benzyloxy)-11-{(1R)-1-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-4-yl]-2-hydroxyethyl}-12-({[tert-butyl(dimethyl)silyl]oxy}methyl)-10-cyano-4-methoxy-5-methyl-11,13-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-triene
|
|
C48H56Cl3N3O9Si |
详情 |
详情
|
(XXXVII) |
58635 |
2,2,2-trichloroethyl (1R,9S,10R,12R)-11-{(1R)-2-(acetyloxy)-1-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-4-yl]ethyl}-3-(benzyloxy)-12-({[tert-butyl(dimethyl)silyl]oxy}methyl)-10-cyano-4-methoxy-5-methyl-11,13-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-tr
|
|
C50H58Cl3N3O10Si |
详情 |
详情
|
(XXXVIII) |
58636 |
2,2,2-trichloroethyl (1R,9S,10R,12R)-11-{(1R)-2-(acetyloxy)-1-[6-(benzyloxy)-7-methyl-1,3-benzodioxol-4-yl]ethyl}-3-(benzyloxy)-10-cyano-12-formyl-4-methoxy-5-methyl-11,13-diazatricyclo[7.3.1.0~2,7~]trideca-2,4,6-triene-13-carboxylate
|
|
C44H42Cl3N3O10 |
详情 |
详情
|
(XL) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XLI) |
58638 |
2,2,2-trichloroethyl (1R,2R,3S,13R,15R,16S)-13-[(acetyloxy)methyl]-22-(allyloxy)-15-cyano-3,5-dihydroxy-21-methoxy-6,20-dimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0~2,14~.0~4,12~.0~7,11~.0~18,23~]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C33H34Cl3N3O10 |
详情 |
详情
|
(XLII) |
58639 |
2,2,2-trichloroethyl (1R,2R,3S,13R,15R,16S)-22-(allyloxy)-15-cyano-3,5-dihydroxy-13-(hydroxymethyl)-21-methoxy-6,20-dimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0~2,14~.0~4,12~.0~7,11~.0~18,23~]tetracosa-4,6,11,18,20,22-hexaene-24-carboxylate
|
|
C31H32Cl3N3O9 |
详情 |
详情
|
(XLIII) |
58640 |
(2R)-3-(acetylsulfanyl)-2-{[(allyloxy)carbonyl]amino}propanoic acid
|
|
C9H13NO5S |
详情 |
详情
|
(XLIV) |
58641 |
2,2,2-trichloroethyl (1R,2R,3S,13R,15R,16S)-13-{[((2R)-3-(acetylsulfanyl)-2-{[(allyloxy)carbonyl]amino}propanoyl)oxy]methyl}-22-(allyloxy)-15-cyano-3,5-dihydroxy-21-methoxy-6,20-dimethyl-8,10-dioxa-14,24-diazahexacyclo[14.7.1.0~2,14~.0~4,12~.0~7,11~
|
|
C40H43Cl3N4O13S |
详情 |
详情
|
合成路线19
该中间体在本合成路线中的序号:
(XXXI) Reaction of 3-methoxybenzyl alcohol (XXIX) with TBDMS-Cl and imidazole in dichloromethane gives the silyl ether (XXX), which is condensed with allyl bromide (XXXI) by means of BuLi in hexane to yield the 2-allyl derivative (XXXII). Deprotection of (XXXII) by means of TBAF in THF affords the benzyl alcohol (XXXIII), which is oxidized with oxalyl chloride and TEA in DMSO/dichloromethane to provide 2-allyl-3-methoxybenzaldehyde (XXXIV). Condensation of compound (XXXIV) with the chiral 1-decyne (XXXV) by means of ethylmagnesium bromide in THF gives the secondary alcohol (XXXVI), which is oxidized with pyridinium chlorochromate (PCC) in dichloromethane yielding ketone (XXXVII). The enantioselective reduction of ketone (XXXVII) by means of trimethylboroxine (TMBO), BH3/Me2S and (R)-(2-pyrrolidinyl)diphenylmethanol in toluene affords the chiral secondary alcohol (XXXVIII) as a single diastereomer. Silylation of alcohol (XXXVIII) with TBDMS-Cl and imidazole yields the corresponding ether (XXXIX), which is submitted to cyclization catalyzed by Co2(CO)8 in refluxing acetonitrile affording the tricyclic ketone (XL). Hydrogenation of the conjugated double bond of (XL) with H2 over Pd/C in ethanol provides the saturated ketone (XLI), which is reduced with NaBH4 in ethanol to give the tricyclic alcohol (XLII). Elimination of the tetrahydropyranyl-protecting group of (XLII) with p-toluensulfonic acid in methanol provides diol (XXV) already described.
【1】
Sorbera, L.A.; Castaner, J.; Rabasseda, X.; UT-15. Drugs Fut 2001, 26, 4, 364.
|
【2】
Rao, M.S.; Staszewski, J.P.; Guo, L.; Penmasta, R.; Moriarty, R.M. (United Therapeutics Corp.); Process for stereoselective synthesis of prostacyclin derivs.. WO 9921830 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
20632 |
diphenyl[(2R)pyrrolidinyl]methanol
|
|
C17H19NO |
详情 |
详情
|
(XXV) |
46571 |
(1R,2R,3aS,9aS)-1-[(3S)-3-hydroxyoctyl]-5-methoxy-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-2-ol
|
|
C22H34O3 |
详情 |
详情
|
(XXIX) |
46574 |
3-Anisylalcohol; (3-methoxyphenyl)methanol; m-Anisyl alcohol; m-methoxybenzyl alcohol; 3-Anisic alcohol; 3-Anise Alcohol; 3-methoxybenzyl alcohol; 3-methoxybenzene methanol
|
6971-51-3 |
C8H10O2 |
详情 | 详情
|
(XXX) |
46575 |
tert-butyl(dimethyl)silyl 3-methoxybenzyl ether; tert-butyl[(3-methoxybenzyl)oxy]dimethylsilane
|
|
C14H24O2Si |
详情 |
详情
|
(XXXI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXXII) |
46576 |
2-allyl-3-([[tert-butyl(dimethyl)silyl]oxy]methyl)phenyl methyl ether; [(2-allyl-3-methoxybenzyl)oxy](tert-butyl)dimethylsilane
|
|
C17H28O2Si |
详情 |
详情
|
(XXXIII) |
46577 |
(2-allyl-3-methoxyphenyl)methanol
|
|
C11H14O2 |
详情 |
详情
|
(XXXIV) |
46578 |
2-allyl-3-methoxybenzaldehyde
|
|
C11H12O2 |
详情 |
详情
|
(XXXV) |
46579 |
(1S)-1-pentyl-4-pentynyl tetrahydro-2H-pyran-2-yl ether; 2-[[(1S)-1-pentyl-4-pentynyl]oxy]tetrahydro-2H-pyran
|
|
C15H26O2 |
详情 |
详情
|
(XXXVI) |
46580 |
(6S)-1-(2-allyl-3-methoxyphenyl)-6-(tetrahydro-2H-pyran-2-yloxy)-2-undecyn-1-ol
|
|
C26H38O4 |
详情 |
详情
|
(XXXVII) |
46581 |
(6S)-1-(2-allyl-3-methoxyphenyl)-6-(tetrahydro-2H-pyran-2-yloxy)-2-undecyn-1-one
|
|
C26H36O4 |
详情 |
详情
|
(XXXVIII) |
46582 |
(1S,6S)-1-(2-allyl-3-methoxyphenyl)-6-(tetrahydro-2H-pyran-2-yloxy)-2-undecyn-1-ol
|
|
C26H38O4 |
详情 |
详情
|
(XXXIX) |
46583 |
[[(1S,6S)-1-(2-allyl-3-methoxyphenyl)-6-(tetrahydro-2H-pyran-2-yloxy)-2-undecynyl]oxy](tert-butyl)dimethylsilane; 2-allyl-3-[(1S,6S)-1-[[tert-butyl(dimethyl)silyl]oxy]-6-(tetrahydro-2H-pyran-2-yloxy)-2-undecynyl]phenyl methyl ether
|
|
C32H52O4Si |
详情 |
详情
|
(XL) |
46584 |
(4R,9aS)-4-[[tert-butyl(dimethyl)silyl]oxy]-8-methoxy-3-[(3S)-3-(tetrahydro-2H-pyran-2-yloxy)octyl]-1,4,9,9a-tetrahydro-2H-cyclopenta[b]naphthalen-2-one
|
|
C33H52O5Si |
详情 |
详情
|
(XLI) |
46570 |
(1R,3aS,9aS)-5-methoxy-1-[(3S)-3-(tetrahydro-2H-pyran-2-yloxy)octyl]-1,3,3a,4,9,9a-hexahydro-2H-cyclopenta[b]naphthalen-2-one
|
|
C27H40O4 |
详情 |
详情
|
(XLII) |
46585 |
(1R,2R,3aS,9aS)-5-methoxy-1-[(3S)-3-(tetrahydro-2H-pyran-2-yloxy)octyl]-2,3,3a,4,9,9a-hexahydro-1H-cyclopenta[b]naphthalen-2-ol
|
|
C27H42O4 |
详情 |
详情
|
合成路线20
该中间体在本合成路线中的序号:
(XXVII) Reduction of the ester function of (XXIV) by means of DIBAL afforded alcohol (XXV), which was further protected as the tetrahydropyranyl ether (XXVI). The free secondary hydroxyl of (XXVI) was then alkylated with allyl bromide (XXVII) and NaH to produce the allyl ether (XXVIII). Selective olefin hydroboration at the allyl ether moiety of (XXVIII), followed by oxidative work-up gave rise to the primary alcohol (XXIX). After silylation of (XXIX), the tetrahydropyranyl ether was hydrolyzed with ethanolic HCl providing the tris-O-silylated compound (XXX)
【1】
Takahashi, T.; Shiono, M. (Kuraray Co., Ltd.); Cyclohexanetriol derivs.. EP 0503630 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXIV) |
59871 |
ethyl 2-((3R,4R,5R)-3,5-bis{[tert-butyl(diphenyl)silyl]oxy}-4-hydroxy-2-methylenecyclohexylidene)acetate
|
|
C43H52O5Si2 |
详情 |
详情
|
(XXV) |
59872 |
(1R,2R,6R)-2,6-bis{[tert-butyl(diphenyl)silyl]oxy}-4-[(Z)-2-hydroxyethylidene]-3-methylenecyclohexanol
|
|
C41H50O4Si2 |
详情 |
详情
|
(XXVI) |
59873 |
(1R,2R,6R)-2,6-bis{[tert-butyl(diphenyl)silyl]oxy}-3-methylene-4-[(Z)-2-(tetrahydro-2H-pyran-2-yloxy)ethylidene]cyclohexanol
|
|
C46H58O5Si2 |
详情 |
详情
|
(XXVII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXVIII) |
59874 |
({(1R,2R,3R)-2-(allyloxy)-3-{[tert-butyl(diphenyl)silyl]oxy}-4-methylene-5-[(Z)-2-(tetrahydro-2H-pyran-2-yloxy)ethylidene]cyclohexyl}oxy)(tert-butyl)diphenylsilane; allyl (1R,2R,6R)-2,6-bis{[tert-butyl(diphenyl)silyl]oxy}-3-methylene-4-[(Z)-2-(tetrahydro-2H-pyran-2-yloxy)ethylidene]cyclohexyl ether |
|
C49H62O5Si2 |
详情 |
详情
|
(XXIX) |
59875 |
3-({(1R,2R,6R)-2,6-bis{[tert-butyl(diphenyl)silyl]oxy}-3-methylene-4-[(Z)-2-(tetrahydro-2H-pyran-2-yloxy)ethylidene]cyclohexyl}oxy)-1-propanol
|
|
C49H64O6Si2 |
详情 |
详情
|
(XXX) |
59876 |
2-[(3R,4R,5R)-3,5-bis{[tert-butyl(diphenyl)silyl]oxy}-4-(3-{[tert-butyl(diphenyl)silyl]oxy}propoxy)-2-methylenecyclohexylidene]-1-ethanol
|
|
C60H74O5Si3 |
详情 |
详情
|
合成路线21
该中间体在本合成路线中的序号:
(VII) The condensation of (2alpha,3alpha,5alpha,16alpha,17alpha)-2,3:16,17-diepoxyandrostan-17-ol acetate (I) with pyrrolidine (II) by means of NaOH in methanol, followed by reduction with NaBH4 in the same solvent gives (2alpha,3alpha,5alpha,16beta,17beta)-2,3-epoxy-16-(1-pyrrolidinyl) androstan-17-ol (III), which is further condensed with morpholine (IV) in refluxing water yielding (2beta,3alpha,5alpha,16beta,17beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)androstane-3,17-diol (V). Partial acetylation of (V) with acetyl chloride in dichloromethane at room temperature affords the corresponding 17-acetoxy derivative (VI), which is finally quaternized with allyl bromide (VII) in dichloromethane.
【1】
Savage, D.S.; Sleig, T.; Carlyle, I.G. (Akzo Nobel N.V.); Novel 2beta-morpholino-androstane derivs. and process for their preparation. AU 8814570; EP 0287150; JP 1988277693; US 4894369 .
|
【2】
Pento, J.T.; Castaner, J.; Rocuronium Bromide. Drugs Fut 1994, 19, 9, 841.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13647 |
(1aR,2aS,2bS,4aS,5aR,6aS,6bR,8aS,9aS)-2a,4a-dimethylhexadecahydro-4bH-oxireno[2'',3'':4',5']cyclopenta[1',2':7,8]phenanthro[2,3-b]oxiren-4-yl acetate
|
|
C21H30O4 |
详情 |
详情
|
(II) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(III) |
13649 |
(1R,2S,3aS,3bR,5aS,6aS,7aR,8aS,8bS,10aS)-8a,10a-Dimethyl-2-(1-pyrrolidinyl)hexadecahydro-1H-cyclopenta[7,8]phenanthro[2,3-b]oxiren-1-ol
|
|
C23H37NO2 |
详情 |
详情
|
(IV) |
10388 |
Morpholine
|
110-91-8 |
C4H9NO |
详情 | 详情
|
(V) |
13651 |
(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-10,13-Dimethyl-2-(4-morpholinyl)-16-(1-pyrrolidinyl)hexadecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol
|
|
C27H46N2O3 |
详情 |
详情
|
(VI) |
13652 |
(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-(4-morpholinyl)-16-(1-pyrrolidinyl)hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate
|
|
C29H48N2O4 |
详情 |
详情
|
(VII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
合成路线22
该中间体在本合成路线中的序号:
(XX) In a different procedure, 3,4-dichlorophenylacetic acid (XIV) was condensed with the lithiated chiral oxazolidinone (XV), via activation as the mixed anhydride with pivaloyl chloride, to afford the N-acyl oxazolidinone (XVI). Diastereoselective alkylation of the sodium enolate of (XVI) with allyl iodide (XVII) afforded the (S)-pentenyl oxazolidinone (XVIII), which was further hydrolyzed to the chiral acid (XIX) by means of lithium peroxide. Alternatively, acid (XIX) was obtained by alkylation of the lithium dianion of 3,4-dichlorophenylacetic acid (XIV) with allyl bromide (XX), followed by resolution of the resultant racemic acid (XXI) with (S)-1-phenylethylamine. Acid (XIX) was converted to the amide (XXII) via the corresponding acid chloride. Reduction of amide (XXII) with DIBAL gave the secondary amine (XXIII), which was subsequently acylated with benzoyl chloride, yielding benzamide (XXIV). Dihydroxylation of the olefin double bond with N-methylmorpholine-N-oxide in the presence of OsO4, followed by oxidative cleavage of the resultant diol (XXV) with sodium periodate furnished aldehyde (XXVI). Finally, reductive amination of aldehyde (XXVI) with piperidine (III) in the presence of NaBH3CN provided the title compound
【1】
Hale, J.J.; Finke, P.E.; MacCross, M.; A facile synthesis of the novel neurokinin A antagonist SR 48968. Bioorg Med Chem Lett 1993, 3, 2, 319.
|
【2】
Finke, P.E.; Mills, S.G.; Hale, J.J.; MacCoss, M. (Merck & Co., Inc.); Process of making chiral 2-aryl-1,4-butanediamine derivs.. WO 9407839 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(III) |
59283 |
N-(4-phenyl-4-piperidinyl)acetamide
|
|
C13H18N2O |
详情 |
详情
|
(XIV) |
30414 |
2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid |
5807-30-7 |
C8H6Cl2O2 |
详情 | 详情
|
(XV) |
58942 |
|
|
C10H10LiNO2 |
详情 |
详情
|
(XVI) |
62381 |
(4S)-4-benzyl-3-[2-(3,4-dichlorophenyl)acetyl]-1,3-oxazolidin-2-one
|
|
C18H15Cl2NO3 |
详情 |
详情
|
(XVII) |
32112 |
3-iodo-1-propene;3-iodo-propen;allyl iodide |
556-56-9 |
C3H5I |
详情 | 详情
|
(XVIII) |
62382 |
(4S)-4-benzyl-3-[(2S)-2-(3,4-dichlorophenyl)-4-pentenoyl]-1,3-oxazolidin-2-one
|
|
C21H19Cl2NO3 |
详情 |
详情
|
(XIX) |
62383 |
(2S)-2-(3,4-dichlorophenyl)-4-pentenoic acid
|
|
C11H10Cl2O2 |
详情 |
详情
|
(XX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXI) |
50421 |
2-(3,4-dichlorophenyl)-4-pentenoic acid
|
|
C11H10Cl2O2 |
详情 |
详情
|
(XXII) |
62384 |
(2S)-2-(3,4-dichlorophenyl)-N-methyl-4-pentenamide
|
|
C12H13Cl2NO |
详情 |
详情
|
(XXIII) |
62385 |
(2S)-2-(3,4-dichlorophenyl)-N-methyl-4-penten-1-amine; N-[(2S)-2-(3,4-dichlorophenyl)-4-pentenyl]-N-methylamine
|
|
C12H15Cl2N |
详情 |
详情
|
(XXIV) |
62386 |
N-[(2S)-2-(3,4-dichlorophenyl)-4-pentenyl]-N-methylbenzamide
|
|
C19H19Cl2NO |
详情 |
详情
|
(XXV) |
62387 |
N-[(2S)-2-(3,4-dichlorophenyl)-4,5-dihydroxypentyl]-N-methylbenzamide
|
|
C19H21Cl2NO3 |
详情 |
详情
|
(XXVI) |
26943 |
N-[(2S)-2-(3,4-dichlorophenyl)-4-oxobutyl]-N-methylbenzamide
|
|
C18H17Cl2NO2 |
详情 |
详情
|
合成路线23
该中间体在本合成路线中的序号:
1) The reaction of cis-(1S,2R)-indanediol (I) with acetonitrile and concentrated H2SO4 gives cis-(1S,2R)-1-aminoindan-2-ol (II), which is cyclocondensed with 3-phenylpropionyl chloride (III), isopropenyl methyl ether and triethylamine to yield the acetonide amide (IV). The condensation of amide (IV) with (S)-(+)-glycidyl p-toluenesulfonate (V) in the presence of lithium hexamethyldisylazide (LHS) affords the chiral epoxide (VI), which is condensed with 4-(tert-butoxycarbonyl)-N-tert-butylpiperazine-2(S)-carboxamide (VII) in refluxing isopropyl acetate and deprotected with aqueous HCl to give the dihydroxy-diamide (VIII). Finally, this compound is condensed with 3-(chloromethyl)pyridine (IX) by means of triethylamine in DMF.
2) The amide (IV) can also be alkylated with allyl bromide and butyllithium to the pentenyl amide (X), which is diastereoselectively converted to the chiral iodohydrine (XI) by means of N-iodosuccinimide (NIS). Finally, this compound is cyclized in basic medium, yielding the epoxide (VI), already obtained.
【1】
Maligres, P.E.; Upadhyay, V.; Rossen, K.; Cianciosi, S.J.; Purick, R.M.; Eng, K.K.; Reamer, R.A.; Askin, D.; Volante, R.P.; Reider, P.J.; Diastereoselective syn-epoxidation of 2-alkyl-4-enamides to epoxyamides: Synthesis of the Merck HIV-1 protease inhibitor epoxide intermediate. Tetrahedron Lett 1995, 36, 13, 2195-8. |
【2】
Mealy, N.; Castaner, J.; Indinavir Sulfate. Drugs Fut 1996, 21, 6, 600.
|
【3】
Askin, D.; Volante, R.P.; Eng, K.K. (Merck & Co., Inc.); Process for making HIV protease inhibitors. WO 9502584 .
|
【4】
Verhoeven, T.R.; Roberts, E.F.; Senanayake, C.H.; Ryan, K.M. (Merck & Co., Inc.); Regiospecific processes to make cis-1-amino-2-alkanol from diol or halohydrin. US 5449830 .
|
【5】
Askin, D.; Eng, K.K.; Rossen, K.; Purick, R.M.; Wells, K.M.; Volante, R.P.; Reider, P.J.; Highly diastereoselective reaction of a chiral, non-racemic amide enolate with (S)-glycidyl tosylate. Synthesis of the orally active HIV-1 protease inhibitor L-735,524. Tetrahedron Lett 1994, 35, 5, 673-6. |
【6】
Dorsey, B.D.; Levin, R.B.; McDaniel, S.L.; et al.; L-735,524: The design of a potent and orally bioavailable HIV protease inhibitor. J Med Chem 1994, 37, 21, 3443-51.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
|
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(I) |
16238 |
(1S,2R)-2,3-dihydro-1H-indene-1,2-diol
|
67528-22-7 |
C9H10O2 |
详情 | 详情
|
(II) |
16239 |
(1S,2R)-1-amino-2,3-dihydro-1H-inden-2-ol; Cis-(1S)-1-amino-2,3-dihydro-1H-inden-2-ol
|
126456-43-7 |
C9H11NO |
详情 | 详情
|
(III) |
16240 |
3-phenylpropanoyl chloride; Hydrocinnamoylchloride
|
645-45-4 |
C9H9ClO |
详情 | 详情
|
(IV) |
16241 |
1-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-3-phenyl-1-propanone
|
|
C21H23NO2 |
详情 |
详情
|
(V) |
16242 |
(2R)oxiranylmethyl 4-methylbenzenesulfonate; (2R)-(-)-Glycidyl tosylate
|
113826-06-5 |
C10H12O4S |
详情 | 详情
|
(VI) |
16243 |
(2R)-1-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-2-benzyl-3-[(2S)oxiranyl]-1-propanone
|
|
C24H27NO3 |
详情 |
详情
|
(VII) |
16244 |
tert-butyl (3S)-3-[(tert-butylamino)carbonyl]tetrahydro-1(2H)-pyrazinecarboxylate
|
150323-35-6 |
C14H27N3O3 |
详情 | 详情
|
(VIII) |
16245 |
(2S)-1-((2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl)-N-(tert-butyl)-2-piperazinecarboxamide
|
|
C30H42N4O4 |
详情 |
详情
|
(IX) |
15793 |
3-(Chloromethyl)pyridine
|
3099-31-8 |
C6H6ClN |
详情 | 详情
|
(X) |
16247 |
(2S)-1-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-2-benzyl-4-penten-1-one
|
|
C24H27NO2 |
详情 |
详情
|
(XI) |
16248 |
(2R,4S)-1-[(3aS,8aR)-2,2-dimethyl-8,8a-dihydro-2H-indeno[1,2-d][1,3]oxazol-3(3aH)-yl]-2-benzyl-4-hydroxy-5-iodo-1-pentanone
|
|
C24H28INO3 |
详情 |
详情
|
合成路线24
该中间体在本合成路线中的序号:
(II) Reaction of the Grignard reagent derived from 4-chlorobenzyl bromide (I) with allyl bromide (II) gives 4-(4-chlorophenyl)but-1-ene (III), which is epoxidized with peracetic acid in dichloromethane to yield 4-(4-chlorophenyl)-1,2-epoxybutane (IV). Opening of (IV) with the anion of imidazole (V) gives 1-[4-(4-chlorophenyl)-2-hydroxybutyl]imidazole (VI), which is oxidized under Swern conditions to 4-(4-chlorophenyl)-1-(1-imidazolyl)-2-butanone (VII). Ketone (VII) is then reacted with (S)-solketal tosylate [(S)-1,2-O-isopropylideneglycerol-3-O-tosylate] (VIII) in the presence of p-toluenesulfonic acid in toluene to give a mixture of stereoisomers, and (2S,4S)-cis-2-[2-(4-chlorophenyl)ethyl]-2-(imidazol-1-ylmethyl)-4-(p-toluenesulfonyloxy)methyl-1,3-dioxolane (IX) is then separated by crystallization. Finally, (IX) is treated with 4-aminothiophenol (X) in the presence of potassium carbonate in acetone.
【1】
Dyson, N.H.; Gardner, J.O.; Prince, A.; Kertesz, D.J. (Syntex (USA), Inc.); Process for preparing 1,3-dioxolane derivs. JP 1995508002; US 5208331 .
|
【2】
Walker, K.A.; Burton, P.M.; Swinney, D.C. (Syntex (USA), Inc.); 1,3-Dioxolane derivs. as cholesterol lowering agents. JP 1992308588; US 5158949 .
|
【3】
Walker, K.A.M.; Rotstein, D.M.; Kertesz, D.J.; et al.; Selective inhibition of mammalian lanosterol 14alpha-demethylase: A possible strategy for cholesterol lowering. J Med Chem 1993, 36, 15, 2235-7.
|
【4】
Prous, J.; Mealy, N.; Castañer, J.; RS-21607-197. Drugs Fut 1994, 19, 2, 125.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16481 |
1-(bromomethyl)-4-chlorobenzene
|
622-95-7 |
C7H6BrCl |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
16483 |
1-(3-butenyl)-4-chlorobenzene
|
|
C10H11Cl |
详情 |
详情
|
(IV) |
16484 |
2-(4-chlorophenethyl)oxirane
|
|
C10H11ClO |
详情 |
详情
|
(V) |
10255 |
Imidazole; 1H-Imidazole
|
288-32-4 |
C3H4N2 |
详情 | 详情
|
(VI) |
16486 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanol
|
|
C13H15ClN2O |
详情 |
详情
|
(VII) |
16487 |
4-(4-chlorophenyl)-1-(1H-imidazol-1-yl)-2-butanone
|
|
C13H13ClN2O |
详情 |
详情
|
(VIII) |
16488 |
(2S)-2,3-dihydroxypropyl 4-methylbenzenesulfonate
|
|
C10H14O5S |
详情 |
详情
|
(IX) |
16489 |
[(2S,4S)-2-(4-chlorophenethyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl 4-methylbenzenesulfonate
|
|
C23H25ClN2O5S |
详情 |
详情
|
(X) |
16490 |
4-aminophenylhydrosulfide; 4-aminothiophenol; 4-aminobenzenethiol
|
1193-02-8 |
C6H7NS |
详情 | 详情
|
合成路线25
该中间体在本合成路线中的序号:
The Western fragment (VI) of SC-53228 was derived from methyl 2,4-dihydroxybenzoate (I). Allylation of this material under standard conditions (allyl bromide, potassium carbonate, DMF) afforded the 4-allyl ether as the predominant product along with a smaller quantity (approx. 5%) of the 2-allyl ether. This mixture was subjected to thermally induced Claisen rearrangement (neat, 190 C) to access the requisite tetrasubstituted aromatic nucleus (II). The yield for these two steps was approx. 55%. Cyclopropanation of the allyl group was best effected by the Denmark modification of Simmons Smith reaction (Et2Zn, Cl(CH2)2Cl, ClCH2l). This process proved to be somewhat capricious in that, as a general rule, some starting material was always recovered from the reaction mixture regardless of the stoichiometry of the reagents used. This unreacted olefin could be removed by treating the crude reaction mixture with palladium (II) salts (palladium trifluoroacetate, tetrabutylammonium chloride in acetone/water). Yields of the cyclopropane product (III) resulting from this 2-step sequence ranged between 50 and 90%. This diol ester was converted, uneventfully, to the monomethyl amide (IV) (CH3NH2, NH4Cl, 77%) and the linker attached under standard conditions (Cl(CH2)3Br, DMF, K2CO3) (V). This reaction proved to be nonselective and low yielding (approx. 45% yield). Methylation (dimethyl sufate, KOH, THF) followed by Finkelstein reaction (NaI, MEK) provided the key Western fragment (VI) in approximately 10% overall yield from methyl 2,4-dihydroxybenzoate.
【1】
Smith, P.F.; Paulson, S.K.; Tsai, B.S.; Fretland, D.J.; Dygos, J.H.; Yu, S.S.; Djuric, S.W.; SC-53228. Drugs Fut 1994, 19, 12, 1093.
|
【2】
Yu, S.; Docter, S.; Djuric, S.; et al.; Synthesis and pharmacological activity of SC-53228, a leukotriene B4 receptor antagonist with high intrinsic potency and selectivity. Bioorg Med Chem Lett 1994, 4, 6, 811-6.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
16623 |
methyl 2,4-dihydroxybenzoate
|
2150-47-2 |
C8H8O4 |
详情 | 详情
|
(II) |
16624 |
methyl 3-allyl-2,4-dihydroxybenzoate
|
|
C11H12O4 |
详情 |
详情
|
(III) |
16625 |
methyl 3-(cyclopropylmethyl)-2,4-dihydroxybenzoate
|
|
C12H14O4 |
详情 |
详情
|
(IV) |
16626 |
3-(cyclopropylmethyl)-2,4-dihydroxy-N-methylbenzamide
|
|
C12H15NO3 |
详情 |
详情
|
(V) |
16627 |
4-(3-chloropropoxy)-3-(cyclopropylmethyl)-2-hydroxy-N-methylbenzamide
|
|
C15H20ClNO3 |
详情 |
详情
|
(VI) |
16628 |
3-(cyclopropylmethyl)-4-(3-iodopropoxy)-2-methoxy-N-methylbenzamide
|
|
C16H22INO3 |
详情 |
详情
|
合成路线26
该中间体在本合成路线中的序号:
(IX) The esterification of L-phenylglycine (I) with AcCl and methanol gives the methyl ester (II), which is N-protected by means of Boc2O and TEA to yield the N-Boc derivative (III). The reduction of (III) with NaBH4 in ethanol/THF affords the alcohol (IV), which is oxidized by means of (COCl)2 and DMSO to provide the carbaldehyde (V). The reaction of (V) with vinylmagnesium bromide (VI) in THF gives the allyl alcohol (VII), which is protected with Tbdms-Cl and imidazole to yield the silyl ether (VIII). The alkylation of (VIII) with allyl bromide (IX) and NaH in DMF affords the N-allyl derivative (X), which is desilylated by means of TBAF and AcOH in THF to provide the allyl alcohol (XI). The ring closing metathesis reaction of (XI) with a Grubbs' catalyst in dichloromethane gives the tetrahydropyridine (XII), which is treated with H2 over Pd/C in ethanol to yield the chiral protected piperidine (XIII). The condensation of (XIII) with 3,5-bis(trifluoromethyl)benzyl bromide (XIV) by means of NaH in DMF affords the benzyl ether (XV), which is finally deprotected with TFA to provide the target piperidine.
【1】
Bhaskar, G.; Rao, B.V.; Stereoselective synthesis of L-733,060. Tetrahedron Lett 2003, 44, 5, 915.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
10716 |
(2S)-2-Amino-2-phenylethanoic acid; L-(+)-alpha-Phenylglycine
|
2935-35-5 |
C8H9NO2 |
详情 | 详情
|
(II) |
10717 |
methyl (2S)-2-amino-2-phenylethanoate
|
|
C9H11NO2 |
详情 |
详情
|
(III) |
12485 |
methyl (2S)-2-[(tert-butoxycarbonyl)amino]-2-phenylethanoate
|
|
C14H19NO4 |
详情 |
详情
|
(IV) |
59225 |
(R)-N-(tert-Butoxycarbonyl)-phenylglycinol; N-t-BOC-D-phenylglycinol
|
102089-74-7 |
C13H19NO3 |
详情 | 详情
|
(V) |
45428 |
tert-butyl (1S)-2-oxo-1-phenylethylcarbamate
|
|
C13H17NO3 |
详情 |
详情
|
(VI) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(VII) |
64501 |
tert-butyl (1S,2S)-2-hydroxy-1-phenyl-3-butenylcarbamate
|
|
C15H21NO3 |
详情 |
详情
|
(VIII) |
64502 |
tert-butyl (1S,2S)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-phenyl-3-butenylcarbamate
|
|
C21H35NO3Si |
详情 |
详情
|
(IX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(X) |
64503 |
tert-butyl allyl((1S,2S)-2-{[tert-butyl(dimethyl)silyl]oxy}-1-phenyl-3-butenyl)carbamate
|
|
C24H39NO3Si |
详情 |
详情
|
(XI) |
64504 |
tert-butyl allyl[(1S,2S)-2-hydroxy-1-phenyl-3-butenyl]carbamate
|
|
C18H25NO3 |
详情 |
详情
|
(XII) |
64505 |
tert-butyl (2S,3S)-3-hydroxy-2-phenyl-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C16H21NO3 |
详情 |
详情
|
(XIII) |
64499 |
tert-butyl (2S,3S)-3-hydroxy-2-phenyl-1-piperidinecarboxylate
|
|
C16H23NO3 |
详情 |
详情
|
(XIV) |
27677 |
1-(bromomethyl)-3,5-bis(trifluoromethyl)benzene
|
32247-96-4 |
C9H5BrF6 |
详情 | 详情
|
(XV) |
64500 |
tert-butyl (2S,3S)-3-{[3,5-bis(trifluoromethyl)benzyl]oxy}-2-phenyl-1-piperidinecarboxylate
|
|
C25H27F6NO3 |
详情 |
详情
|
合成路线27
该中间体在本合成路线中的序号:
(X) Synthesis of undecenoic ester intermediate (XXI): The reaction of 2,2-dimethylpropane-1,3-diol (I) with benzaldehyde, TsOH and DIBAL gives the monobenzyl ether (II), which is oxidized with SO3/pyridine in dichloromethane, yielding the propionaldehyde (III). The condensation of (III) with butanone (IV) by means of LDA and TFAA affords the heptenone (V), which is epoxidated with H2O2 and NaOH in aq. methanol to provide the racemic epoxide (rac)-(VI). The reaction of ketone (VI) with O-methylhydroxylamine and NaOAc in methanol gives the corresponding oxime (rac)-(VII), which is treated with CuCN and Me-Li in ethyl ether to yield the beta-hydroxy oxime (rac)-(VIII). The treatment of (VIII) with H2 and Raney-Ni in acetone/THF affords the corresponding beta-hydroxy ketone (rac)-(IX), which is allylated with allyl bromide (X) and LHMDS in the presence of 1,3-dimethylperhydropyrimidin-2-one to give the beta-hydroxynonen-5-one (rac)-(XI). The reduction of (XI) with Me4NBH(OAc)3 and HOAc in acetonitrile yields the diol (rac)-(XII), which is protected with 2-methoxypropene (XIII) and TsOH, affording the 1,3-dioxane (rac)-(XIV). The reaction of (XIV) with Li in liquid ammonia, tert-butanol and THF provides the debenzylated primary alcohol (rac)-(XV), which is oxidized with tetrapropylammonium perrhuthenate in dichloromethane, giving the corresponding aldehyde (rac)-(XVI).
【1】
Sawada, D.; et al.; Enantioselective total synthesis of epothilones A and B using multifunctional asymmetric catalysis. J Am Chem Soc 2000, 122, 43, 10521.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12641 |
Neopentyl glycol; 2,2-Dimethyl-1,3-propanediol
|
126-30-7 |
C5H12O2 |
详情 | 详情
|
(II) |
44529 |
3-(benzyloxy)-2,2-dimethyl-1-propanol
|
|
C12H18O2 |
详情 |
详情
|
(III) |
44504 |
3-(benzyloxy)-2,2-dimethylpropanal
|
|
C12H16O2 |
详情 |
详情
|
(IV) |
33891 |
Methyl ethyl ketone; 2-Butanone
|
78-93-3 |
C4H8O |
详情 | 详情
|
(V) |
44505 |
(E)-7-(benzyloxy)-6,6-dimethyl-4-hepten-3-one
|
|
C16H22O2 |
详情 |
详情
|
(VI) |
44506 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone
|
|
C16H22O3 |
详情 |
详情
|
(VII) |
44507 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone O-methyloxime
|
|
C17H25NO3 |
详情 |
详情
|
(VIII) |
44508 |
(4R,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone O-methyloxime
|
|
C18H29NO3 |
详情 |
详情
|
(IX) |
44509 |
(4S,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone
|
|
C17H26O3 |
详情 |
详情
|
(X) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XI) |
44510 |
(4S,6S,7R)-9-(benzyloxy)-7-hydroxy-4,6,8,8-tetramethyl-1-nonen-5-one
|
|
C20H30O3 |
详情 |
详情
|
(XII) |
44511 |
(3R,4R,5S,6S)-1-(benzyloxy)-2,2,4,6-tetramethyl-8-nonene-3,5-diol
|
|
C20H32O3 |
详情 |
详情
|
(XIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(XIV) |
44512 |
benzyl 2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propyl ether; (4R,5S,6S)-4-[2-(benzyloxy)-1,1-dimethylethyl]-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxane
|
|
C23H36O3 |
详情 |
详情
|
(XV) |
44513 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]-1-propanol
|
|
C16H30O3 |
详情 |
详情
|
(XVI) |
44514 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propanal
|
|
C16H28O3 |
详情 |
详情
|
合成路线28
该中间体在本合成路线中的序号:
(XV) The oxidation of the lactol (XIII) with Br2 and BaCO3 gives the lactone (XIV), which is stereoselectively alkylated with allyl bromide (XV) by means of LDA in HMPA to yield lactone (XVI). The opening of the lactone ring of (XVI) with MeONa affords the dihydroxyester (XVII), which is protected by reaction with anisaldehyde dimethylacetal (XVIII) and CSA to provide the benzylidene derivative (XIX). The reduction of the ester group of (XIX) with LiAlH4 gives the corresponding carbinol (XX), which is acylated with Ms-Cl and TEA to yield the mesylate (XXI). The reduction of the mesyloxy group of (XXI) with LiAlH4 affords the dimethyl compound (XXII), which is submitted to a regioselective cleavage of the Pmp protecting group by means of DIBAL in toluene to provide the primary alcohol (XXIII). The oxidation of (XXIII) with DMP gives the corresponding aldehyde (XXIV), which is condensed with tert-butyl isobutyrylacetate (XXV) by means of NaH and BuLi to yield the unsaturated ketoester (XXVI). Stereoselective reduction of the beta-oxo group of (XXVI) by means of Me4NBH(OAc)3 affords the desired diol (XXVII), which is regioselectively silylated at the beta-hydroxy group by means of Tbdms-OTf to provide the monosilyl ether (XXVIII). The oxidation of the remaining hydroxy group of (XXVIII) by means of DMP gives the unsaturated ketoester (XXIX).
【1】
Wong, C.-H.; Liu, J.; Aldolase-catalyzed asymmetric synthesis of novel pyranose synthons as a new entry to heterocycles and epothilones. Angew Chem. Int Ed 2002, 41, 8, 1404.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
54267 |
(4S,5S)-5-methyltetrahydro-2H-pyran-2,4-diol
|
|
C6H12O3 |
详情 |
详情
|
(XIV) |
54268 |
(4S,5S)-4-hydroxy-5-methyltetrahydro-2H-pyran-2-one
|
|
C6H10O3 |
详情 |
详情
|
(XV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVI) |
54269 |
(3S,4R,5S)-3-allyl-4-hydroxy-5-methyltetrahydro-2H-pyran-2-one
|
|
C9H14O3 |
详情 |
详情
|
(XVII) |
54270 |
methyl (2S)-2-[(1R,2S)-1,3-dihydroxy-2-methylpropyl]-4-pentenoate
|
|
C10H18O4 |
详情 |
详情
|
(XVIII) |
26485 |
1-(dimethoxymethyl)-4-methoxybenzene
|
2186-92-7 |
C10H14O3 |
详情 | 详情
|
(XIX) |
54271 |
methyl (2S)-2-[(4R,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-pentenoate
|
n/a |
C18H24O5 |
详情 | 详情
|
(XX) |
54272 |
(2R)-2-[(4S,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-penten-1-ol
|
n/a |
C17H24O4 |
详情 | 详情
|
(XXI) |
54273 |
(2R)-2-[(4R,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-pentenyl methanesulfonate
|
n/a |
C18H26O6S |
详情 | 详情
|
(XXII) |
54274 |
(4S,5S)-2-(4-methoxyphenyl)-5-methyl-4-[(1S)-1-methyl-3-butenyl]-1,3-dioxane; methyl 4-{(4S,5S)-5-methyl-4-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-2-yl}phenyl ether
|
n/a |
C17H24O3 |
详情 | 详情
|
(XXIII) |
54275 |
(2S,3S,4S)-3-[(4-methoxybenzyl)oxy]-2,4-dimethyl-6-hepten-1-ol
|
n/a |
C17H26O3 |
详情 | 详情
|
(XXIV) |
54276 |
(2R,3S,4S)-3-[(4-methoxybenzyl)oxy]-2,4-dimethyl-6-heptenal
|
n/a |
C17H24O3 |
详情 | 详情
|
(XXV) |
54277 |
tert-butyl 4-methyl-3-oxopentanoate
|
94250-54-1 |
C10H18O3 |
详情 | 详情
|
(XXVI) |
54278 |
tert-butyl (5S,6S,7S,8S)-5-hydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-3-oxo-10-undecenoate
|
n/a |
C27H42O6 |
详情 | 详情
|
(XXVII) |
54279 |
tert-butyl (3S,5S,6S,7S,8S)-3,5-dihydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-10-undecenoate
|
n/a |
C27H44O6 |
详情 | 详情
|
(XXVIII) |
54280 |
tert-butyl (3S,5S,6S,7S,8S)-3-{[tert-butyl(dimethyl)silyl]oxy}-5-hydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-10-undecenoate
|
n/a |
C33H58O6Si |
详情 | 详情
|
(XXIX) |
54281 |
tert-butyl (3S,6R,7S,8S)-3-{[tert-butyl(dimethyl)silyl]oxy}-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-5-oxo-10-undecenoate
|
n/a |
C33H56O6Si |
详情 | 详情
|
合成路线29
该中间体在本合成路线中的序号:
(X) The reaction of 2,2-dimethylpropane-1,3-diol (I) with benzaldehyde, Ts-OH and DIBAL gives the monobenzyl ether (II), which is oxidized with SO3/pyridine in dichloromethane, yielding the propionaldehyde (III). The condensation of (III) with butanone (IV) by means of LDA and TFAA affords the heptenone (V), which is epoxidated with H2O2 and NaOH in aq. methanol to provide the racemic epoxide (rac)-(VI). The reaction of ketone (VI) with O-methylhydroxylamine and NaOAc in methanol gives the corresponding oxime (rac)-(VII), which is treated with CuCN and MeLi in ethyl ether to yield the beta-hydroxy oxime (rac)-(VIII). The treatment of (VIII) with H2 and Raney-Ni in acetone/THF affords the corresponding beta-hydroxy ketone (rac)-(IX), which is allylated with allyl bromide (X) and LHMDS in the presence of 1,3-dimethylperhydropyrimidin-2-one to give the beta-hydroxynonen-5-one (rac)-(XI). The reduction of (XI) with Me4NBH(OAc)3 and HOAc in acetonitrile yields the diol (rac)-(XII), which is protected with 2-methoxypropene (XIII) and Ts-OH, affording the 1,3-dioxane (rac)-(XIV). The reaction of (XIV) with Li in liquid ammonia, tert-butanol and THF provides the debenzylated primary alcohol (rac)-(XV), which is oxidized with tetrapropylammonium perrhuthenate in dichloromethane, giving the corresponding aldehyde (rac)-(XVI).
【1】
Sawada, D.; et al.; Enantioselective total synthesis of epothilones A and B using multifunctional asymmetric catalysis. J Am Chem Soc 2000, 122, 43, 10521.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12641 |
Neopentyl glycol; 2,2-Dimethyl-1,3-propanediol
|
126-30-7 |
C5H12O2 |
详情 | 详情
|
(II) |
44529 |
3-(benzyloxy)-2,2-dimethyl-1-propanol
|
|
C12H18O2 |
详情 |
详情
|
(III) |
44504 |
3-(benzyloxy)-2,2-dimethylpropanal
|
|
C12H16O2 |
详情 |
详情
|
(IV) |
33891 |
Methyl ethyl ketone; 2-Butanone
|
78-93-3 |
C4H8O |
详情 | 详情
|
(V) |
44505 |
(E)-7-(benzyloxy)-6,6-dimethyl-4-hepten-3-one
|
|
C16H22O2 |
详情 |
详情
|
(VI) |
44506 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone
|
|
C16H22O3 |
详情 |
详情
|
(VII) |
44507 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone O-methyloxime
|
|
C17H25NO3 |
详情 |
详情
|
(VIII) |
44508 |
(4R,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone O-methyloxime
|
|
C18H29NO3 |
详情 |
详情
|
(IX) |
44509 |
(4S,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone
|
|
C17H26O3 |
详情 |
详情
|
(X) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XI) |
44510 |
(4S,6S,7R)-9-(benzyloxy)-7-hydroxy-4,6,8,8-tetramethyl-1-nonen-5-one
|
|
C20H30O3 |
详情 |
详情
|
(XII) |
44511 |
(3R,4R,5S,6S)-1-(benzyloxy)-2,2,4,6-tetramethyl-8-nonene-3,5-diol
|
|
C20H32O3 |
详情 |
详情
|
(XIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(XIV) |
44512 |
benzyl 2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propyl ether; (4R,5S,6S)-4-[2-(benzyloxy)-1,1-dimethylethyl]-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxane
|
|
C23H36O3 |
详情 |
详情
|
(XV) |
44513 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]-1-propanol
|
|
C16H30O3 |
详情 |
详情
|
(XVI) |
44514 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propanal
|
|
C16H28O3 |
详情 |
详情
|
合成路线30
该中间体在本合成路线中的序号:
(VII) Treatment of (R)-1-chloro-2,3-propanediol (I) with either K2CO3 or Cs2CO3 in CH2Cl2, followed by O-protection with Trt-Cl and Et3N in CH2Cl2, yields (S)-trityl glycidol (II). Alternatively, derivative (II) can also be obtained either by direct O-protection of (R)-glycidol (III) by means of Trt-Cl and Et3N in refluxing CH2Cl2 or by cyclization of protected propanediol derivative (IV)--obtained from treatment of compound (I) with Trt-Cl and Et3N in CH2Cl2--by means of KOH in EtOH. Reaction of (S)-trityl glycidol (II) with vinyl magnesium bromide (V) by means of CuI in THF provides (S)-1-(triphenylmethoxy)-4-penten-2-ol (VI), which is then condensed with allyl bromide (VII) with KOtBu or NaH in THF to afford compound (VIII). Ozonolysis of (VIII) in CH2Cl2/MeOH, followed by reductive quench with NaBH4 in NaOH, gives (S)-3-(2-hydroxyethoxy)-4-(triphenylmethoxy)-1-butanol (IX), which is then treated with MsCl/Et3N in CH2Cl2 to yield bismesylate (X). Coupling of compound (X) with 2,3-bis(1H-indol-3-yl)-N-methylmaleimide (XI) [obtained by treatment of dichloromaleic anhydride (XII) with methylamine hydrochloride by means of NaOMe in HOAc to furnish dichloro-N-methylmaleimide (XIII), followed by Grignard reaction of (XIII) with indole (XIV) in toluene/THF by means of EtMgBr in Et2O] by means of Cs2CO3 in DMF gives the 14-membered macrocycle (XV).
【1】
Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
|
【2】
Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
|
【3】
Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
|
【4】
Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
|
【5】
Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49696 |
(S)-(+)-Alpha-Chlorohydrin; (S)-(+)-3-Chloro-1,2-propanediol; (S)-3-Chloro-1,2-propanediol
|
60827-45-4 |
C3H7ClO2 |
详情 | 详情
|
(II) |
41006 |
(2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane
|
|
C22H20O2 |
详情 |
详情
|
(III) |
19241 |
(2S)oxiranylmethanol
|
60456-23-7 |
C3H6O2 |
详情 | 详情
|
(IV) |
51942 |
(2R)-1-chloro-3-(trityloxy)-2-propanol
|
|
C22H21ClO2 |
详情 |
详情
|
(V) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(VI) |
41007 |
(2S)-1-(trityloxy)-4-penten-2-ol
|
|
C24H24O2 |
详情 |
详情
|
(VII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VIII) |
41008 |
1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether
|
|
C27H28O2 |
详情 |
详情
|
(IX) |
41010 |
(3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol
|
|
C25H28O4 |
详情 |
详情
|
(X) |
51943 |
(7S)-2,11-dimethyl-2,11-dimethylene-7-[(trityloxy)methyl]-3,6,10-trioxa-2lambda(6),11lambda(6)-dithia-1,11-dodecadiene; 2-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]ethyl (1S)-3-[[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]-1-[(trityloxy)methyl]propyl ether |
|
C31H40O4S2 |
详情 |
详情
|
(XI) |
51012 |
5-(tert-butyl) 1-(2,3,5,6-tetrafluorophenyl) (2S)-2-[[(2S)-2-[[(benzyloxy)carbonyl]amino]-5-(tert-butoxy)-5-oxopentanoyl]amino]pentanedioate
|
|
C32H38F4N2O9 |
详情 |
详情
|
(XII) |
21947 |
3,4-dichloro-2,5-furandione
|
1122-17-4 |
C4Cl2O3 |
详情 | 详情
|
(XIII) |
41029 |
3,4-dichloro-1-methyl-1H-pyrrole-2,5-dione
|
|
C5H3Cl2NO2 |
详情 |
详情
|
(XIV) |
15292 |
Indole; 1H-indole
|
120-72-9 |
C8H7N |
详情 | 详情
|
(XV) |
41016 |
(18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C46H39N3O4 |
详情 |
详情
|
合成路线31
该中间体在本合成路线中的序号:
(IV) The reaction of dimethyl malonate (I) with 3-(tert-butyldimethylsilyloxy)propyl iodide (II) by means of NaH in THF gives the alkylmalonate (III), which by a new alkylation with allyl bromide (IV) and NaH in DME affords the dialkylmalonate (V). The reduction of (V) with LiBH4 in THF yields the 1,3-propanediol (VI), which is cyclized with 2,2-dimethoxypropane and CSA in dichloromethane giving the 1,3-dioxane (VII). The ozonolysis of the double bond of (VII) with O3 in dichloromethane yields the aldehyde (VIII), which is protected by heating with cyclohexylamine (IX) to afford the imine (X).The condensation of (X) with 8(E)-decenal (XI) by means of LDA in ethyl ether gives the unsaturated aldehyde (XII), which is treated with Pmb-Cl and KH in DME/HMPA to yield the enol ether (XIII). The desilylation of (XIII) with TBAF in THF gives the propanol derivative (XIV), which is oxidized with SO3/pyridine to the corresponding aldehyde (XV). The condensation of (XV) with 4-(triisopropylsilyloxy)-1(E)-butenyl iodide (XVI) by means of BuLi in THF, followed by oxidation of the intermediate alcohol with SO3/pyridine provides the unsaturated ketone (XVII).
【1】
Nicolaou, K.C.; et al.; Total synthesis of the CP molecules CP-263,114 and CP-225,917 - Part 1: Synthesis of key intermediates and intelligence gathering. Angew Chem. Int Ed Engl 1999, 38, 11, 1669.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10722 |
1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane
|
77-76-9 |
C5H12O2 |
详情 | 详情
|
(I) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(II) |
35676 |
tert-butyl(3-iodopropoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-iodopropyl ether
|
|
C9H21IOSi |
详情 |
详情
|
(III) |
35677 |
dimethyl 2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C14H28O5Si |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
35678 |
dimethyl 2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C17H32O5Si |
详情 |
详情
|
(VI) |
35679 |
2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-1,3-propanediol
|
|
C15H32O3Si |
详情 |
详情
|
(VII) |
35680 |
3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propyl tert-butyl(dimethyl)silyl ether; [3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propoxy](tert-butyl)dimethylsilane
|
|
C18H36O3Si |
详情 |
详情
|
(VIII) |
35681 |
2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]acetaldehyde
|
|
C17H34O4Si |
详情 |
详情
|
(IX) |
17966 |
cyclohexanamine; cyclohexyl amine; cyclohexylamine
|
108-91-8 |
C6H13N |
详情 | 详情
|
(X) |
35682 |
N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]-N-cyclohexylamine; N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]cyclohexanamine
|
|
C23H45NO3Si |
详情 |
详情
|
(XI) |
35683 |
(E)-8-decenal
|
|
C10H18O |
详情 |
详情
|
(XII) |
35684 |
(2Z,10E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]-2,10-dodecadienal
|
|
C27H50O4Si |
详情 |
详情
|
(XIII) |
35685 |
tert-butyl[3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propoxy]dimethylsilane; tert-butyl(dimethyl)silyl 3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propyl ether |
|
C35H58O4Si |
详情 |
详情
|
(XIV) |
35686 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-1-propanol
|
|
C29H44O4 |
详情 |
详情
|
(XV) |
35687 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propanal
|
|
C29H42O4 |
详情 |
详情
|
(XVI) |
35688 |
(E)-4-iodo-3-butenyl triisopropylsilyl ether; [[(E)-4-iodo-3-butenyl]oxy](triisopropyl)silane
|
|
C13H27IOSi |
详情 |
详情
|
(XVII) |
35689 |
(E)-1-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-7-[(triisopropylsilyl)oxy]-4-hepten-3-one
|
|
C42H68O5Si |
详情 |
详情
|
合成路线32
该中间体在本合成路线中的序号:
(IV) The intermediate aldehyde (XV) has been obtained as follows: The reaction of dimethyl malonate (I) with 3-(tert-butyldimethylsilyloxy)propyl iodide (II) by means of NaH in THF gives the alkylmalonate (III), which by a new alkylation with allyl bromide (IV) and NaH in DME affords the dialkylmalonate (V). The reduction of (V) with LiBH4 in THF yields the 1,3-propanediol (VI), which is cyclized with 2,2-dimethoxypropane and CSA in dichloromethane giving the 1,3-dioxane (VII). The ozonolysis of the double bond of (VII) with O3 in dichloromethane yields the aldehyde (VIII), which is protected by heating with cyclohexylamine (IX) to afford the imine (X). The condensation of (X) with 8(E)-decenal (XI) by means of LDA in ethyl ether gives the unsaturated aldehyde (XII), which is treated with PmbCl and KH in DME/HMPA to yield the enol ether (XIII). The desilylation of (XIII) with TBAF in THF gives the propanol derivative (XIV), which is oxidized with SO3.Pyr to the corresponding aldehyde (XV).
【1】
Nicolaou, K.C.; et al.; Total synthesis of the CP molecules CP-263,114 and CP-225,917 - Part 1: Synthesis of key intermediates and intelligence gathering. Angew Chem. Int Ed Engl 1999, 38, 11, 1669.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(II) |
35676 |
tert-butyl(3-iodopropoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-iodopropyl ether
|
|
C9H21IOSi |
详情 |
详情
|
(III) |
35677 |
dimethyl 2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C14H28O5Si |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
35678 |
dimethyl 2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C17H32O5Si |
详情 |
详情
|
(VI) |
35679 |
2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-1,3-propanediol
|
|
C15H32O3Si |
详情 |
详情
|
(VII) |
35680 |
3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propyl tert-butyl(dimethyl)silyl ether; [3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propoxy](tert-butyl)dimethylsilane
|
|
C18H36O3Si |
详情 |
详情
|
(VIII) |
35681 |
2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]acetaldehyde
|
|
C17H34O4Si |
详情 |
详情
|
(IX) |
17966 |
cyclohexanamine; cyclohexyl amine; cyclohexylamine
|
108-91-8 |
C6H13N |
详情 | 详情
|
(X) |
35682 |
N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]-N-cyclohexylamine; N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]cyclohexanamine
|
|
C23H45NO3Si |
详情 |
详情
|
(XI) |
35683 |
(E)-8-decenal
|
|
C10H18O |
详情 |
详情
|
(XII) |
35684 |
(2Z,10E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]-2,10-dodecadienal
|
|
C27H50O4Si |
详情 |
详情
|
(XIII) |
35685 |
tert-butyl[3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propoxy]dimethylsilane; tert-butyl(dimethyl)silyl 3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propyl ether |
|
C35H58O4Si |
详情 |
详情
|
(XIV) |
35686 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-1-propanol
|
|
C29H44O4 |
详情 |
详情
|
(XV) |
35687 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propanal
|
|
C29H42O4 |
详情 |
详情
|
合成路线33
该中间体在本合成路线中的序号:
(VIII) The reaction of 2(R)-(acetoxymethyl)-5-methyl-3(E)-hexen-1-ol (I) with MsCl and TEA in dichloromethane gives the mesylate (II), which is treated with NaN3 in hot DMF to yield the azido derivative (III). The hydrolysis of (III) catalyzed by Pseudomonas cepacia affords the azido alcohol (IV), which is reduced with PPh3 in THF/water to provide the aminoalcohol (V). The N-protection of (V) by means of Boc-ON and Et3N gives the carbamate (VI), which is O-protected by means of Tips-Cl and imidazole yielding the silyl ether (VII). The alkylation of the carbamate (VII) with allyl bromide (VIII) and NaH in DMF affords the allyl carbamate (IX), which is submitted to a ring closure metathesis reaction catalyzed by Grubb's catalyst to provide the chiral tetrahydropyridine (X). The desilylation of (X) by means of TBAF in THF gives N-(tert-butoxycarbonyl)-3(R)-(hydroxymethyl)-1,2,3,6-tetrahydropyridine (XI), which is treated with mCPBA in dichloromethane to yield an inseparable diastereomeric mixture of epoxides (XII) + (XIII). Finally, this mixture is treated with either HClO4 in acetone, HCl in ethyl acetate or with refluxing aq. KOH to afford separable mixtures of the target isofagomine and (XIV), one of its diastereomers.
【1】
Guanti, G.; Riva, R.; Asymmetrized tris(hydroxymethyl)methane as precursor of iminosugars: Application to the synthesis of isofagomine. Tetrahedron Lett 2003, 44, 2, 357.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
61784 |
(2R,3E)-2-(hydroxymethyl)-5-methyl-3-hexenyl acetate
|
|
C10H18O3 |
详情 |
详情
|
(II) |
61785 |
(2S,3E)-5-methyl-2-{[(methylsulfonyl)oxy]methyl}-3-hexenyl acetate
|
|
C11H20O5S |
详情 |
详情
|
(III) |
61786 |
(2R,3E)-2-(azidomethyl)-5-methyl-3-hexenyl acetate
|
|
C10H17N3O2 |
详情 |
详情
|
(IV) |
61787 |
(2R,3E)-2-(azidomethyl)-5-methyl-3-hexen-1-ol
|
|
C8H15N3O |
详情 |
详情
|
(V) |
61788 |
(2R,3E)-2-(aminomethyl)-5-methyl-3-hexen-1-ol
|
|
C8H17NO |
详情 |
详情
|
(VI) |
61789 |
tert-butyl (2R,3E)-2-(hydroxymethyl)-5-methyl-3-hexenylcarbamate
|
|
C13H25NO3 |
详情 |
详情
|
(VII) |
61790 |
tert-butyl (2R,3E)-5-methyl-2-{[(triisopropylsilyl)oxy]methyl}-3-hexenylcarbamate
|
|
C22H45NO3Si |
详情 |
详情
|
(VIII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IX) |
61791 |
tert-butyl allyl((2R,3E)-5-methyl-2-{[(triisopropylsilyl)oxy]methyl}-3-hexenyl)carbamate
|
|
C25H49NO3Si |
详情 |
详情
|
(X) |
61792 |
tert-butyl (3R)-3-{[(triisopropylsilyl)oxy]methyl}-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C20H39NO3Si |
详情 |
详情
|
(XI) |
61793 |
tert-butyl (3R)-3-(hydroxymethyl)-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C11H19NO3 |
详情 |
详情
|
(XII) |
61794 |
tert-butyl (1R,5R,6S)-5-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
|
C11H19NO4 |
详情 |
详情
|
(XIII) |
61795 |
tert-butyl (1S,5R,6R)-5-(hydroxymethyl)-7-oxa-3-azabicyclo[4.1.0]heptane-3-carboxylate
|
|
C11H19NO4 |
详情 |
详情
|
(XIV) |
61796 |
(3S,4S,5R)-5-(hydroxymethyl)-3,4-piperidinediol
|
|
C6H13NO3 |
详情 |
详情
|
合成路线34
该中间体在本合成路线中的序号:
The alkylation of diosmetin (I) with allyl bromide in the presence of NaH in DMF furnished the triallyl ether (II). Claisen rearrangement of (II) in refluxing trichlorobenzene then gave the title compound.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
30012 |
5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one
|
520-34-3 |
C16H12O6 |
详情 | 详情
|
(II) |
32941 |
5,7-bis(allyloxy)-2-[3-(allyloxy)-4-methoxyphenyl]-4H-chromen-4-one
|
|
C25H24O6 |
详情 |
详情
|
合成路线35
该中间体在本合成路线中的序号:
Condensation of L-phenylalanine methyl ester (I) with benzaldehyde gave aldimine (II). Then, alkylation of (II) with allyl bromide in the presence of LDA, and subsequent imine hydrolysis afforded the racemic alpha-allylphenylalanine methyl ester (III), which was protected as the N-Boc derivative (IV) upon treatment with Boc2O. Ozonolysis of the olefin group of (IV), followed by reductive workup with Me2S yielded the aldehyde ester (V). This was cyclized with hydrazine, affording pyridazinone (VI), which was further hydrogenated over PtO2 to give (VII). The 1,3-dipolar cycloaddition of the iminium ion (VIII), formed by treatment of (VII) with formaldehyde, with boiling ethyl acrylate furnished a mixture of pyrazolopyridazines (IXa-b). After chromatographic isolation of the racemic cis amino ester, hydrolysis with LiOH yielded carboxylic acid (X), which was activated as the mixed anhydride (XI) with isobutyl chloroformate. Coupling of racemic anhydride (XI) with the L-arginine analogue (XII) provided a diastereomeric mixture of amides, from which the desired isomer (XIII) was isolated by column chromatography. Finally, deprotection of (XIII) by means of trifluoroacetic acid furnished the title compound.
【1】
Nakanishi, H.; Ogbu, C.O.; Shea, J.P.; Cao, B.; Kahn, M.; Boatman, P.D.; Kim, H.-O.; Eguchi, M.; Secondary structure peptide mimetics: Design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors. J Med Chem 1999, 42, 8, 1367.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IXa) |
36777 |
methyl (1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C21H29N3O5 |
详情 |
详情
|
(IXb) |
36778 |
methyl (1R,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C21H29N3O5 |
详情 |
详情
|
(I) |
12324 |
methyl (2R)-2-amino-3-phenylpropanoate |
21685-51-8 |
C10H13NO2 |
详情 | 详情
|
(II) |
36770 |
methyl (2S)-3-phenyl-2-[[(E)-benzylidene]amino]propanoate
|
|
C17H17NO2 |
详情 |
详情
|
(III) |
36771 |
methyl 2-amino-2-benzyl-4-pentenoate
|
|
C13H17NO2 |
详情 |
详情
|
(IV) |
36772 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-pentenoate
|
|
C18H25NO4 |
详情 |
详情
|
(V) |
36773 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoate
|
|
C17H23NO5 |
详情 |
详情
|
(VI) |
36774 |
tert-butyl 4-benzyl-3-oxo-2,3,4,5-tetrahydro-4-pyridazinylcarbamate
|
|
C16H21N3O3 |
详情 |
详情
|
(VII) |
36775 |
tert-butyl 4-benzyl-3-oxohexahydro-4-pyridazinylcarbamate
|
|
C16H23N3O3 |
详情 |
详情
|
(VIII) |
36776 |
4-benzyl-4-[(tert-butoxycarbonyl)amino]-1-methylene-3-oxohexahydropyridazin-1-ium
|
|
C17H24N3O3 |
详情 |
详情
|
(X) |
36779 |
(1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylic acid
|
|
C20H27N3O5 |
详情 |
详情
|
(XI) |
36780 |
|
|
C25H35N3O7 |
详情 |
详情
|
(XII) |
36781 |
[[[[(4S)-4-amino-6-chloro-5-oxohexyl]amino](imino)methyl]amino](4-methoxy-2,3,6-trimethylphenyl)dioxo-lambda(6)-sulfane
|
|
C17H27ClN4O4S |
详情 |
详情
|
(XIII) |
36782 |
|
|
C38H52ClN7O10S |
详情 |
详情
|
合成路线36
该中间体在本合成路线中的序号:
(IV) The reaction of phenylalanine methyl ester (I) with benzaldehyde (II) and TEA in dichloromethane gives the aldimine (III), which is condensed with allyl bromide (IV) by means of n-BuLi in THF yielding the adduct (V). Treatment of (V) with HCl in methanol cleaves the benzylidene protecting group to afford the alpha-allylphenylalanine methyl ester (VI), which is reprotected with Boc2O and NaHCO3 in THF providing the carbamate (VII). The ozonolysis of (VII) with O3 in MeOH/CH2Cl2 gives the aldehyde (VIII), which is cyclized with hydrazine in refluxing THF yielding the tetrahydropyridazinone (IX). Hydrogenation of (IX) with H2 over PtO2 in methanol affords the hexahydropyridazinone (X), which is cyclocondensed with ethyl acrylate (XI) and formaldehyde to furnish the pyrazolopyridazine (XII). Hydrolysis of the ester group of (XII) with LiOH in THF/water gives the acid (XIII), which is finally condensed with N-omega(4-methoxytrityl)-L-arginylchloromethane (XIV) by means of isobutyl chloroformate and NMM in THF yielding, after working up, a diastereomeric mixture of amides, from which the target diastereomer is obtained by column chromatography.
【1】
Nakanishi, H.; Ogbu, C.O.; Shea, J.P.; Cao, B.; Kahn, M.; Boatman, P.D.; Kim, H.-O.; Eguchi, M.; Secondary structure peptide mimetics: Design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors. J Med Chem 1999, 42, 8, 1367.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40419 |
methyl 2-amino-3-phenylpropanoate
|
5619-07-8 |
C10H13NO2 |
详情 | 详情
|
(II) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(III) |
40420 |
methyl 3-phenyl-2-[[(E)-benzylidene]amino]propanoate
|
|
C17H17NO2 |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
40416 |
methyl 2-benzyl-2-[[(E)-benzylidene]amino]-4-pentenoate
|
|
C20H21NO2 |
详情 |
详情
|
(VI) |
36771 |
methyl 2-amino-2-benzyl-4-pentenoate
|
|
C13H17NO2 |
详情 |
详情
|
(VII) |
36772 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-pentenoate
|
|
C18H25NO4 |
详情 |
详情
|
(VIII) |
36773 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoate
|
|
C17H23NO5 |
详情 |
详情
|
(IX) |
36774 |
tert-butyl 4-benzyl-3-oxo-2,3,4,5-tetrahydro-4-pyridazinylcarbamate
|
|
C16H21N3O3 |
详情 |
详情
|
(X) |
36775 |
tert-butyl 4-benzyl-3-oxohexahydro-4-pyridazinylcarbamate
|
|
C16H23N3O3 |
详情 |
详情
|
(XI) |
10164 |
ethyl acrylate
|
140-88-5 |
C5H8O2 |
详情 | 详情
|
(XII) |
40417 |
ethyl (1S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C22H31N3O5 |
详情 |
详情
|
(XIII) |
36779 |
(1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylic acid
|
|
C20H27N3O5 |
详情 |
详情
|
(XIV) |
40418 |
N-[(4S)-4-amino-6-chloro-5-oxohexyl]-N'-[(4-methoxyphenyl)(diphenyl)methyl]guanidine
|
|
C27H31ClN4O2 |
详情 |
详情
|
合成路线37
该中间体在本合成路线中的序号:
Condensation of L-phenylalanine methyl ester (V) with benzaldehyde gave aldimine (VI). Then, alkylation of (VI) with allyl bromide in the presence of LDA, and subsequent imine hydrolysis afforded the racemic alpha-allylphenylalanine methyl ester (VII), which was protected as the N-Boc derivative (VIII) upon treatment with Boc2O. Ozonolysis of the olefin group of (VIII), followed by reductive workup with Me2S yielded the aldehyde ester (IX). This was cyclized with hydrazine, affording pyridazinone (X), which was further hydrogenated over PtO2 to give (XI). The 1,3-dipolar cycloaddition of the iminium ion (XII), formed by treatment of (XI) with formaldehyde, and boiling ethyl acrylate furnished a mixture of pyrazolopyridazines (XIIIa-b). After chromatographic isolation of the racemic cis amino ester, its hydrolysis with LiOH yielded carboxylic acid (XIV). Coupling of (XIV) with aminoalcohol (IVa-b) using EDC and HOBt provided the corresponding amide (XVa-d) as a mixture of 4 diastereomers. Oxidation of the secondary alcohol of (XVa-d) with Dess-Martin periodinane gave the diastereomeric ketones (XVIa-b). Then, deprotection of (XVIa-b) by means of trifluoroacetic acid, followed by separation of the isomers by HPLC furnished the title compound.
【1】
Nakanishi, H.; Ogbu, C.O.; Shea, J.P.; Cao, B.; Kahn, M.; Boatman, P.D.; Kim, H.-O.; Eguchi, M.; Secondary structure peptide mimetics: Design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors. J Med Chem 1999, 42, 8, 1367.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XIIIa) |
36777 |
methyl (1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C21H29N3O5 |
详情 |
详情
|
(XIIIb) |
36778 |
methyl (1R,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C21H29N3O5 |
详情 |
详情
|
(IVa) |
36787 |
2-[(1S,2S)-2-amino-1-hydroxy-5-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]pentyl]-1,3-benzothiazole
|
|
C23H31N5O4S2 |
详情 |
详情
|
(IVb) |
36788 |
2-[(1R,2S)-2-amino-1-hydroxy-5-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]pentyl]-1,3-benzothiazole
|
|
C23H31N5O4S2 |
详情 |
详情
|
(XVa) |
36789 |
tert-butyl (3S,6S)-3-[([(1S)-1-[(S)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H56N8O8S2 |
详情 |
详情
|
(XVb) |
36790 |
tert-butyl (3S,6S)-3-[([(1S)-1-[(R)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H56N8O8S2 |
详情 |
详情
|
(XVc) |
36791 |
tert-butyl (3S,6S)-3-[([(1R)-1-[(R)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H56N8O8S2 |
详情 |
详情
|
(XVd) |
36792 |
tert-butyl (3S,6S)-3-[([(1R)-1-[(S)-1,3-benzothiazol-2-yl(hydroxy)methyl]-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H56N8O8S2 |
详情 |
详情
|
(XVIa) |
36793 |
tert-butyl (3S,6S)-3-[([(1S)-1-(1,3-benzothiazol-2-ylcarbonyl)-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H54N8O8S2 |
详情 |
详情
|
(XVIb) |
36794 |
tert-butyl (3R,6S)-3-[([(1S)-1-(1,3-benzothiazol-2-ylcarbonyl)-4-[(imino[[(4-methoxy-2,3,6-trimethylphenyl)sulfonyl]amino]methyl)amino]butyl]amino)carbonyl]-6-benzyl-5-oxohexahydro-1H-pyrazolo[1,2-a]pyridazin-6-ylcarbamate
|
|
C43H54N8O8S2 |
详情 |
详情
|
(V) |
12324 |
methyl (2R)-2-amino-3-phenylpropanoate |
21685-51-8 |
C10H13NO2 |
详情 | 详情
|
(VI) |
36770 |
methyl (2S)-3-phenyl-2-[[(E)-benzylidene]amino]propanoate
|
|
C17H17NO2 |
详情 |
详情
|
(VII) |
36771 |
methyl 2-amino-2-benzyl-4-pentenoate
|
|
C13H17NO2 |
详情 |
详情
|
(VIII) |
36772 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-pentenoate
|
|
C18H25NO4 |
详情 |
详情
|
(IX) |
36773 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoate
|
|
C17H23NO5 |
详情 |
详情
|
(X) |
36774 |
tert-butyl 4-benzyl-3-oxo-2,3,4,5-tetrahydro-4-pyridazinylcarbamate
|
|
C16H21N3O3 |
详情 |
详情
|
(XI) |
36775 |
tert-butyl 4-benzyl-3-oxohexahydro-4-pyridazinylcarbamate
|
|
C16H23N3O3 |
详情 |
详情
|
(XII) |
36776 |
4-benzyl-4-[(tert-butoxycarbonyl)amino]-1-methylene-3-oxohexahydropyridazin-1-ium
|
|
C17H24N3O3 |
详情 |
详情
|
(XIV) |
36779 |
(1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylic acid
|
|
C20H27N3O5 |
详情 |
详情
|
合成路线38
该中间体在本合成路线中的序号:
(IV) The reaction of phenylalanine methyl ester (I) with benzaldehyde (II) and TEA in dichloromethane gives the aldimine (III), which is condensed with allyl bromide (IV) by means of n-BuLi in THF yielding the adduct (V). Treatment of (V) with HCl in methanol cleaves the benzylidene protecting group to afford the alpha-allylphenylalanine methyl ester (VI), which is reprotected with Boc2O and NaHCO3 in THF providing the carbamate (VII). The ozonolysis of (VII) with O3 in MeOH/CH2Cl2 gives the aldehyde (VIII), which is cyclized with hydrazine in refluxing THF yielding the tetrahydropyridazinone (IX). Hydrogenation of (IX) with H2 over PtO2 in methanol affords the hexahydropyridazinone (X), which is cyclocondensed with ethyl acrylate (XI) and formaldehyde to furnish the pyrazolopyridazine (XII). Hydrolysis of the ester group of (XII) with LiOH in THF/water gives the acid (XIII), which is finally condensed with the argininol derivative (XIV) by means of EDC, HOBT and DIEA in THF yielding the corresponding amide (XV). Finally, the secondary alcohol of (XV) is oxidized with Dess Martin periodinane (DMP) to afford, after working up, a diastereomeric mixture of amides, from which the target diastereomer is obtained by HPLC chromatography.
【1】
Nakanishi, H.; Ogbu, C.O.; Shea, J.P.; Cao, B.; Kahn, M.; Boatman, P.D.; Kim, H.-O.; Eguchi, M.; Secondary structure peptide mimetics: Design, synthesis, and evaluation of beta-strand mimetic thrombin inhibitors. J Med Chem 1999, 42, 8, 1367.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
40419 |
methyl 2-amino-3-phenylpropanoate
|
5619-07-8 |
C10H13NO2 |
详情 | 详情
|
(II) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(III) |
40420 |
methyl 3-phenyl-2-[[(E)-benzylidene]amino]propanoate
|
|
C17H17NO2 |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
40416 |
methyl 2-benzyl-2-[[(E)-benzylidene]amino]-4-pentenoate
|
|
C20H21NO2 |
详情 |
详情
|
(VI) |
36771 |
methyl 2-amino-2-benzyl-4-pentenoate
|
|
C13H17NO2 |
详情 |
详情
|
(VII) |
36772 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-pentenoate
|
|
C18H25NO4 |
详情 |
详情
|
(VIII) |
36773 |
methyl 2-benzyl-2-[(tert-butoxycarbonyl)amino]-4-oxobutanoate
|
|
C17H23NO5 |
详情 |
详情
|
(IX) |
36774 |
tert-butyl 4-benzyl-3-oxo-2,3,4,5-tetrahydro-4-pyridazinylcarbamate
|
|
C16H21N3O3 |
详情 |
详情
|
(X) |
36775 |
tert-butyl 4-benzyl-3-oxohexahydro-4-pyridazinylcarbamate
|
|
C16H23N3O3 |
详情 |
详情
|
(XI) |
10164 |
ethyl acrylate
|
140-88-5 |
C5H8O2 |
详情 | 详情
|
(XII) |
40417 |
ethyl (1S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylate
|
|
C22H31N3O5 |
详情 |
详情
|
(XIII) |
36779 |
(1S,7S)-7-benzyl-7-[(tert-butoxycarbonyl)amino]-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxylic acid
|
|
C20H27N3O5 |
详情 |
详情
|
(XIV) |
40421 |
N-[(4S)-4-amino-5-(1,3-benzothiazol-2-yl)-5-hydroxypentyl]-N'-[(4-methoxyphenyl)(diphenyl)methyl]guanidine
|
|
C33H35N5O2S |
详情 |
详情
|
(XV) |
40422 |
(1S)-7-amino-N-[(1S)-4-[[amino(imino)methyl]amino]-1-[1,3-benzothiazol-2-yl(hydroxy)methyl]butyl]-7-benzyl-8-oxohexahydro-1H-pyrazolo[1,2-a]pyridazine-1-carboxamide
|
|
C28H36N8O3S |
详情 |
详情
|
合成路线39
该中间体在本合成路线中的序号:
(X) The reaction of 2,2-dimethylpropane-1,3-diol (I) with benzaldehyde, Ts-OH and DIBAL gives the monobenzyl ether (II), which is oxidized with SO3/pyridine in dichloromethane, yielding the propionaldehyde (III). The condensation of (III) with butanone (IV) by means of LDA and TFAA affords the heptenone (V), which is epoxidated with H2O2 and NaOH in aq. methanol to provide the racemic epoxide (rac)-(VI). The reaction of ketone (VI) with O-methylhydroxylamine and NaOAc in methanol gives the corresponding oxime (rac)-(VII), which is treated with CuCN and MeLi in ethyl ether to yield the beta-hydroxy oxime (rac)-(VIII). The treatment of (VIII) with H2 and Raney-Ni in acetone/THF affords the corresponding beta-hydroxy ketone (rac)-(IX), which is allylated with allyl bromide (X) and LHMDS in the presence of 1,3-dimethylperhydropyrimidin-2-one to give the beta-hydroxynonen-5-one (rac)-(XI). The reduction of (XI) with Me4NBH(OAc)3 and HOAc in acetonitrile yields the diol (rac)-(XII), which is protected with 2-methoxypropene (XIII) and Ts-OH, affording the 1,3-dioxane (rac)-(XIV). The reaction of (XIV) with Li in liquid ammonia, tert-butanol and THF provides the debenzylated primary alcohol (rac)-(XV), which is oxidized with tetrapropylammonium perrhuthenate in dichloromethane, giving the corresponding aldehyde (rac)-(XVI).
【1】
Sawada, D.; et al.; Enantioselective total synthesis of epothilones A and B using multifunctional asymmetric catalysis. J Am Chem Soc 2000, 122, 43, 10521.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12641 |
Neopentyl glycol; 2,2-Dimethyl-1,3-propanediol
|
126-30-7 |
C5H12O2 |
详情 | 详情
|
(II) |
44529 |
3-(benzyloxy)-2,2-dimethyl-1-propanol
|
|
C12H18O2 |
详情 |
详情
|
(III) |
44504 |
3-(benzyloxy)-2,2-dimethylpropanal
|
|
C12H16O2 |
详情 |
详情
|
(IV) |
33891 |
Methyl ethyl ketone; 2-Butanone
|
78-93-3 |
C4H8O |
详情 | 详情
|
(V) |
44505 |
(E)-7-(benzyloxy)-6,6-dimethyl-4-hepten-3-one
|
|
C16H22O2 |
详情 |
详情
|
(VI) |
44506 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone
|
|
C16H22O3 |
详情 |
详情
|
(VII) |
44507 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone O-methyloxime
|
|
C17H25NO3 |
详情 |
详情
|
(VIII) |
44508 |
(4R,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone O-methyloxime
|
|
C18H29NO3 |
详情 |
详情
|
(IX) |
44509 |
(4S,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone
|
|
C17H26O3 |
详情 |
详情
|
(X) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XI) |
44510 |
(4S,6S,7R)-9-(benzyloxy)-7-hydroxy-4,6,8,8-tetramethyl-1-nonen-5-one
|
|
C20H30O3 |
详情 |
详情
|
(XII) |
44511 |
(3R,4R,5S,6S)-1-(benzyloxy)-2,2,4,6-tetramethyl-8-nonene-3,5-diol
|
|
C20H32O3 |
详情 |
详情
|
(XIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(XIV) |
44512 |
benzyl 2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propyl ether; (4R,5S,6S)-4-[2-(benzyloxy)-1,1-dimethylethyl]-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxane
|
|
C23H36O3 |
详情 |
详情
|
(XV) |
44513 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]-1-propanol
|
|
C16H30O3 |
详情 |
详情
|
(XVI) |
44514 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propanal
|
|
C16H28O3 |
详情 |
详情
|
合成路线40
该中间体在本合成路线中的序号:
(VI) Protection of (R)-glycidol (I) with trityl chloride (II) and TEA in dichloromethane gives the trityl ether (III), which is condensed with vinylmagnesium bromide (IV) in THF to yield the pentenol (V). The alkylation of (V) with allyl bromide (VI) by means of NaH in THF affords the allyl ether (VII), which is oxidized with O3 in methanol/dichloromethane, giving dialdehyde (VIII). Reduction of (VIII) with NaBH4 in ethanol provides diol (IX), which is treated with mesyl chloride and TEA in dichloromethane to afford the fully protected alcohol (X). Cyclization of (X) with 3,4-bis(3-indolyl)-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione (XI) by means of Cs2CO3 in DMF yields the hexacyclic compound (XII), which is N-demethylated by reaction with KOH in refluxing ethanol to give the hexacyclic furan derivative (XIII), which is then treated with hexamethyldisilazane (HMDS) in hot methanol to afford the hexacyclic demethylated pyrrole (XIV). Elimination of the trityl protecting group of (XIV) with HCl in dichloromethane gives the methanol derivative (XV), which is treated with Br2, pyridine and triphenyl phosphite in dichloromethane to yield the bromomethyl derivative (XVI). Finally, this compound is treated with dimethylamine in DMF to provide LY-333531. Alternatively, compound (XV) is treated with methanesulfonic anhydride and pyridine in THF, giving the mesylate (XVII), which is then treated with dimethylamine as before.
【1】
Faul, M.M.; Sullivan, K.A.; Neel, D.A.; Krumrich, C.A.; Jirousek, M.R.; Winneroski, L.L.; Gillig, J.R.; Rito, C.J.; Macrocyclic bisindolylmaleimides: Synthesis by inter- and intramolecular alkylation. J Org Chem 1998, 63, 6, 1961.
|
【2】
Sorbera, L.A.; Rabasseda, X.; Silvestre, J.S.; Castañer, J.; LY-333531 Mesylate Hydrate. Drugs Fut 2000, 25, 10, 1017-1026.
|
【3】
Engel, G.L.; Farid, N.A.; Faul, M.M.; Jirousek, M.R.; Richardson, L.A.; Winneroski, L.L. Jr. (Eli Lilly and Company); Protein kinase C inhibitor. EP 0776895; JP 1999500149; US 5710145; WO 9718809 .
|
【4】
Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. US 5721272 .
|
【5】
Rito, C.J.; Mcdonald, J.H. III; Jirousek, M.R.; Winneroski, L.L. Jr.; Heath, W.F. Jr.; Faul, M.M. (Eli Lilly and Company); Improved synthesis of bisindolylmaleimides. EP 0657411; US 5541347 .
|
【6】
Faul, M.M.; Winneroski, L.L. Jr.; Krumrich, C.A. (Eli Lilly and Company); Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides. EP 0776899 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
16260 |
(R)-(+)-Glycidol; (2R)-Oxiranemethanol; (2R)oxiranylmethanol
|
57044-25-4 |
C3H6O2 |
详情 | 详情
|
(II) |
28630 |
Triphenylchloromethane; 1-[Chloro(diphenyl)methyl]benzene; Trityl chloride
|
76-83-5 |
C19H15Cl |
详情 | 详情
|
(III) |
41006 |
(2S)-oxiranylmethyl trityl ether; (2S)-2-[(trityloxy)methyl]oxirane
|
|
C22H20O2 |
详情 |
详情
|
(IV) |
16524 |
bromo(vinyl)magnesium
|
1826-67-1 |
C2H3BrMg |
详情 | 详情
|
(V) |
41007 |
(2S)-1-(trityloxy)-4-penten-2-ol
|
|
C24H24O2 |
详情 |
详情
|
(VI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VII) |
41008 |
1-[[[(2S)-2-(allyloxy)-4-pentenyl]oxy](diphenyl)methyl]benzene; allyl (1S)-1-[(trityloxy)methyl]-3-butenyl ether
|
|
C27H28O2 |
详情 |
详情
|
(VIII) |
41009 |
(3S)-3-(2-oxoethoxy)-4-(trityloxy)butanal
|
|
C25H24O4 |
详情 |
详情
|
(IX) |
41010 |
(3S)-3-(2-hydroxyethoxy)-4-(trityloxy)-1-butanol
|
|
C25H28O4 |
详情 |
详情
|
(X) |
41011 |
(3S)-3-[2-[(methylsulfonyl)oxy]ethoxy]-4-(trityloxy)butyl methanesulfonate
|
|
C27H32O8S2 |
详情 |
详情
|
(XI) |
41012 |
3,4-di(1H-indol-3-yl)-1-methyl-1H-pyrrole-2,5-dione
|
113963-68-1 |
C21H15N3O2 |
详情 | 详情
|
(XII) |
41016 |
(18S)-4-methyl-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C46H39N3O4 |
详情 |
详情
|
(XIII) |
41017 |
(18S)-18-[(trityloxy)methyl]-4,17-dioxa-14,21-diazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C45H36N2O5 |
详情 |
详情
|
(XIV) |
41014 |
(18S)-18-[(trityloxy)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C45H37N3O4 |
详情 |
详情
|
(XV) |
41013 |
(18S)-18-(hydroxymethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C26H23N3O4 |
详情 |
详情
|
(XVI) |
41018 |
(18S)-18-(bromomethyl)-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione
|
|
C26H22BrN3O3 |
详情 |
详情
|
(XVII) |
41015 |
[(18S)-3,5-dioxo-17-oxa-4,14,21-triazahexacyclo[19.6.1.1(7,14).0(2,6).0(8,13).0(22,27)]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaen-18-yl]methyl methanesulfonate
|
|
C27H25N3O6S |
详情 |
详情
|
合成路线41
该中间体在本合成路线中的序号:
(II) Alkylation of the sodium salt of 5-nitroguaiacol (I) with allyl bromide (II) gave the allyl ether (III). The methoxy group of (III) was then displaced by NaOH in hot DMSO to produce 2-(allyloxy)-4-nitrophenol (IV), which was further alkylated with (R)-glycidyl tosylate (V), yielding the chiral oxirane (VI). Claisen rearrangement of the allyl ether function of (VI), followed by intramolecular cyclization between the phenol and epoxide groups in hot mesitylene furnished the benzodioxane derivative (VII). Treatment of (VII) with p-toluenesulfonyl chloride afforded tosylate (VIII). Oxidative cleavage of the allyl group of (VIII) with KMnO4 under phase-transfer conditions gave rise to the carboxylic acid (IX). Catalytic hydrogenation of the nitro group of (IX), followed by lactamization of the resultant aminoacid (X) under acidic conditions produced the dioxinoindolone system (XI). Then, nucleophilic displacement of the tosylate group of (XI) with benzylamine (XII) yielded the desired amine, which was finally converted to the corresponding fumarate salt.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56181 |
sodium 2-methoxy-5-nitrobenzenolate
|
|
C7H6NNaO4 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
56182 |
allyl 2-methoxy-5-nitrophenyl ether; 2-(allyloxy)-1-methoxy-4-nitrobenzene
|
|
C10H11NO4 |
详情 |
详情
|
(IV) |
56183 |
2-(allyloxy)-4-nitrophenol
|
|
C9H9NO4 |
详情 |
详情
|
(V) |
16242 |
(2R)oxiranylmethyl 4-methylbenzenesulfonate; (2R)-(-)-Glycidyl tosylate
|
113826-06-5 |
C10H12O4S |
详情 | 详情
|
(VI) |
56184 |
(2R)-2-{[2-(allyloxy)-4-nitrophenoxy]methyl}oxirane; allyl 5-nitro-2-[(2R)oxiranylmethoxy]phenyl ether
|
|
C12H13NO5 |
详情 |
详情
|
(VII) |
56185 |
[(2S)-8-allyl-7-nitro-2,3-dihydro-1,4-benzodioxin-2-yl]methanol
|
|
C12H13NO5 |
详情 |
详情
|
(VIII) |
56186 |
[(2R)-8-allyl-7-nitro-2,3-dihydro-1,4-benzodioxin-2-yl]methyl 4-methylbenzenesulfonate
|
|
C19H19NO7S |
详情 |
详情
|
(IX) |
56187 |
2-[(3R)-3-({[(4-methylphenyl)sulfonyl]oxy}methyl)-6-nitro-2,3-dihydro-1,4-benzodioxin-5-yl]acetic acid
|
|
C18H17NO9S |
详情 |
详情
|
(X) |
56188 |
2-[(3R)-6-amino-3-({[(4-methylphenyl)sulfonyl]oxy}methyl)-2,3-dihydro-1,4-benzodioxin-5-yl]acetic acid
|
|
C18H19NO7S |
详情 |
详情
|
(XI) |
56189 |
[(2R)-8-oxo-2,3,8,9-tetrahydro-7H-[1,4]dioxino[2,3-e]indol-2-yl]methyl 4-methylbenzenesulfonate
|
|
C18H17NO6S |
详情 |
详情
|
(XII) |
15147 |
Benzylamine; Phenylmethanamine
|
100-46-9 |
C7H9N |
详情 | 详情
|
合成路线42
该中间体在本合成路线中的序号:
(X) The condensation of 6-methoxyindan-1-one (I) with phosphonate (II) by means of NaH in THF gives 2-(6-methoxyindan-1-ylidene)acetonitrile (III), which is hydrogenated with h2 over Raney Co in ethanol/NH3 to yield 2-(6-methoxyindan-1-ylidene)ethylamine (IV). The acylation of (IV) with propionyl chloride (V) and TEA in THF affords the corresponding amide (VI), which is submitted to an asymmetric reduction with H2 and a chiral Ru catalyst to provide N-[2-(6-methoxyindan-1(S)-yl)ethyl]propionamide (VII). The bromination of (VII) with Br2 and NaOAc in methanol gives the 5-bromo derivative (VIII), which is demethylated by means of BBr3 in dichloromethane to yield the hydroxy compound (IX). The reaction of (IX) with allyl bromide (X) by means of NaH in DMF affords the allyl ether (XI), which is submitted to a Claisen rearrangement in N,N-diethylaniline at 200 C to provide the 7-allyl derivative (XII).The reaction of (XII) with ozone in methanol gives the acetaldehyde derivative (XIII), which is reduced with NaBH4 in methanol to yield the ethanol derivative (XIV). The hydrogenolysis of the Br substituent of (XIV) by means of H2 over Pd/C in methanol/TEA affords the dihydroxy compound (XV), which is treated with MsCl and pyridine to provide the mesylate (XVI). Finally, this compound is cyclized by means of TEA in refluxing ethyl acetate to furnish the target indeno[5,4-b]furan derivative.
【1】
Chilman-Blair, K.; Castaner, J.; Silvestre, J.S.; Bayes, M.; TAK-375. Drugs Fut 2003, 28, 10, 950.
|
【2】
Uchikawa, O.; Fukatsu, K.; Tokunoh, R.; et al.; Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists. J Med Chem 2002, 45, 19, 4222.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34515 |
6-methoxy-1-phenyl-1-indanol
|
|
C16H16O2 |
详情 |
详情
|
(II) |
10045 |
Diethyl cyanomethylphosphonate
|
2537-48-6 |
C6H12NO3P |
详情 | 详情
|
(III) |
62218 |
2-(6-methoxy-2,3-dihydro-1H-inden-1-ylidene)acetonitrile
|
|
C12H11NO |
详情 |
详情
|
(IV) |
62219 |
2-(6-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethylamine; 2-(6-methoxy-2,3-dihydro-1H-inden-1-ylidene)-1-ethanamine
|
|
C12H15NO |
详情 |
详情
|
(V) |
15967 |
propanoyl chloride; propionyl chloride
|
79-03-8 |
C3H5ClO |
详情 | 详情
|
(VI) |
62220 |
N-[2-(6-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethyl]propanamide
|
|
C15H19NO2 |
详情 |
详情
|
(VII) |
62221 |
N-{2-[(1S)-6-methoxy-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C15H21NO2 |
详情 |
详情
|
(VIII) |
62222 |
N-{2-[(1S)-5-bromo-6-methoxy-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C15H20BrNO2 |
详情 |
详情
|
(IX) |
62223 |
N-{2-[(1S)-5-bromo-6-hydroxy-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C14H18BrNO2 |
详情 |
详情
|
(X) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XI) |
62224 |
N-{2-[(1S)-6-(allyloxy)-5-bromo-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C17H22BrNO2 |
详情 |
详情
|
(XII) |
62225 |
N-{2-[(1S)-7-allyl-5-bromo-6-hydroxy-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C17H22BrNO2 |
详情 |
详情
|
(XIII) |
62226 |
N-{2-[(1S)-5-bromo-6-hydroxy-7-(2-oxoethyl)-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C16H20BrNO3 |
详情 |
详情
|
(XIV) |
62227 |
N-{2-[(1S)-5-bromo-6-hydroxy-7-(2-hydroxyethyl)-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C16H22BrNO3 |
详情 |
详情
|
(XV) |
62228 |
N-{2-[(1S)-6-hydroxy-7-(2-hydroxyethyl)-2,3-dihydro-1H-inden-1-yl]ethyl}propanamide
|
|
C16H23NO3 |
详情 |
详情
|
(XVI) |
62229 |
2-{(3S)-5-hydroxy-3-[2-(propionylamino)ethyl]-2,3-dihydro-1H-inden-4-yl}ethyl methanesulfonate
|
|
C17H25NO5S |
详情 |
详情
|
合成路线43
该中间体在本合成路线中的序号:
(IV) The reaction of dimethyl malonate (I) with 3-(tert-butyldimethylsilyloxy)propyl iodide (II) by means of NaH in THF gives the alkylmalonate (III), which by a new alkylation with allyl bromide (IV) and NaH in DME affords the dialkylmalonate (V). The reduction of (V) with LiBH4 in THF yields the 1,3-propanediol (VI), which is cyclized with 2,2-dimethoxypropane and CSA in dichloromethane giving the 1,3-dioxane (VII). The ozonolysis of the double bond of (VII) with O3 in dichloromethane yields the aldehyde (VIII), which is protected by heating with cyclohexylamine (IX) to afford the imine (X).The condensation of (X) with 8(E)-decenal (XI) by means of LDA in ethyl ether gives the unsaturated aldehyde (XII), which is treated with Pmb-Cl and KH in DME/HMPA to yield the enol ether (XIII). The desilylation of (XIII) with TBAF in THF gives the propanol derivative (XIV), which is oxidized with SO3/pyridine to the corresponding aldehyde (XV). The condensation of (XV) with 4-(triisopropylsilyloxy)-1(E)-butenyl iodide (XVI) by means of BuLi in THF, followed by oxidation of the intermediate alcohol with SO3/pyridine provides the unsaturated ketone (XVII).
【1】
Nicolaou, K.C.; et al.; Total synthesis of the CP molecules CP-263,114 and CP-225,917 - Part 1: Synthesis of key intermediates and intelligence gathering. Angew Chem. Int Ed Engl 1999, 38, 11, 1669.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
10722 |
1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane
|
77-76-9 |
C5H12O2 |
详情 | 详情
|
(I) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(II) |
35676 |
tert-butyl(3-iodopropoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-iodopropyl ether
|
|
C9H21IOSi |
详情 |
详情
|
(III) |
35677 |
dimethyl 2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C14H28O5Si |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
35678 |
dimethyl 2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C17H32O5Si |
详情 |
详情
|
(VI) |
35679 |
2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-1,3-propanediol
|
|
C15H32O3Si |
详情 |
详情
|
(VII) |
35680 |
3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propyl tert-butyl(dimethyl)silyl ether; [3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propoxy](tert-butyl)dimethylsilane
|
|
C18H36O3Si |
详情 |
详情
|
(VIII) |
35681 |
2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]acetaldehyde
|
|
C17H34O4Si |
详情 |
详情
|
(IX) |
17966 |
cyclohexanamine; cyclohexyl amine; cyclohexylamine
|
108-91-8 |
C6H13N |
详情 | 详情
|
(X) |
35682 |
N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]-N-cyclohexylamine; N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]cyclohexanamine
|
|
C23H45NO3Si |
详情 |
详情
|
(XI) |
35683 |
(E)-8-decenal
|
|
C10H18O |
详情 |
详情
|
(XII) |
35684 |
(2Z,10E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]-2,10-dodecadienal
|
|
C27H50O4Si |
详情 |
详情
|
(XIII) |
35685 |
tert-butyl[3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propoxy]dimethylsilane; tert-butyl(dimethyl)silyl 3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propyl ether |
|
C35H58O4Si |
详情 |
详情
|
(XIV) |
35686 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-1-propanol
|
|
C29H44O4 |
详情 |
详情
|
(XV) |
35687 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propanal
|
|
C29H42O4 |
详情 |
详情
|
(XVI) |
35688 |
(E)-4-iodo-3-butenyl triisopropylsilyl ether; [[(E)-4-iodo-3-butenyl]oxy](triisopropyl)silane
|
|
C13H27IOSi |
详情 |
详情
|
(XVII) |
35689 |
(E)-1-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-7-[(triisopropylsilyl)oxy]-4-hepten-3-one
|
|
C42H68O5Si |
详情 |
详情
|
合成路线44
该中间体在本合成路线中的序号:
(IV) The intermediate aldehyde (XV) has been obtained as follows: The reaction of dimethyl malonate (I) with 3-(tert-butyldimethylsilyloxy)propyl iodide (II) by means of NaH in THF gives the alkylmalonate (III), which by a new alkylation with allyl bromide (IV) and NaH in DME affords the dialkylmalonate (V). The reduction of (V) with LiBH4 in THF yields the 1,3-propanediol (VI), which is cyclized with 2,2-dimethoxypropane and CSA in dichloromethane giving the 1,3-dioxane (VII). The ozonolysis of the double bond of (VII) with O3 in dichloromethane yields the aldehyde (VIII), which is protected by heating with cyclohexylamine (IX) to afford the imine (X).The condensation of (X) with 8(E)-decenal (XI) by means of LDA in ethyl ether gives the unsaturated aldehyde (XII), which is treated with Pmb-Cl and KH in DME/HMPA to yield the enol ether (XIII). The desilylation of (XIII) with TBAF in THF gives the propanol derivative (XIV), which is oxidized with SO3.Pyr to the corresponding aldehyde (XV).
【1】
Nicolaou, K.C.; et al.; Total synthesis of the CP molecules CP-263,114 and CP-225,917 - Part 1: Synthesis of key intermediates and intelligence gathering. Angew Chem. Int Ed Engl 1999, 38, 11, 1669.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(II) |
35676 |
tert-butyl(3-iodopropoxy)dimethylsilane; tert-butyl(dimethyl)silyl 3-iodopropyl ether
|
|
C9H21IOSi |
详情 |
详情
|
(III) |
35677 |
dimethyl 2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C14H28O5Si |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
35678 |
dimethyl 2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)malonate
|
|
C17H32O5Si |
详情 |
详情
|
(VI) |
35679 |
2-allyl-2-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-1,3-propanediol
|
|
C15H32O3Si |
详情 |
详情
|
(VII) |
35680 |
3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propyl tert-butyl(dimethyl)silyl ether; [3-(5-allyl-2,2-dimethyl-1,3-dioxan-5-yl)propoxy](tert-butyl)dimethylsilane
|
|
C18H36O3Si |
详情 |
详情
|
(VIII) |
35681 |
2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]acetaldehyde
|
|
C17H34O4Si |
详情 |
详情
|
(IX) |
17966 |
cyclohexanamine; cyclohexyl amine; cyclohexylamine
|
108-91-8 |
C6H13N |
详情 | 详情
|
(X) |
35682 |
N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]-N-cyclohexylamine; N-[(E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]ethylidene]cyclohexanamine
|
|
C23H45NO3Si |
详情 |
详情
|
(XI) |
35683 |
(E)-8-decenal
|
|
C10H18O |
详情 |
详情
|
(XII) |
35684 |
(2Z,10E)-2-[5-(3-[[tert-butyl(dimethyl)silyl]oxy]propyl)-2,2-dimethyl-1,3-dioxan-5-yl]-2,10-dodecadienal
|
|
C27H50O4Si |
详情 |
详情
|
(XIII) |
35685 |
tert-butyl[3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propoxy]dimethylsilane; tert-butyl(dimethyl)silyl 3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propyl ether |
|
C35H58O4Si |
详情 |
详情
|
(XIV) |
35686 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)-1-propanol
|
|
C29H44O4 |
详情 |
详情
|
(XV) |
35687 |
3-(5-[(2E,9E)-1-[(E)-2-(4-methoxyphenyl)ethylidene]-2,9-undecadienyl]-2,2-dimethyl-1,3-dioxan-5-yl)propanal
|
|
C29H42O4 |
详情 |
详情
|
合成路线45
该中间体在本合成路线中的序号:
(IV) The acylation of (-)-2,10-camphorsultam (II) with octanoyl chloride (I) provides the N-octanoyl sultam (III). Diastereoselective alkylation of the lithium enolate of (III) with allyl bromide (IV) gives rise to the (2S)-2-propenoyloctanoyl sultam (V). Hydrolysis of the N-acyl sultam (V) to furnish acid (VI) is then effected by treatment with hydrogen peroxide-tetrabutylammonium hydroxide. Finally, catalytic hydrogenation of the unsaturated acid (VI) in the presence of either Pd/C or Pt/C yields the required (R)-2-propyloctanoic acid. Alternatively, the title compound is obtained by hydrogenation of the N-acyl sultam (V) to the saturated derivative (VII), followed by hydrolytic removal of the camphorsultam moiety.
【1】
Hasegawa, T.; Kawanaka, Y.; Kasamatsu, E.; Iguchi, Y.; Yonekawa, Y.; Okamoto, M.; Ohta, C.; Hashimoto, S.; Ohuchida, S.; Process development of ONO-2506: A therapeutic agent for stroke and Alzheimer's disease. Org Process Res Dev 2003, 7, 2, 168.
|
【2】
Hasegawa, T.; Yamamoto, H.; A practical synthesis of optically active (R)-2-propyloctanoic acid: Therapeutic agent for Alzheimer's disease. Bull Chem Soc Jpn 2000, 73, 2, 423.
|
【3】
Hasegawa, T.; Yamamoto, H.; A practical removal method of camphorsultam. Synlett 1998, 8, 882.
|
【4】
Yamamoto, H. (Ono Pharmaceutical Co., Ltd.); Novel intermediates and processes for the preparation of optically active octanoic acid derivs.. EP 1078921; US 6333415; WO 9958513 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11123 |
Octanoyl chloride; n-Caprylyl chloride;Capryloyl chloride |
111-64-8 |
C8H15ClO |
详情 | 详情
|
(II) |
58242 |
(1S,5R,7R)-10,10-dimethyl-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione
|
|
C10H17NO2S |
详情 |
详情
|
(III) |
58243 |
(1S,5R,7R)-10,10-dimethyl-4-octanoyl-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione
|
|
C18H31NO3S |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
58244 |
(1S,5R,7R)-4-[(2S)-2-hexyl-4-pentenoyl]-10,10-dimethyl-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione
|
|
C21H35NO3S |
详情 |
详情
|
(VI) |
58245 |
(1S,5R,7R)-10,10-dimethyl-4-[(2R)-2-propyloctanoyl]-3lambda~6~-thia-4-azatricyclo[5.2.1.0~1,5~]decane-3,3-dione
|
|
C21H37NO3S |
详情 |
详情
|
(VII) |
58246 |
(2S)-2-hexyl-4-pentenoic acid
|
|
C11H20O2 |
详情 |
详情
|
合成路线46
该中间体在本合成路线中的序号:
(II) The alkylation of 4(S)-benzyl-3-nonanoyloxazolidin-2-one (I) with allyl bromide (II) by means of lithium diisopropylamide (LDA), followed by hydrolysis with LiOOH gives the chiral pentenoic acid (III), which is treated with dimethylamine and cyanophosphonic acid diethyl ester yielding the dimethylamide (IV). The iodination of (IV) with I2/dimethoxyethane (DME) with simultaneous cyclization yields 3(R)-heptyl-5(S)-(iodomethyl)tetrahydrofuran-2-one (V). The condensation of (V) with thioacetic acid by means of NaH, followed by a reductive cleavage and tritylation with triphenylmethanol and trifluoroacetic acid (TFA) affords 3(R)-heptyl-5(S)-(tritylsulfanylmethyl)tetrahydrofuran-2-one (VI). The ring opening of (VI) with NaOH, follwed by silylation with tert-butyldimethylsilyl chloride gives 4(S)-(tert-butyldimethyl-silyloxy)-2(R)-heptyl-5-(tritylsulfanyl)pentanoic acid (VII), which is condensed with 2(S)-amino-N,3,3-trimethylbutyramide (VIII) by means of cyanophosphonic acid diethyl ester and desilylated with tetrabutylammonium fluoride to yield 2(S)-[2(R)-heptyl-4-(S)-hydroxy-5-(tritylsulfanyl)pentanamido]-N,3,3-trimethylbutyramide (IX). Finally, this compound is detritylated with trifluoroacetic acid (TFA) to afford the target compound (X).
【1】
Levin, J.I.; DiJoseph, J.F.; Killar, L.M.; Sharr, M.A.; Skotnicki, J.S.; Patel, D.V.; Xiao, X.-Y.; Shi, L.; Navre, M.; Campbell, D.A.; The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1998, 8, 10, 1163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
27010 |
(4S)-4-benzyl-3-nonanoyl-1,3-oxazolidin-2-one
|
|
C19H27NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
27011 |
(2R)-2-hexyl-4-pentenoic acid
|
|
C11H20O2 |
详情 |
详情
|
(IV) |
27012 |
(2R)-2-hexyl-N,N-dimethyl-4-pentenamide
|
|
C13H25NO |
详情 |
详情
|
(V) |
27013 |
(3R,5S)-3-heptyl-5-(iodomethyl)dihydro-2(3H)-furanone
|
|
C12H21IO2 |
详情 |
详情
|
(VI) |
27014 |
(3R,5S)-3-heptyl-5-[(tritylsulfanyl)methyl]dihydro-2(3H)-furanone
|
|
C31H36O2S |
详情 |
详情
|
(VII) |
27015 |
(2R)-2-[(2S)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-(tritylsulfanyl)propyl]nonanoic acid
|
|
C37H52O3SSi |
详情 |
详情
|
(VIII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(IX) |
27016 |
(2R)-2-[(2S)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-(tritylsulfanyl)propyl]-N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]nonanamide
|
|
C44H66N2O3SSi |
详情 |
详情
|
合成路线47
该中间体在本合成路线中的序号:
(II) The alkylation of 4(S)-benzyl-3-(4-methylpentanoyl)oxazolidin-2-one (I) with allyl bromide (II) by means of lithium diisopro-pylamide (LDA), followed by hydrolysis with LiOOH gives the chiral pentenoic acid (III), which is iodinated with I2, KI, KHCO3 with simultaneous cyclization yielding (R,R)-5-(iodomethyl)-3-isobutyltetrahydrofuran-2-one (IV). The condensation of (IV) with thioacetic acid by means of NaH, followed by a reductive cleavage and tritylation with triphenylmethanol and trifluoroacetic acid gives (R,R)-3-isobutyl-5-(tritylsulfanylmethyl)tetrahydrofuran-2-one (V). The ring opening of (V) with NaOH, follwed by silylation with tert-butyldimethylsilyl chloride gives (R,R)-4-(tert-butyldimethylsilyloxy)-2-isobutyl-5-(tritylsulfanyl)pentanoic acid (VI), which is condensed with 2(S)-amino-N,3,3-trimethylbutyramide (VII) by means of cyanophosphonic acid diethyl ester and desilylated with tetrabutylammonium fluoride to yield 2(S)-[2(R)-isobutyl-4-(R)-hydroxy-5-(triphenylmethylsulfanyl)pen-tanamido]-N,3,3-trimethylbutyramide (VIII). Finally, this compound is detritylated with trifluoroacetic acid (TFA) to afford the target compound.
【1】
Levin, J.I.; DiJoseph, J.F.; Killar, L.M.; Sharr, M.A.; Skotnicki, J.S.; Patel, D.V.; Xiao, X.-Y.; Shi, L.; Navre, M.; Campbell, D.A.; The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1998, 8, 10, 1163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
25391 |
(4S)-4-benzyl-3-(4-methylpentanoyl)-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
26985 |
(2R)-2-isobutyl-4-pentenoic acid
|
|
C9H16O2 |
详情 |
详情
|
(IV) |
27021 |
(3R,5R)-5-(iodomethyl)-3-isobutyldihydro-2(3H)-furanone
|
|
C9H15IO2 |
详情 |
详情
|
(V) |
27022 |
(3R,5R)-3-isobutyl-5-[(tritylsulfanyl)methyl]dihydro-2(3H)-furanone
|
|
C28H30O2S |
详情 |
详情
|
(VI) |
27023 |
(2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-isobutyl-5-(tritylsulfanyl)pentanoic acid
|
|
C34H46O3SSi |
详情 |
详情
|
(VII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(VIII) |
27024 |
(2R,4R)-N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-4-hydroxy-2-isobutyl-5-(tritylsulfanyl)pentanamide
|
|
C35H46N2O3S |
详情 |
详情
|
合成路线48
该中间体在本合成路线中的序号:
(II) The alkylation of 4(S)-benzyl-3-(4-methylpentanoyl)oxazolidin-2-one (I) with allyl bromide (II) by means of lithium diisopro-pylamide (LDA), followed by hydrolysis with LiOOH gives the chiral pentenoic acid (III), which is treated with dimethylamine and cyanophosphonic acid diethyl ester yielding the dimethylamide (IV). The iodination of (IV) with I2/dimethoxyethane (DME) with simultaneous cyclization yields 5(S)-(iodomethyl)-3(R)-isobutyltetrahydrofuran-2-one (V). The condensation of (V) with thioacetic acid by means of NaH, followed by a reductive cleavage and tritylation with triphenylmethanol and TFA affords 3(R)-isobutyl-5(S)-(triphenylmethylsulfanylmethyl)tetrahydrofuran-2-one (VI). The ring opening of (VI) with NaOH, follwed by silylation with tert-butyldimethylsilyl chloride gives 4(S)-(tert-butyldimethylsilyloxy)-2(R)-isobutyl-5-(tritylsulfanyl)pentanoic acid (VII), which is condensed with 2(S)-amino-N,3,3-trimethylbutyramide (VIII) by means of cyanophosphonic acid diethyl ester and desilylated with tetrabutylammonium fluoride to yield 2(S)-[2(R)-isobutyl-4-(S)-hydroxy-5-(tritylsulfanyl)pentanamido]-N,3,3-trimethylbutyramide (IX). Finally, this compound is detritylated with trifluoroacetic acid (TFA) to afford the target campound (X).
【1】
Levin, J.I.; DiJoseph, J.F.; Killar, L.M.; Sharr, M.A.; Skotnicki, J.S.; Patel, D.V.; Xiao, X.-Y.; Shi, L.; Navre, M.; Campbell, D.A.; The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1998, 8, 10, 1163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
25391 |
(4S)-4-benzyl-3-(4-methylpentanoyl)-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
26985 |
(2R)-2-isobutyl-4-pentenoic acid
|
|
C9H16O2 |
详情 |
详情
|
(IV) |
26986 |
(2R)-2-isobutyl-N,N-dimethyl-4-pentenamide
|
|
C11H21NO |
详情 |
详情
|
(V) |
26987 |
(3R,5S)-5-(iodomethyl)-3-isobutyldihydro-2(3H)-furanone
|
|
C9H15IO2 |
详情 |
详情
|
(VI) |
26988 |
(3R,5S)-3-isobutyl-5-[(tritylsulfanyl)methyl]dihydro-2(3H)-furanone
|
|
C28H30O2S |
详情 |
详情
|
(VII) |
26989 |
(2R,4S)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-isobutyl-5-(tritylsulfanyl)pentanoic acid
|
|
C34H46O3SSi |
详情 |
详情
|
(VIII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(IX) |
26990 |
(2R,4S)-N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-4-hydroxy-2-isobutyl-5-(tritylsulfanyl)pentanamide
|
|
C35H46N2O3S |
详情 |
详情
|
合成路线49
该中间体在本合成路线中的序号:
(II) The alkylation of 4(S)-benzyl-3-nonanoyloxazolidin-2-one (I) with allyl bromide (II) by means of lithium diisopropylamide (LDA), followed by hydrolysis with LiOOH gives the chiral pentenoic acid (III), which is iodinated with I2, KI, KHCO3 with simultaneous cyclization yielding (R,R)-3-heptyl-5-(iodomethyl)tetrahydrofuran-2-one (IV). The condensation of (IV) with thioacetic acid by means of NaH, followed by a reductive cleavage and tritylation with triphenylmethanol and trifluoroacetic acid (TFA) affords (R,R)-3-heptyl-5-(triphenylmethyl-sulfanylmethyl)tetrahydrofuran-2-one (V). The ring opening of (V) with NaOH, follwed by silylation with tert-butyldimethylsilyl chloride gives (R,R)-4-(tert-butyldimethylsilyloxy)-2-heptyl-5-(tritylsulfanyl)pentanoic acid (VI), which is condensed with 2(S)-amino-N,3,3-trimethylbutyramide (VII) by means of cyanophosphonic acid diethyl ester and desilylated with tetrabutylammonium fluoride to yield 2(S)-[2(R)-heptyl-4(R)-hydroxy-5-(tritylsulfanyl)pentanamido]-N,3,3-trimethylbutyramide (VIII). Finally, compound (VIII) is oxidized with TFA, pyridine, DMSO and EDC, and detritylated with TFA to give the target compound.
【1】
Levin, J.I.; DiJoseph, J.F.; Killar, L.M.; Sharr, M.A.; Skotnicki, J.S.; Patel, D.V.; Xiao, X.-Y.; Shi, L.; Navre, M.; Campbell, D.A.; The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1998, 8, 10, 1163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
27010 |
(4S)-4-benzyl-3-nonanoyl-1,3-oxazolidin-2-one
|
|
C19H27NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
27011 |
(2R)-2-hexyl-4-pentenoic acid
|
|
C11H20O2 |
详情 |
详情
|
(IV) |
27017 |
(3R,5R)-3-heptyl-5-(iodomethyl)dihydro-2(3H)-furanone
|
|
C12H21IO2 |
详情 |
详情
|
(V) |
27018 |
(3R,5R)-3-heptyl-5-[(tritylsulfanyl)methyl]dihydro-2(3H)-furanone
|
|
C31H36O2S |
详情 |
详情
|
(VI) |
27019 |
(2R)-2-[(2R)-2-[[tert-butyl(dimethyl)silyl]oxy]-3-(tritylsulfanyl)propyl]nonanoic acid
|
|
C37H52O3SSi |
详情 |
详情
|
(VII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(VIII) |
27020 |
(2R)-N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-2-[(2R)-2-hydroxy-3-(tritylsulfanyl)propyl]nonanamide
|
|
C38H52N2O3S |
详情 |
详情
|
合成路线50
该中间体在本合成路线中的序号:
(II) The alkylation of 4(S)-benzyl-3-(4-methylpentanoyl)oxazolidin-2-one (I) with allyl bromide (II) by means of lithium diisopro-pylamide (LDA), followed by hydrolysis with LiOOH gives the chiral pentenoic acid (III), which is iodinated with I2, KI, KHCO3 with simultaneous cyclization yielding (R,R)-5-(iodomethyl)-3-isobutyltetrahydrofuran-2-one (IV). The condensation of (IV) with thioacetic acid by means of NaH, followed by a reductive cleavage and tritylation with triphenylmethanol and trifluoroacetic acid gives (R,R)-3-isobutyl-5-(tritylsulfanylmethyl)tetrahydrofuran-2-one (V). The ring opening of (V) with NaOH, follwed by silylation with tert-butyldimethylsilyl chloride gives (R,R)-4-(tert-butyldimethylsilyloxy)-2-isobutyl-5-(tritylsulfanyl)pentanoic acid (VI), which is condensed with 2(S)-amino-N,3,3-trimethylbutyramide (VII) by means of cyanophosphonic acid diethyl ester and desilylated with tetrabutylammonium fluoride to yield 2(S)-[2(R)-isobutyl-4-(R)-hydroxy-5-(triphenylmethylsulfanyl)pen-tanamido]-N,3,3-trimethylbutyramide (VIII). Finally, compound (VIII) is oxidized with TFA, pyridine, DMSO and EDC, and detritylated with TFA to give the target compound.
【1】
Levin, J.I.; DiJoseph, J.F.; Killar, L.M.; Sharr, M.A.; Skotnicki, J.S.; Patel, D.V.; Xiao, X.-Y.; Shi, L.; Navre, M.; Campbell, D.A.; The asymmetric synthesis and in vitro characterization of succinyl mercaptoalcohol and mercaptoketone inhibitors of matrix metalloproteinases. Bioorg Med Chem Lett 1998, 8, 10, 1163. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
42235 |
Diethyl phosphorocyanidate; Diethyl cyanophosphonate; Cyanophosphonic acid diethyl ester; Diethyl phosphoryl cyanide; DEPC
|
2942-58-7 |
C5H10NO3P |
详情 | 详情
|
(I) |
25391 |
(4S)-4-benzyl-3-(4-methylpentanoyl)-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
26985 |
(2R)-2-isobutyl-4-pentenoic acid
|
|
C9H16O2 |
详情 |
详情
|
(IV) |
27021 |
(3R,5R)-5-(iodomethyl)-3-isobutyldihydro-2(3H)-furanone
|
|
C9H15IO2 |
详情 |
详情
|
(V) |
27022 |
(3R,5R)-3-isobutyl-5-[(tritylsulfanyl)methyl]dihydro-2(3H)-furanone
|
|
C28H30O2S |
详情 |
详情
|
(VI) |
27023 |
(2R,4R)-4-[[tert-butyl(dimethyl)silyl]oxy]-2-isobutyl-5-(tritylsulfanyl)pentanoic acid
|
|
C34H46O3SSi |
详情 |
详情
|
(VII) |
18843 |
(2S)-2-amino-N,3,3-trimethylbutanamide
|
89226-12-0 |
C7H16N2O |
详情 | 详情
|
(VIII) |
27024 |
(2R,4R)-N-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-4-hydroxy-2-isobutyl-5-(tritylsulfanyl)pentanamide
|
|
C35H46N2O3S |
详情 |
详情
|
合成路线51
该中间体在本合成路线中的序号:
(IX) Orcinol (I) was acetylated with Ac2O in pyridine to give diacetate (II), which was submitted to a Fries rearrangement in the presence of AlCl3 in chlorobenzene at 90 C to afford acetophenone (III). Subsequent condensation of (III) with 2,3,4,6-tetra-O-acetyl-alpha-D-glucopyranosyl bromide (IV) was effected either in the presence of CdCO3 in boiling toluene or K2CO3 and tributyl benzylammonium chloride in CH2Cl2 at r.t. The resulting (glucopyranosyloxy)acetophenone (V) was condensed with 5-formylbenzofuran (VI) in the presence of KOH to give chalcone (VII). Hydrogenation of (VII) over Pt/C then yielded the (benzofuranyl)propiophenone (VIII). After protection of the 6'-hydroxyl group of (VIII) as the allyl ether (X) with allyl bromide (IX) and K2CO3, the primary alcohol of (X) was acylated with ClCOOMe to furnish carbonate ester (XI). Finally, the O-allyl group of (XI) was cleaved with palladium catalyst and ammonium formate.
【1】
Doggrell, S.A.; Castañer, J.; T-1095. Drugs Fut 2001, 26, 8, 750.
|
【2】
Tsujihara, K.; et al.; Na+-glucose contransporter (SGLT) inhibitors as antidiabetic agents. 4. Synthesis and pharmacological properties of 4'-dehydroxyphlorizin derivatives substituted on the B ring. J Med Chem 1999, 42, 26, 5311.
|
【3】
Hongu, M.; Matsumoto, M.; Oku, A.; Saito, K.; Tsujihara, K. (Tanabe Seiyaku Co., Ltd.); Propiophenone derivs. and process for preparing the same. EP 0850948; JP 1998237089; US 6048842 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
16993 |
methyl chlorocarbonate;Carbonochloridic acid methyl ester;[(chlorocarbonyl)oxy]methane;methyl chloroformate |
79-22-1 |
C2H3ClO2 |
详情 | 详情
|
(I) |
27257 |
5-Methyl-1,3-benzenediol; Orcinol
|
505-15-4 |
C7H8O2 |
详情 | 详情
|
(II) |
27258 |
3-(acetoxy)-5-methylphenyl acetate
|
|
C11H12O4 |
详情 |
详情
|
(III) |
27259 |
1-(2,6-dihydroxy-4-methylphenyl)-1-ethanone
|
|
C9H10O3 |
详情 |
详情
|
(IV) |
27260 |
(2R,3R,4S,5S,6R)-4,5-bis(acetoxy)-6-[(acetoxy)methyl]-2-bromotetrahydro-2H-pyran-3-yl acetate
|
572-09-8 |
C14H19BrO9 |
详情 | 详情
|
(V) |
27261 |
(2R,3R,4S,5R,6S)-6-(2-acetyl-3-hydroxy-5-methylphenoxy)-4,5-bis(acetoxy)-2-[(acetoxy)methyl]tetrahydro-2H-pyran-3-yl acetate
|
|
C23H28O12 |
详情 |
详情
|
(VI) |
27262 |
1-benzofuran-5-carbaldehyde
|
|
C9H6O2 |
详情 |
详情
|
(VII) |
27263 |
(E)-3-(1-benzofuran-5-yl)-1-(2-hydroxy-4-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]phenyl)-2-propen-1-one
|
|
C24H24O9 |
详情 |
详情
|
(VIII) |
27264 |
3-(1-benzofuran-5-yl)-1-(2-hydroxy-4-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]phenyl)-1-propanone
|
|
C24H26O9 |
详情 |
详情
|
(IX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(X) |
27265 |
1-(2-(allyloxy)-4-methyl-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl]oxy]phenyl)-3-(1-benzofuran-5-yl)-1-propanone
|
|
C27H30O9 |
详情 |
详情
|
(XI) |
27266 |
((2R,3S,4S,5R,6S)-6-[3-(allyloxy)-2-[3-(1-benzofuran-5-yl)propanoyl]-5-methylphenoxy]-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl)methyl methyl carbonate
|
|
C29H32O11 |
详情 |
详情
|
合成路线52
该中间体在本合成路线中的序号:
The cyclization of L-serine (I) with pivalaldehyde (II) by means of LDA in THF gives the oxazolidine (III), which is acylated with formic and acetic anhydride yielding the N-formyloxazolidine (IV). The reaction of (IV) with LDA affords the chiral enol (V), which is treated with allyl bromide in THF to give the chiral 4-allyloxazolidine (VI). Cleavage of the oxazolidine ring with acetyl chloride and treatment with benzyl chloroformate yields the protected chiral 2-allylserine (VII), which is oxidized with oxalyl chloride to the corresponding aldehyde (VIII). The Wittig condensation of (VIII) with triphenylphosphoranylideneacetic acid methyl ester (IX) affords the intermediate (X), which is submitted to UV irradiation with an Hanovia medium pressure mercury lamp through a Pyrex filter in benzene containing benzophenone. A mixture of isomeric bicyclic compounds from which the desired compound (XI) is isolated by column chromatography. The hydrogenation of (IX) with H2 over Pd/C in methanol provides the bicyclic aminoester (XII), which is finally hydrolyzed with 6N HCl.
【1】
von Diester, S.; et al.; Stereoselektive Alkylierung an C(alpha) von Serin, Glycerinsaure, Threonin und Weinsaure uber heterocyclische Enolate mit exocyclischer Doppelbindung. Helv Chim Acta 1987, 70, 1194-1216.
|
【2】
Kozikowski, A.P.; et al.; Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist. J Med Chem 1998, 41, 10, 1641.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
20915 |
methyl (2S)-2-amino-3-hydroxypropanoate
|
5680-80-8 |
C4H9NO3 |
详情 | 详情
|
(II) |
19797 |
Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal
|
630-19-3 |
C5H10O |
详情 | 详情
|
(III) |
36839 |
methyl (4S)-2-(tert-butyl)-1,3-oxazolidine-4-carboxylate
|
|
C9H17NO3 |
详情 |
详情
|
(IV) |
36840 |
methyl (4S)-2-(tert-butyl)-3-formyl-1,3-oxazolidine-4-carboxylate
|
|
C10H17NO4 |
详情 |
详情
|
(V) |
36841 |
lithium [(2R)-2-(tert-butyl)-3-formyl-1,3-oxazolidin-4-ylidene](methoxy)methanolate
|
|
C10H16LiNO4 |
详情 |
详情
|
(VI) |
36842 |
methyl (2R,4S)-4-allyl-2-(tert-butyl)-3-formyl-1,3-oxazolidine-4-carboxylate
|
|
C13H21NO4 |
详情 |
详情
|
(VII) |
36843 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-2-(hydroxymethyl)-4-pentenoate
|
|
C15H19NO5 |
详情 |
详情
|
(VIII) |
36844 |
methyl (2S)-2-[[(benzyloxy)carbonyl]amino]-2-(2-oxoethyl)-4-pentenoate
|
|
C16H19NO5 |
详情 |
详情
|
(IX) |
14689 |
Methyl (triphenylphosphoranylidene)acetate; (methoxycarbonylmethylene)triphenylphosphorane;Methyl 2-(triphenyl-lambda(5)-phosphanylidene)acetate |
2605-67-6 |
C21H19O2P |
详情 | 详情
|
(X) |
36845 |
dimethyl (E,4S)-4-allyl-4-[[(benzyloxy)carbonyl]amino]-2-pentenedioate
|
|
C18H21NO6 |
详情 |
详情
|
(XI) |
36846 |
dimethyl (1R,2S,4R,5S)-2-[[(benzyloxy)carbonyl]amino]bicyclo[2.1.1]hexane-2,5-dicarboxylate
|
|
C18H21NO6 |
详情 |
详情
|
(XII) |
36847 |
dimethyl (1R,2S,4R,5S)-2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylate
|
|
C10H15NO4 |
详情 |
详情
|
合成路线53
该中间体在本合成路线中的序号:
(II) The alkylation of 2',4''-di-O-(trimethylsilyl)erythromycin A 9-O-(1-isopropoxycyclohexyl)oxime (I) with allyl bromide (II) by means of potassium tert-butoxide in DMSO/THF, followed first by acidification with acetic acid and then by treatment with NaHSO3/HCO2H, gives 6-O-allylerythromycin A (III), which is acylated with acetic anhydride in acetonitrile, yielding the diacetate (IV). Reaction of (IV) with either carbonyldiimidazole (CDI) and LiH or CDI and sodium hexamethyldisilazane (NaHMDS) in THF affords the 12-O-(imidazolylcarbonyl)erythromycin derivative (V), which is cyclized with NH4OH in acetonitrile / THF, giving the cyclic carbamate (VI). Elimination of the cladinose group of (VI) by treatment with HCl in ethanol/water followed by reaction with N-chlorosuccinimide (NCS) and dimethyl sulfide in dichloromethane provides the ketolide (VII), which is condensed with 3-bromoquinoline (VIII) under Heck coupling conditions, palladium acetate, tris(o-tolyl)phosphine and Et3N in acetonitrile, and finally deprotected with MeOH 60-80%.
【1】
Ma, Z.; et al.; Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens. J Med Chem 2001, 44, 24, 4137.
|
【2】
Or, Y.; Clark, R.F.; Ma, Z.; Design, synthesis, and characterization of ABT-773: A novel ketolide highly active against multidrug-resistant pathogens. 39th Intersci Conf Antimicrob Agents Chemother (Sept 26 1999, San Francisco) 1999, Abst F2133.
|
【3】
Ewing, P.; Or, Y.S.; Nilius, A.M.; Wang, S.; Clark, R.F.; Alder, J.; Chu, D.T.W.; Mitten, M.; Flamm, R.K.; Ma, Z.; Design, synthesis, and antimicrobial activity of 6-O-substituted ketolides active against resistant respiratory tract pathogens. J Med Chem 2000, 43, 6, 1045-49. |
【4】
Rabasseda, X.; Sorbera, L.A.; Castañer, J.; ABT-773. Drugs Fut 2000, 25, 5, 445.
|
【5】
Adachi, T.; Sekiguchi, K.; Sota, K.; Asaka, T.; Matsunaga, T.; Morimoto, S.; Watanabe, Y.; Kashimura, M. (Taisho Pharmaceutical Co., Ltd.); Erythromycin A derivs.. EP 0272110; US 4990602 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35291 |
|
|
C52H100N2O14Si2 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
28391 |
(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-6-[[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-14-ethyl-12,13-dihydroxy-4-[[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy]-3,5,7,9,11,13-hexamethyl-2,10-oxacyclotetradecanedione |
|
C40H71NO13 |
详情 |
详情
|
(IV) |
35292 |
|
|
C44H75NO15 |
详情 |
详情
|
(V) |
35293 |
|
|
C48H75N3O15 |
详情 |
详情
|
(VI) |
35294 |
|
|
C45H74N2O15 |
详情 |
详情
|
(VII) |
35295 |
|
|
C35H56N2O11 |
详情 |
详情
|
(VIII) |
28432 |
3-bromoquinoline
|
5332-24-1 |
C9H6BrN |
详情 | 详情
|
合成路线54
该中间体在本合成路线中的序号:
(XXI) The intermediate gamma-butyrolactone (XXVIII) has been obtained as follows: Allylation of the imidazolidinone intermediate (V) with allyl bromide (XXI) and LiHMDS in THF gives the chiral intermediate (XXII), which by dihydroxylation and cleavage of the chiral auxiliary with OsO4 and NMMO in tert-butanol/acetone/water yields the lactone alcohol (XXIII). Oxidation of (XXIII) with NaIO4 and RuCl3 in CCl4/acetonitrile/water affords the carboxylic acid (XXIV), which by treatment with (COCl)2 in toluene provides the acyl chloride (XXV). Esterification of (XXV) with benzyl alcohol gives the corresponding benzyl ester as a diastereomeric mixture, from which the desired isomer (XXVI) is separated by flash chromatography. Hydrogenolysis of the benzyl ester (XXVI) with H2 over Pd/C in ethyl acetate yields the carboxylic acid (XXVII), which is treated with oxalyl chloride in toluene to afford the desired gamma-butyrolactone intermediate (XXVIII).
【1】
Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
|
【2】
Rüeger, H.; Maibaum, J.; Stutz, S.; Spindler, F.; Göschke, R.; A convergent synthesis approach towards CGP60536B, a non-peptide orally potent renin inhibitor, via an enantiomerically pure ketolactone intermediate. Tetrahedron Lett 2000, 41, 51, 10085. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
28131 |
(4S)-4-benzyl-3-(3-methylbutanoyl)-1,3-oxazolidin-2-one
|
|
C15H19NO3 |
详情 |
详情
|
(XXI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXII) |
50566 |
(4S)-4-benzyl-3-[(2S)-2-isopropyl-4-pentenoyl]-1,3-oxazolidin-2-one
|
|
C18H23NO3 |
详情 |
详情
|
(XXIII) |
50567 |
(3S)-5-(hydroxymethyl)-3-isopropyldihydro-2(3H)-furanone
|
|
C8H14O3 |
详情 |
详情
|
(XXIV) |
50568 |
(4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylic acid
|
|
C8H12O4 |
详情 |
详情
|
(XXV) |
50569 |
(4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride
|
|
C8H11ClO3 |
详情 |
详情
|
(XXVI) |
50570 |
benzyl (2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylate
|
|
C15H18O4 |
详情 |
详情
|
(XXVII) |
50571 |
(2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarboxylic acid
|
|
C8H12O4 |
详情 |
详情
|
(XXVIII) |
50572 |
(2S,4S)-4-isopropyl-5-oxotetrahydro-2-furancarbonyl chloride
|
|
C8H11ClO3 |
详情 |
详情
|
合成路线55
该中间体在本合成路线中的序号:
(XXI) The chiral azido intermediate (XXXIV) can also be obtained as follows: Reaction of (+)-pseudoephedrine isovaleramide (XLIII) with allyl bromide (XXI) by means of LDA in THF gives the pentenoyl amide (XLIV), which is treated with NBS in DME/water to yield the spiro compound (XLV). Hydrolysis of the bromomethyl group of (XLV) with tetrabutylammonium acetate and K2CO3 affords the carbinol (XLVI), which is oxidized to aldehyde (XLVII) with SO3/pyridine and TEA in DMSO/dichloromethane. Condensation of (XLVII) with the propyl chloride intermediate (XXX) by means of Mg, dibromoethane and CeCl3 in refluxing THF provides the already reported chiral hydroxylactone (XXXII), which is treated first with 4-bromobenzenesulfonyl chloride and then with NaN3 to give the desired azido derivative (XXXIV).
【1】
Mealy, N.E.; Castañer, R.M.; Silvestre, J.S.; Castañer, J.; Aliskiren Fumarate. Drugs Fut 2001, 26, 12, 1139.
|
【2】
Carey, J.S.; Sandham, D.A.; Taylor, R.J.; Fassler, A.; A convergent synthesis of the renin inhibitor CGP60536B. Tetrahedron Lett 2000, 41, 51, 10091.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXX) |
50574 |
4-[(2R)-2-(chloromethyl)-3-methylbutyl]-1-methoxy-2-(3-methoxypropoxy)benzene; 3-[5-[(2R)-2-(chloromethyl)-3-methylbutyl]-2-methoxyphenoxy]propyl methyl ether
|
324763-39-5 |
C17H27ClO3 |
详情 | 详情
|
(XXXII) |
50576 |
(3S,5S)-5-[(1R,3S)-1-hydroxy-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone
|
|
C25H40O6 |
详情 |
详情
|
(XXXIV) |
50578 |
(3S,5S)-5-[(1S,3S)-1-azido-3-[4-methoxy-3-(3-methoxypropoxy)benzyl]-4-methylpentyl]-3-isopropyldihydro-2(3H)-furanone
|
|
C25H39N3O5 |
详情 |
详情
|
(XLIII) |
50585 |
N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-N,3-dimethylbutanamide
|
|
C15H23NO2 |
详情 |
详情
|
(XLIV) |
50586 |
(2S)-N-[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]-2-isopropyl-N-methyl-4-pentenamide
|
|
C18H27NO2 |
详情 |
详情
|
(XLV) |
50587 |
(2S,3S,5R,7S,9S)-7-(bromomethyl)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane
|
|
C18H26BrNO2 |
详情 |
详情
|
(XLVI) |
50588 |
[(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]non-7-yl]methanol
|
|
C18H27NO3 |
详情 |
详情
|
(XLVII) |
50589 |
(2S,3S,5R,7S,9S)-9-isopropyl-3,4-dimethyl-2-phenyl-1,6-dioxa-4-azaspiro[4.4]nonane-7-carbaldehyde
|
|
C18H25NO3 |
详情 |
详情
|
合成路线56
该中间体在本合成路线中的序号:
(I) The hydroboration of allyl bromide (I) with diisopinocampheylborane gives the 3-bromopropylboronic ester (II), which by treatment with acetaldehyde and water yields the boronic acid (III). The reaction of (III) with NaN3 and ethanol affords 3-azidoboronic acid ethyl ester (IV), which is transesterified with optically active pipanediol (V) giving the cyclic ester (VI). The homologation of (VI) with LDA, ZnCl2 and dichloromethane in THF yields the alpha-chlorobutylboronic ester (VII), which is aminated with hexamethyldisylazane (HMDS) and BuLi to provide the silylated alpha-aminoboronic ester (VIII). The desilylation of (VIII) with methanol, and its protection with benzyl chloroformate gives the protected alpha-aminoboronic ester (IX). The hydrogenation of the azido group of (IX) with H2 over PtO2 affords the 4-aminobutylboronic ester (X), which is treated with N,N'-bis(tert-butoxycarbonyl)thiourea (XI), HgCl2 and TEA in DMF to give the guanidine derivative (XII). Finally, this compound is hydrolyzed and deprotected with refluxing 6N HCl.
【1】
Lebarbier, C.; Carreaux, F.; Carboni, B.; Boucher, J.L.; Synthesis of boronic acid analogs of L-arginine as alternate substrates or inhibitors of nitric oxide synthase. Bioorg Med Chem Lett 1998, 8, 18, 2573.
|
【2】
Lebarbier, C.; et al.; Synthesis of a boronic acid analogue of L-ornithine. Synthesis 1996, 1371.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
10101 |
Benzyloxycarbonyl chloride; Benzyl chloroformate; 1-[[(Chlorocarbonyl)oxy]methyl]benzene
|
501-53-1 |
C8H7ClO2 |
详情 | 详情
|
(I) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(II) |
36654 |
bis[[(1R,2S,3S,5S)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]methyl] 3-bromopropylboronate
|
|
C25H44BBrO2 |
详情 |
详情
|
(III) |
36655 |
3-bromopropylboronic acid
|
|
C3H8BBrO2 |
详情 |
详情
|
(IV) |
36656 |
diethyl 3-azidopropylboronate
|
|
C7H16BN3O2 |
详情 |
详情
|
(V) |
32535 |
(1R,2S,3R,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol |
|
C10H18O2 |
详情 |
详情
|
(VI) |
36657 |
3-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]propyl azide; (1S,2R,6S,8S)-4-(3-azidopropyl)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane
|
|
C13H22BN3O2 |
详情 |
详情
|
(VII) |
36658 |
(4S)-4-chloro-4-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butyl azide; (1S,2R,6S,8S)-4-[(1S)-4-azido-1-chlorobutyl]-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane
|
|
C14H23BClN3O2 |
详情 |
详情
|
(VIII) |
36659 |
N-[(1R)-4-azido-1-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butyl](trimethyl)-N-(trimethylsilyl)silanamine; N-[(1R)-4-azido-1-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butyl]-N,N-bis(trimethylsilyl)amine |
|
C20H41BN4O2Si2 |
详情 |
详情
|
(IX) |
36660 |
benzyl (1R)-4-azido-1-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butylcarbamate
|
|
C22H31BN4O4 |
详情 |
详情
|
(X) |
36661 |
benzyl (1R)-4-amino-1-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butylcarbamate
|
|
C22H33BN2O4 |
详情 |
详情
|
(XI) |
21843 |
tert-butyl [(tert-butoxycarbonyl)amino]carbothioylcarbamate
|
145013-05-4 |
C11H20N2O4S |
详情 | 详情
|
(XII) |
36662 |
benzyl (1R)-4-([[(tert-butoxycarbonyl)amino][(tert-butoxycarbonyl)imino]methyl]amino)-1-[(1S,2R,6S,8S)-6,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butylcarbamate
|
|
C33H51BN4O8 |
详情 |
详情
|
合成路线57
该中间体在本合成路线中的序号:
(V) The sodium salt of L-phenylalanine (I) was condensed with pivalaldehyde (II) in boiling pentane to afford imine (III). Subsequent reaction of (III) with benzyl chloroformate generated oxazolidinone (IV) as a 9:1 mixture of diastereoisomers, which were separated chromatographically. The required cis compound was treated with allyl bromide (V) in the presence of potassium hexamethyldisilazide in THF at -78 C to provide (VI) as the major isomer. Aldehyde (VII) was then obtained by ozonolysis of (VI) at -78 C. Reductive amination of (VII) with L-homophenylalanine methyl ester (VIII) using NaBH3CN yielded the corresponding amine (IX) which, upon heating in toluene in the presence of 1-hydroxybenzotriazole, afforded pyrrolidinone (X). Reduction of the ester function of (X) with Ca(BH4)2 gave alcohol (XI), which was finally oxidized under Swern conditions to the target aldehyde.
【1】
Scheidt, K.A.; Roush, W.R.; McKerrow, J.H.; Selzer, P.M.; Hansell, E.; Rosenthal, P.J.; Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. Bioorg Med Chem 1998, 6, 12, 2477.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13952 |
(S)-(-)-Phenylalanine; L-Phenylalanine
|
63-91-2 |
C9H11NO2 |
详情 | 详情
|
(II) |
19797 |
Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal
|
630-19-3 |
C5H10O |
详情 | 详情
|
(III) |
24385 |
sodium (2S)-2-[[(E)-2,2-dimethylpropylidene]amino]-3-phenylpropanoate
|
|
C14H18NNaO2 |
详情 |
详情
|
(IV) |
24386 |
benzyl (4S)-4-benzyl-2-(tert-butyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C22H25NO4 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
24388 |
benzyl (2S,4S)-4-allyl-4-benzyl-2-(tert-butyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C25H29NO4 |
详情 |
详情
|
(VII) |
24389 |
benzyl (2S,4R)-4-benzyl-2-(tert-butyl)-5-oxo-4-(2-oxoethyl)-1,3-oxazolidine-3-carboxylate
|
|
C24H27NO5 |
详情 |
详情
|
(VIII) |
24390 |
methyl (2S)-2-amino-4-phenylbutanoate
|
|
C11H15NO2 |
详情 |
详情
|
(IX) |
24391 |
benzyl (2S,4R)-4-benzyl-2-(tert-butyl)-4-(2-[[(1S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]ethyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C35H42N2O6 |
详情 |
详情
|
(X) |
24392 |
methyl (2S)-2-((3R)-3-benzyl-3-[[(benzyloxy)carbonyl]amino]-2-oxopyrrolidinyl)-4-phenylbutanoate
|
|
C30H32N2O5 |
详情 |
详情
|
(XI) |
24393 |
benzyl (3R)-3-benzyl-1-[(1S)-1-(hydroxymethyl)-3-phenylpropyl]-2-oxopyrrolidinylcarbamate
|
|
C29H32N2O4 |
详情 |
详情
|
合成路线58
该中间体在本合成路线中的序号:
(V) The sodium salt of L-phenylalanine (I) was condensed with pivalaldehyde (II) in boiling pentane to afford imine (III). Subsequent reaction of (III) with benzyl chloroformate generated oxazolidinone (IV) as a 9:1 mixture of diastereoisomers, which were separated chromatographically. The required cis compound was treated with allyl bromide (V) in the presence of potassium hexamethyldisilazide in THF at -78 C to provide (VI) as the major isomer. Aldehyde (VII) was then obtained by ozonolysis of (VI) at -78 C. Reductive amination of (VII) with L-homophenylalanine methyl ester (VIII) using NaBH3CN yielded the corresponding amine (IX) which, upon heating in toluene in the presence of 1-hydroxybenzotriazole, afforded pyrrolidinone (X). The carbobenzoxy group of (X) was then removed by hydrogenolysis over Pd/C, and the resulting amine was acylated with benzenesulfonyl chloride to produce sulfonamide (XI). Finally, the target aldehyde was obtained by the sequence of ester reduction of (XI) with Ca(BH4)2, followed by Swern oxidation of the resulting alcohol.
【1】
Scheidt, K.A.; Roush, W.R.; McKerrow, J.H.; Selzer, P.M.; Hansell, E.; Rosenthal, P.J.; Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. Bioorg Med Chem 1998, 6, 12, 2477.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
13952 |
(S)-(-)-Phenylalanine; L-Phenylalanine
|
63-91-2 |
C9H11NO2 |
详情 | 详情
|
(II) |
19797 |
Trimethylacetaldehyde; pivalaldehyde; 2,2-Dimethylpropionaldehyde; 2,2-Dimethylpropanal
|
630-19-3 |
C5H10O |
详情 | 详情
|
(III) |
24385 |
sodium (2S)-2-[[(E)-2,2-dimethylpropylidene]amino]-3-phenylpropanoate
|
|
C14H18NNaO2 |
详情 |
详情
|
(IV) |
24386 |
benzyl (4S)-4-benzyl-2-(tert-butyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C22H25NO4 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
24388 |
benzyl (2S,4S)-4-allyl-4-benzyl-2-(tert-butyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C25H29NO4 |
详情 |
详情
|
(VII) |
24389 |
benzyl (2S,4R)-4-benzyl-2-(tert-butyl)-5-oxo-4-(2-oxoethyl)-1,3-oxazolidine-3-carboxylate
|
|
C24H27NO5 |
详情 |
详情
|
(VIII) |
24390 |
methyl (2S)-2-amino-4-phenylbutanoate
|
|
C11H15NO2 |
详情 |
详情
|
(IX) |
24391 |
benzyl (2S,4R)-4-benzyl-2-(tert-butyl)-4-(2-[[(1S)-1-(methoxycarbonyl)-3-phenylpropyl]amino]ethyl)-5-oxo-1,3-oxazolidine-3-carboxylate
|
|
C35H42N2O6 |
详情 |
详情
|
(X) |
24392 |
methyl (2S)-2-((3R)-3-benzyl-3-[[(benzyloxy)carbonyl]amino]-2-oxopyrrolidinyl)-4-phenylbutanoate
|
|
C30H32N2O5 |
详情 |
详情
|
(XI) |
24394 |
methyl (2S)-2-[(3R)-3-benzyl-2-oxo-3-[(phenylsulfonyl)amino]pyrrolidinyl]-4-phenylbutanoate
|
|
C28H30N2O5S |
详情 |
详情
|
合成路线59
该中间体在本合成路线中的序号:
(II) The alkylation of the prochiral trans-2,5-dimethylpiperazine (I) with allyl bromide (II) produced a racemic mixture of N-allyl piperazines. After separation of the (+)-isomer by precipitation with (+)-camphoric acid, the desired (-)-piperazine (III) was isolated from the remaining enriched mixture by crystallization as the di-p-toluoyl-D-tartrate salt.
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20687 |
(2R,5S)-2,5-dimethylpiperazine
|
|
C6H14N2 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
20690 |
(2R,5S)-1-allyl-2,5-dimethylpiperazine
|
|
C9H18N2 |
详情 |
详情
|
合成路线60
该中间体在本合成路线中的序号:
(XV) The reaction of the chiral epoxide (I) with 4-methoxybenzaldehyde (II) by means of NaAl(OMe)3H in THF gives the 1,3-dioxane (III), which is opened by reduction with DIBAL in dichloromethane to yield the chiral benzyl ether (IV). The oxidation of the primary alcohol of (IV) with DMP in dichloromethane affords the corresponding aldehyde (V), which is condensed with the boronate (VI) and S,S-diisopropyl tartrate in toluene to provide the unsaturated alcohol (VII).The protection of (VII) with Tbdps-Cl and imidazole yields the fully protected triol (VIII), which is oxidized at the terminal double bond with 9-BBN in THF to give the primary alcohol (IX). The oxidation of (IX) with DMP in dichloromethane affords the aldehyde (X), which is condensed with methylenetriphenylphosphorane (XI) in THF to provide the terminal olefin (XII). Elimination of the Pmb protecting group of (XII) with DDQ in dichloromethane gives the alcohol (XIII), which is esterified with 2-allyl-6-methoxybenzoic acid (XIV)(obtained by allylation of 2-methoxybenzoic acid (XV) with allyl bromide (XVI), BuLi and MgBr2) by means of DEAD and PPh3 yielding the ester (XVII). The cyclization of (XVII) by means of a metathesis reaction catalyzed by a ruthenium catalyst in refluxing dichloromethane affords the bicyclic lactone (XVIII), which is treated with BBr3 in dichloromethane to provide the dihydroxylated lactone (XIX).
【1】
Labrecque, D.; et al.; Enantioselective total synthesis of salicylihalamides A and B. Tetrahedron Lett 2001, 42, 14, 2645.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47480 |
[(2R,3R)-3-[3-(benzyloxy)propyl]oxiranyl]methanol
|
|
C13H18O3 |
详情 |
详情
|
(II) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(III) |
47481 |
(4R)-4-[3-(benzyloxy)propyl]-2-(4-methoxyphenyl)-1,3-dioxane; benzyl 3-[(4R)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl]propyl ether
|
|
C21H26O4 |
详情 |
详情
|
(IV) |
47482 |
(3R)-6-(benzyloxy)-3-[(4-methoxybenzyl)oxy]-1-hexanol
|
|
C21H28O4 |
详情 |
详情
|
(V) |
47483 |
(3R)-6-(benzyloxy)-3-[(4-methoxybenzyl)oxy]hexanal
|
|
C21H26O4 |
详情 |
详情
|
(VI) |
47484 |
dimethyl (E)-2-butenylboronate
|
|
C6H13BO2 |
详情 |
详情
|
(VII) |
47485 |
(3S,4R,6R)-9-(benzyloxy)-6-[(4-methoxybenzyl)oxy]-3-methyl-1-nonen-4-ol
|
|
C25H34O4 |
详情 |
详情
|
(VIII) |
47486 |
[((1R,2S)-1-[(2R)-5-(benzyloxy)-2-[(4-methoxybenzyl)oxy]pentyl]-2-methyl-3-butenyl)oxy](tert-butyl)diphenylsilane; benzyl (4R,6R,7S)-6-[[tert-butyl(diphenyl)silyl]oxy]-4-[(4-methoxybenzyl)oxy]-7-methyl-8-nonenyl ether
|
|
C41H52O4Si |
详情 |
详情
|
(IX) |
47487 |
(3S,4R,6R)-9-(benzyloxy)-4-[[tert-butyl(diphenyl)silyl]oxy]-6-[(4-methoxybenzyl)oxy]-3-methyl-1-nonanol
|
|
C41H54O5Si |
详情 |
详情
|
(X) |
47488 |
(3S,4R,6R)-9-(benzyloxy)-4-[[tert-butyl(diphenyl)silyl]oxy]-6-[(4-methoxybenzyl)oxy]-3-methylnonanal
|
|
C41H52O5Si |
详情 |
详情
|
(XI) |
27301 |
methylene(triphenyl)phosphorane
|
|
C19H17P |
详情 |
详情
|
(XII) |
47489 |
[((1R,2S)-1-[(2R)-5-(benzyloxy)-2-[(4-methoxybenzyl)oxy]pentyl]-2-methyl-4-pentenyl)oxy](tert-butyl)diphenylsilane; benzyl (4R,6R,7S)-6-[[tert-butyl(diphenyl)silyl]oxy]-4-[(4-methoxybenzyl)oxy]-7-methyl-9-decenyl ether
|
|
C42H54O4Si |
详情 |
详情
|
(XIII) |
47490 |
(4R,6R,7S)-1-(benzyloxy)-6-[[tert-butyl(diphenyl)silyl]oxy]-7-methyl-9-decen-4-ol
|
|
C34H46O3Si |
详情 |
详情
|
(XIV) |
13926 |
2-Methoxybenzoic acid; o-Methoxybenzoic Acid
|
579-75-9 |
C8H8O3 |
详情 | 详情
|
(XV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVI) |
47491 |
2-allyl-6-methoxybenzoic acid
|
|
C11H12O3 |
详情 |
详情
|
(XVII) |
47492 |
(1S,3R,4S)-1-[3-(benzyloxy)propyl]-3-[[tert-butyl(diphenyl)silyl]oxy]-4-methyl-6-heptenyl 2-allyl-6-methoxybenzoate
|
|
C45H56O5Si |
详情 |
详情
|
(XVIII) |
47493 |
(3S,5R,6S)-3-[3-(benzyloxy)propyl]-5-[[tert-butyl(diphenyl)silyl]oxy]-14-methoxy-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one
|
|
C43H52O5Si |
详情 |
详情
|
(XIX) |
47494 |
(3S,5R,6S)-5-[[tert-butyl(diphenyl)silyl]oxy]-14-hydroxy-3-(3-hydroxypropyl)-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one
|
|
C35H44O5Si |
详情 |
详情
|
合成路线61
该中间体在本合成路线中的序号:
(II) The chiral tetrahydropyran intermediate (XI) has been obtained as follows. The reaction of (-)-pseudoephedrine propionamide (I) with the allyl bromide (II) by the Myers' method gives pentenamide (III), which is reduced with LiNH2BH3 in THF to yield 2(S)-methyl-4-penten-1-ol (IV). Swern oxidation of (IV) affords the corresponding aldehyde (V), which is submitted to an asymmetric aldol condensation with the silyl enol ether (VI) catalyzed by Cu(OTf)2, (S)-Tol-BINAP and (Bu4N)Ph3SiF2 in THF to provide the adduct (VII). The methanolysis of (VII) with Me-OH in refluxing toluene gives the beta-keto ester (VIII), which is treated with Et2BOMe, NaBH4 and HF to yield the chiral hydroxy lactone (IX). The reduction of (IX) with DIBAL in THF affords the lactol (X), which is finally methylated with Ts-OH in refluxing methanol to provide the target tetrahydropyran intermediate (XI).
【1】
Bauer, M.; Maier, M.E.; Synthesis of the core structure of salicylihalamide A by intramolecular Suzuki reaction. Org Lett 2002, 4, 13, 2205.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
56935 |
N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N-methylpropanamide
|
|
C13H19NO2 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
56936 |
(2S)-N-[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]-N,2-dimethyl-4-pentenamide
|
|
C16H23NO2 |
详情 |
详情
|
(IV) |
56937 |
(2S)-2-methyl-4-penten-1-ol
|
|
C6H12O |
详情 |
详情
|
(V) |
26241 |
(2S)-2-methyl-4-pentenal
|
|
C6H10O |
详情 |
详情
|
(VI) |
53651 |
[(2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl)oxy](trimethyl)silane; 2,2-dimethyl-4-methylene-4H-1,3-dioxin-6-yl trimethylsilyl ether
|
n/a |
C10H18O3Si |
详情 | 详情
|
(VII) |
56938 |
6-[(2R,3S)-2-hydroxy-3-methyl-5-hexenyl]-2,2-dimethyl-4H-1,3-dioxin-4-one
|
|
C13H20O4 |
详情 |
详情
|
(VIII) |
56939 |
methyl (5R,6S)-5-hydroxy-6-methyl-3-oxo-8-nonenoate
|
|
C11H18O4 |
详情 |
详情
|
(IX) |
56940 |
(4S,6R)-4-hydroxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-2-one
|
|
C10H16O3 |
详情 |
详情
|
(X) |
56941 |
(4S,6R)-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-2,4-diol
|
|
C10H18O3 |
详情 |
详情
|
(XI) |
56942 |
(4S,6R)-2-methoxy-6-[(1S)-1-methyl-3-butenyl]tetrahydro-2H-pyran-4-ol
|
|
C11H20O3 |
详情 |
详情
|
合成路线62
该中间体在本合成路线中的序号:
(XV) The reaction of the chiral epoxide (I) with 4-methoxybenzaldehyde (II) by means of NaAl(OMe)3H in THF gives the 1,3-dioxane (III), which is opened by reduction with DIBAL in dichloromethane to yield the chiral benzyl ether (IV). The oxidation of the primary alcohol of (IV) with DMP in dichloromethane affords the corresponding aldehyde (V), which is condensed with the boronate (VI) and S,S-diisopropyl tartrate in toluene to provide the unsaturated alcohol (VII).The protection of (VII) with Tbdps-Cl and imidazole yields the fully protected triol (VIII), which is oxidized at the terminal double bond with 9-BBN in THF to give the primary alcohol (IX). The oxidation of (IX) with DMP in dichloromethane affords the aldehyde (X), which is condensed with methylenetriphenylphosphorane (XI) in THF to provide the terminal olefin (XII). Elimination of the Pmb protecting group of (XII) with DDQ in dichloromethane gives the alcohol (XIII), which is esterified with 2-allyl-6-methoxybenzoic acid (XIV)(obtained by allylation of 2-methoxybenzoic acid (XV) with allyl bromide (XVI), BuLi and MgBr2) by means of DEAD and PPh3 yielding the ester (XVII). The cyclization of (XVII) by means of a metathesis reaction catalyzed by a ruthenium catalyst in refluxing dichloromethane affords the bicyclic lactone (XVIII), which is treated with BBr3 in dichloromethane to provide the dihydroxylated lactone (XIX).
【1】
Labrecque, D.; et al.; Enantioselective total synthesis of salicylihalamides A and B. Tetrahedron Lett 2001, 42, 14, 2645.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
47480 |
[(2R,3R)-3-[3-(benzyloxy)propyl]oxiranyl]methanol
|
|
C13H18O3 |
详情 |
详情
|
(II) |
27251 |
4-methoxybenzaldehyde; Anisicaldehyde; p-anisaldehyde
|
123-11-5 |
C8H8O2 |
详情 | 详情
|
(III) |
47481 |
(4R)-4-[3-(benzyloxy)propyl]-2-(4-methoxyphenyl)-1,3-dioxane; benzyl 3-[(4R)-2-(4-methoxyphenyl)-1,3-dioxan-4-yl]propyl ether
|
|
C21H26O4 |
详情 |
详情
|
(IV) |
47482 |
(3R)-6-(benzyloxy)-3-[(4-methoxybenzyl)oxy]-1-hexanol
|
|
C21H28O4 |
详情 |
详情
|
(V) |
47483 |
(3R)-6-(benzyloxy)-3-[(4-methoxybenzyl)oxy]hexanal
|
|
C21H26O4 |
详情 |
详情
|
(VI) |
47484 |
dimethyl (E)-2-butenylboronate
|
|
C6H13BO2 |
详情 |
详情
|
(VII) |
47485 |
(3S,4R,6R)-9-(benzyloxy)-6-[(4-methoxybenzyl)oxy]-3-methyl-1-nonen-4-ol
|
|
C25H34O4 |
详情 |
详情
|
(VIII) |
47486 |
[((1R,2S)-1-[(2R)-5-(benzyloxy)-2-[(4-methoxybenzyl)oxy]pentyl]-2-methyl-3-butenyl)oxy](tert-butyl)diphenylsilane; benzyl (4R,6R,7S)-6-[[tert-butyl(diphenyl)silyl]oxy]-4-[(4-methoxybenzyl)oxy]-7-methyl-8-nonenyl ether
|
|
C41H52O4Si |
详情 |
详情
|
(IX) |
47487 |
(3S,4R,6R)-9-(benzyloxy)-4-[[tert-butyl(diphenyl)silyl]oxy]-6-[(4-methoxybenzyl)oxy]-3-methyl-1-nonanol
|
|
C41H54O5Si |
详情 |
详情
|
(X) |
47488 |
(3S,4R,6R)-9-(benzyloxy)-4-[[tert-butyl(diphenyl)silyl]oxy]-6-[(4-methoxybenzyl)oxy]-3-methylnonanal
|
|
C41H52O5Si |
详情 |
详情
|
(XI) |
27301 |
methylene(triphenyl)phosphorane
|
|
C19H17P |
详情 |
详情
|
(XII) |
47489 |
[((1R,2S)-1-[(2R)-5-(benzyloxy)-2-[(4-methoxybenzyl)oxy]pentyl]-2-methyl-4-pentenyl)oxy](tert-butyl)diphenylsilane; benzyl (4R,6R,7S)-6-[[tert-butyl(diphenyl)silyl]oxy]-4-[(4-methoxybenzyl)oxy]-7-methyl-9-decenyl ether
|
|
C42H54O4Si |
详情 |
详情
|
(XIII) |
47490 |
(4R,6R,7S)-1-(benzyloxy)-6-[[tert-butyl(diphenyl)silyl]oxy]-7-methyl-9-decen-4-ol
|
|
C34H46O3Si |
详情 |
详情
|
(XIV) |
13926 |
2-Methoxybenzoic acid; o-Methoxybenzoic Acid
|
579-75-9 |
C8H8O3 |
详情 | 详情
|
(XV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVI) |
47491 |
2-allyl-6-methoxybenzoic acid
|
|
C11H12O3 |
详情 |
详情
|
(XVII) |
47492 |
(1S,3R,4S)-1-[3-(benzyloxy)propyl]-3-[[tert-butyl(diphenyl)silyl]oxy]-4-methyl-6-heptenyl 2-allyl-6-methoxybenzoate
|
|
C45H56O5Si |
详情 |
详情
|
(XVIII) |
47493 |
(3S,5R,6S)-3-[3-(benzyloxy)propyl]-5-[[tert-butyl(diphenyl)silyl]oxy]-14-methoxy-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one
|
|
C43H52O5Si |
详情 |
详情
|
(XIX) |
47494 |
(3S,5R,6S)-5-[[tert-butyl(diphenyl)silyl]oxy]-14-hydroxy-3-(3-hydroxypropyl)-6-methyl-3,4,5,6,7,10-hexahydro-1H-2-benzoxacyclododecin-1-one
|
|
C35H44O5Si |
详情 |
详情
|
合成路线63
该中间体在本合成路线中的序号:
(II) The reaction of 2-fluoro-5-(trifluoromethyl)phenol (I) with allyl bromide (II) by means of K2CO3 in DMF gives the phenol ether (III), which is submitted to an allylic rearrangement by heating at 190 C to yield 2-allyl-6-fluoro-3-(trifluoromethyl)phenol (IV). The cyclization of (IV) by means of MCPBA and KOH affords the dihydrobenzofuran (V), which is treated with Ac2O and pyridine to provide the acetate (VI). The dehydrogenation of (VI) by means of NBS and AIBN, followed by a treatment with tBu-OK and K2CO3 in methanol, gives 1-[7-fluoro-4-(trifluoromethyl)benzofuran-2-yl]methanol (VII), which is oxidized with oxalyl chloride and TEA in DMSO to yield the corresponding carbaldehyde (VIII). The condensation of (VIII) with 4-acryloylbenzoic acid methyl ester (IX) by means of 3-benzyl-5-(2-hydroxyethyl)-4-methylthiazolium chloride (BHMT) and TEA in DMF affords the 1,4-butanedione derivative (X), which is submitted to a pyrrole synthesis by cyclization with AcONH4 in refluxing ethanol to provide the disubstituted pyrrole (XI). Finally, the ester group of (XI) is hydrolyzed with NaOH in ethanol to furnish the target carboxylic acid.
【1】
Yoshimura, H.; et al.; Discovery of novel and potent retinoic acid receptor alpha agonists: Syntheses and evaluation of benzofuranyl-pyrrole and benzothiophenyl-pyrrole derivatives. J Med Chem 2000, 43, 15, 2929.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50315 |
2-Fluoro-5-(trifluoromethyl)phenol
|
141483-15-0 |
C7H4F4O |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
50316 |
2-(allyloxy)-1-fluoro-4-(trifluoromethyl)benzene; allyl 2-fluoro-5-(trifluoromethyl)phenyl ether
|
|
C10H8F4O |
详情 |
详情
|
(IV) |
50317 |
2-allyl-6-fluoro-3-(trifluoromethyl)phenol
|
|
C10H8F4O |
详情 |
详情
|
(V) |
50318 |
[7-fluoro-4-(trifluoromethyl)-2,3-dihydro-1-benzofuran-2-yl]methanol
|
|
C10H8F4O2 |
详情 |
详情
|
(VI) |
50319 |
[7-fluoro-4-(trifluoromethyl)-2,3-dihydro-1-benzofuran-2-yl]methyl acetate
|
|
C12H10F4O3 |
详情 |
详情
|
(VII) |
50320 |
[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]methanol
|
|
C10H6F4O2 |
详情 |
详情
|
(VIII) |
35847 |
7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-carbaldehyde
|
|
C10H4F4O2 |
详情 |
详情
|
(IX) |
35857 |
methyl 4-acryloylbenzoate
|
|
C11H10O3 |
详情 |
详情
|
(X) |
35850 |
methyl 4-[4-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-4-oxobutanoyl]benzoate
|
|
C21H14F4O5 |
详情 |
详情
|
(XI) |
35851 |
methyl 4-[5-[7-fluoro-4-(trifluoromethyl)-1-benzofuran-2-yl]-1H-pyrrol-2-yl]benzoate
|
|
C21H13F4NO3 |
详情 |
详情
|
合成路线64
该中间体在本合成路线中的序号:
(XII) The intermediate phenyl sulfone (XXIII) has been obtained as follows. The reaction of tetrahydropyranyl glycidol (I) with isopropenyl bromide (X) by means of CuCN in THF gives the secondary alcohol (XI), which is treated with allyl bromide (XII) and KH in THF to yield the allyl ether (XIII). A ring closing metathesis reaction with (XIII) catalyzed by a Ru catalyst yields the protected dihydropyran derivative (XIV), which is treated with CSA in methanol to afford the carbinol (XV). The oxidation of (XV) with (COCl)2 and DMSO in dichloromethane provides the carbaldehyde (XVI), which is treated with CBr4 and PPh3 in dichloromethane to give the dibromovinyl derivative (XVII). The condensation of (XVII) with the intermediate aldehyde (VI) by means of BuLi in THF yields the propargyl alcohol derivative (XVIII), which is oxidized with DMP to the corresponding acetylenic ketone (XIX). Alternatively, acetylenic ketone (XIX) can also be obtained by condensation of dibromovinyl derivative (XVII) with the intermediate Weinreb amide (IX) by means of BuLi in THF. The enantioselective reduction of ketone (XIX) with L-Selectride in THF affords the chiral propargyl alcohol (XX), which is reduced with Red-Al and treated with TFA to provide the trans-allylic alcohol (XXI). The reaction of the diol (XXI) with Pmp-CH(OEt)2 and CSA gives the acetal (XXII), which is finally reduced with DIBAL in dichloromethane to yield the intermediate Pmb-protected phenyl sulfone (XXIII).
【1】
Ghosh, A.K.; Wang, Y.; Kim, J.T.; Total synthesis of microtubule-stabilizing agent (-)-laulimalide. J Org Chem 2001, 66, 26, 8973.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63105 |
2-[(2R)oxiranyloxy]tetrahydro-2H-pyran; (2R)oxiranyl tetrahydro-2H-pyran-2-yl ether
|
|
C7H12O3 |
详情 |
详情
|
(VI) |
63109 |
(2S)-2-[(4-methoxybenzyl)oxy]-4-(phenylsulfonyl)butanal
|
|
C18H20O5S |
详情 |
详情
|
(IX) |
63111 |
(2S)-N-methoxy-2-[(4-methoxybenzyl)oxy]-N-methyl-4-(phenylsulfonyl)butanamide
|
|
C20H25NO6S |
详情 |
详情
|
(X) |
42375 |
2-bromo-1-propene;2-bromopropene;Isopropenyl bromide;a-Methylvinyl bromide |
557-93-7 |
C3H5Br |
详情 | 详情
|
(XI) |
63112 |
(2S)-4-methyl-1-(tetrahydro-2H-pyran-2-yloxy)-4-penten-2-ol
|
|
C11H20O3 |
详情 |
详情
|
(XII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XIII) |
63113 |
allyl (1S)-3-methyl-1-[(tetrahydro-2H-pyran-2-yloxy)methyl]-3-butenyl ether; 2-{[(2S)-2-(allyloxy)-4-methyl-4-pentenyl]oxy}tetrahydro-2H-pyran
|
|
C14H24O3 |
详情 |
详情
|
(XIV) |
63114 |
2-{[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]methoxy}tetrahydro-2H-pyran; [(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]methyl tetrahydro-2H-pyran-2-yl ether
|
|
C12H20O3 |
详情 |
详情
|
(XV) |
61173 |
[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]methanol
|
|
C7H12O2 |
详情 |
详情
|
(XVI) |
61148 |
(2S)-4-methyl-3,6-dihydro-2H-pyran-2-carbaldehyde
|
|
C7H10O2 |
详情 |
详情
|
(XVII) |
63115 |
(2S)-2-(2,2-dibromovinyl)-4-methyl-3,6-dihydro-2H-pyran
|
|
C8H10Br2O |
详情 |
详情
|
(XVIII) |
63116 |
(4S)-4-[(4-methoxybenzyl)oxy]-1-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-6-(phenylsulfonyl)-1-hexyn-3-ol
|
|
C26H30O6S |
详情 |
详情
|
(XIX) |
63117 |
(4S)-4-[(4-methoxybenzyl)oxy]-1-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-6-(phenylsulfonyl)-1-hexyn-3-one
|
|
C26H28O6S |
详情 |
详情
|
(XX) |
63118 |
(3S,4S)-4-[(4-methoxybenzyl)oxy]-1-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-6-(phenylsulfonyl)-1-hexyn-3-ol
|
|
C26H30O6S |
详情 |
详情
|
(XXI) |
63119 |
(E,3S,4S)-1-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-6-(phenylsulfonyl)-1-hexene-3,4-diol
|
|
C18H24O5S |
详情 |
详情
|
(XXII) |
63120 |
2-((4S,5S)-2-(4-methoxyphenyl)-5-{(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]ethenyl}-1,3-dioxolan-4-yl)ethyl phenyl sulfone; (2S)-2-((E)-2-{(4S,5S)-2-(4-methoxyphenyl)-5-[2-(phenylsulfonyl)ethyl]-1,3-dioxolan-4-yl}ethenyl)-4-methyl-3,6-dihydro-2H-pyran |
|
C26H30O6S |
详情 |
详情
|
(XXIII) |
63121 |
(3S,4S,5E)-4-[(4-methoxybenzyl)oxy]-6-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-1-(phenylsulfonyl)-5-hexen-3-ol
|
|
C26H32O6S |
详情 |
详情
|
合成路线65
该中间体在本合成路线中的序号:
(XXIX) Synthesis of the target Laulimalide. The condensation of the tin derivative (XXVI) with the chiral isopropenyl boron derivative (XXVII) gives the secondary alcohol (XXVIII), which is alkylated with allyl bromide (XXIX) and KHMDS to yield the allyl ether (XXX). The ring closing metathesis reaction in (XXX) by means of Schrock catalyst affords the dihydropyranyl stannane (XXXI), which is treated with N-iodosuccinimide to provide the iodovinyl compound (XXXII). The reaction of (XXXII) with BuLi and MgBr2 gives the vinylmagnesium derivative (XXXIII), which is condensed with the unsaturated aldehyde intermediate (XXV) to yield the olefinic alcohol (XXXIV). The reaction of (XXXIV) with Tbdms-Cl and imidazole affords the silyl ether (XXXV), which is selectively deprotected with formic acid, and oxidated with DMP to provide the chiral unsaturated aldehyde (XXXVI).
【1】
Nelson, S.G.; Cheung, W.S.; Kassick, A.J.; Hilfiker, M.A.; A de novo enantioselective total synthesis of (-)-laulimalide. J Am Chem Soc 2002, 124, 46, 13654.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XXV) |
63887 |
(2S,4E)-2-[(4-methoxybenzyl)oxy]-6-(trityloxy)-4-hexenal
|
|
C33H32O4 |
详情 |
详情
|
(XXVI) |
63888 |
(E)-3-(tributylstannyl)-2-propenal
|
|
C15H30OSn |
详情 |
详情
|
(XXVII) |
63889 |
|
|
C5H11B |
详情 |
详情
|
(XXVIII) |
63890 |
(1E)-5-methyl-1-(tributylstannyl)-1,5-hexadien-3-ol
|
|
C19H38OSn |
详情 |
详情
|
(XXIX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXX) |
63891 |
[(1E)-3-(allyloxy)-5-methyl-1,5-hexadienyl](tributyl)stannane; allyl 3-methyl-1-[(E)-2-(tributylstannyl)ethenyl]-3-butenyl ether
|
|
C22H42OSn |
详情 |
详情
|
(XXXI) |
63894 |
tributyl{(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]ethenyl}stannane
|
|
C20H38OSn |
详情 |
详情
|
(XXXII) |
63893 |
(2S)-2-[(E)-2-iodoethenyl]-4-methyl-3,6-dihydro-2H-pyran
|
|
C8H11IO |
详情 |
详情
|
(XXXIII) |
63892 |
bromo{(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]ethenyl}magnesium
|
|
C8H11BrMgO |
详情 |
详情
|
(XXXIV) |
63895 |
(1E,3S,4S,6E)-4-[(4-methoxybenzyl)oxy]-1-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-8-(trityloxy)-1,6-octadien-3-ol
|
|
C41H44O5 |
详情 |
详情
|
(XXXV) |
63896 |
tert-butyl(dimethyl)silyl (1S,2S,4E)-2-[(4-methoxybenzyl)oxy]-1-{(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]ethenyl}-6-(trityloxy)-4-hexenyl ether; tert-butyl{[(1S,2S,4E)-2-[(4-methoxybenzyl)oxy]-1-{(E)-2-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]ethenyl}-6-(trityloxy)-4-hexenyl]oxy}dimethylsilane |
|
C47H58O5Si |
详情 |
详情
|
(XXXVI) |
63897 |
(2E,5S,6S,7E)-6-{[tert-butyl(dimethyl)silyl]oxy}-5-[(4-methoxybenzyl)oxy]-8-[(2S)-4-methyl-3,6-dihydro-2H-pyran-2-yl]-2,7-octadienal
|
|
C28H42O5Si |
详情 |
详情
|
合成路线66
该中间体在本合成路线中的序号:
(A) The condensation of 6-acetyl-7-hydroxy-1,2,3,4-tetrahydronaphthalene (I) with allyl bromide (A) by means of K2CO3 in DMF gives 6-acetyl-7-allyloxy-1,2,3,4-tetrahydronaphthalene (II), which is isomerized to 5-allyl-7-acetyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene (III) by heating at 200 C. Hydrogenation of (III) with H2 over Pd/C in ethanol affords 5-propyl-7-acetyl-6-hydroxy-1,2,3,4-tetrahydronaphthalene (IV), which is then cyclized with diethyl oxalate (B) by means of sodium ethoxide in refluxing etha-nol to yield ethyl 10-propyl-4-oxo-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (V) [an alternative way to prepare (V) is the cyclization of (III) with diethyl oxalate (B) by means of sodium ethoxide to give ethyl 10-allyl-4-oxo-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (VI), which is then reduced to (V) with H2 over Pd/C in ethanol]. The nitration of (V) with nitric acid in sulfuric acid gives ethyl 10-propyl-4-oxo-5-nitro-6,7,8,9-tetrahydro-4H-naphtho[2,3-b]pyran-2-carboxylate (VII), which is reduced with H2 over Pd/C in ethanol-acetic acid to afford the corresponding amino derivative (VIII). Finally, this compound is diazotated with NaNO2 and H2SO4 and then treated with 50% H2SO4 at 120 C.
【1】
Brown, R.C.; et al.; DE 2553688 .
|
【2】
BE 0836121 .
|
【3】
Castañer, J.; Blancafort, P.; Hillier, K.; Serradell, M.N.; Proxicromil. Drugs Fut 1979, 4, 12, 889.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(A) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(B) |
17571 |
Diethyl oxalate; Ethyl 2-ethoxy-2-oxoacetate
|
95-92-1 |
C6H10O4 |
详情 | 详情
|
(I) |
39625 |
1-(3-hydroxy-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C12H14O2 |
详情 |
详情
|
(II) |
39626 |
1-[3-(allyloxy)-5,6,7,8-tetrahydro-2-naphthalenyl]-1-ethanone
|
|
C15H18O2 |
详情 |
详情
|
(III) |
39627 |
1-(4-allyl-3-hydroxy-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C15H18O2 |
详情 |
详情
|
(IV) |
39628 |
1-(3-hydroxy-4-propyl-5,6,7,8-tetrahydro-2-naphthalenyl)-1-ethanone
|
|
C15H20O2 |
详情 |
详情
|
(V) |
39629 |
ethyl 4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H22O4 |
详情 |
详情
|
(VI) |
39630 |
ethyl 10-allyl-4-oxo-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H20O4 |
详情 |
详情
|
(VII) |
39631 |
ethyl 5-nitro-4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H21NO6 |
详情 |
详情
|
(VIII) |
39632 |
ethyl 5-amino-4-oxo-10-propyl-6,7,8,9-tetrahydro-4H-benzo[g]chromene-2-carboxylate
|
|
C19H23NO4 |
详情 |
详情
|
合成路线67
该中间体在本合成路线中的序号:
This compound has been obtained by three related ways:
1.- The Grignard condensation of ethyl cyclohexanecarboxylate (I) with benzylmagnesium bromide (II) in THF gives 1-cyclohexyl-2-phenylethanone (III), which is condensed with bromoacetaldehyde diethyl acetal (IV) by means of potassium tert-butoxide in DMSO to yield 4-cyclohexyl-4-oxo-3-phenylbutyraldehyde diethylacetal (V). The methylation of (V) by means of methyl iodide and potassium tert-butoxide in the same solvent affords 4-cyclohexyl-3-methyl-4-oxo-3-phenylbutyraldehyde diethylacetal (VI), which is treated with HCl in acetone to give the corresponding aldehyde (VII). The reductocondensation of (VII) with 1-(2-methoxyphenyl)piperazine (VIII) by means of sodium triacetoxyborohydride in dichloromethane/acetic acid yields 1-cyclohexyl-4-[4-(2-methoxyphenyl)piperazin-1-yl]-2-methyl-2-phenyl-1-butanone (X) as a racemic mixture, which is resolved by chiral chromatography over a Chiralpak AD column.
2.- The Grignard condensation of 2-phenylpropionaldehyde (XI) with cyclohexylmagnesium chloride (XII) in ethyl ether/THF gives 1-cyclohexyl-2-phenyl-1-propanol (XIII), which is oxidized with DMSO and P2O5 in dichloromethane yielding the corresponding ketone (XIV). The condensation of (XIV) with allyl bromide by means of potassium tert-butoxide in THF affords 1-cyclohexyl-2-methyl-2-phenyl-4-penten-1-one (XV), which is ozonolyzed with O3 in methanol catalyzed by a small amount of Sudan III affording the previously reported aldehyde (VII).
3.- The condensation of aldehyde (VII) with 1-(2-methoxyphenyl)piperazine (VIII) can also be performed in isopropyl acetate giving 1-cyclohexyl-4-[4-(2-methoxyphenyl)piperazin-1-yl]-2-methyl-2-phenyl-3-buten-1-one (IX), which is hydrogenated with H2 over Pd/C in isopropanol to afford the previously reported racemic mixture (X).
【1】
Xu, Y.C.; et al.; Synthesis and pharmacology of LY426965: A potent, selective orally active, and long-lasting 5-HT1A receptor antagonist. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 107.
|
【2】
Kohlman, D.T.; O'Toole, J.C.; Godfrey, A.G.; Xu, Y.-C.; Zhang, T.Y. (Eli Lilly and Company); Arylpiperazines having activity at the serotonin 1A receptor. EP 0924205; WO 9931077 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
31858 |
ethyl cyclohexanecarboxylate
|
3289-28-9 |
C9H16O2 |
详情 | 详情
|
(II) |
28308 |
benzyl(bromo)magnesium; benzylmagnesium bromide
|
1589-82-8 |
C7H7BrMg |
详情 | 详情
|
(III) |
31859 |
1-cyclohexyl-2-phenyl-1-ethanone
|
|
C14H18O |
详情 |
详情
|
(IV) |
12113 |
2-Bromo-1-ethoxyethyl ethyl ether; 2-Bromo-1,1-diethoxyethane; Bromoacetaldehyde diethylacetal
|
2032-35-1 |
C6H13BrO2 |
详情 | 详情
|
(V) |
31860 |
1-cyclohexyl-4,4-diethoxy-2-phenyl-1-butanone
|
|
C20H30O3 |
详情 |
详情
|
(VI) |
31861 |
1-cyclohexyl-4,4-diethoxy-2-methyl-2-phenyl-1-butanone
|
|
C21H32O3 |
详情 |
详情
|
(VII) |
31862 |
4-cyclohexyl-3-methyl-4-oxo-3-phenylbutanal
|
|
C17H22O2 |
详情 |
详情
|
(VIII) |
11882 |
1-(2-Methoxyphenyl)piperazine; Methyl 2-piperazinophenyl ether; 1-(2-Methoxyphenyl)-piperazine
|
35386-24-4 |
C11H16N2O |
详情 | 详情
|
(IX) |
31863 |
(E)-1-cyclohexyl-4-[4-(2-methoxyphenyl)-1-piperazinyl]-2-methyl-2-phenyl-3-buten-1-one
|
|
C28H36N2O2 |
详情 |
详情
|
(X) |
31864 |
1-cyclohexyl-4-[4-(2-methoxyphenyl)-1-piperazinyl]-2-methyl-2-phenyl-1-butanone
|
|
C28H38N2O2 |
详情 |
详情
|
(XI) |
31865 |
hydratropaldehyde
|
93-53-8 |
C9H10O |
详情 | 详情
|
(XII) |
31866 |
chloro(cyclohexyl)magnesium
|
|
C6H11ClMg |
详情 |
详情
|
(XIII) |
31867 |
1-cyclohexyl-2-phenyl-1-propanol
|
|
C15H22O |
详情 |
详情
|
(XIV) |
31868 |
1-cyclohexyl-2-phenyl-1-propanone
|
|
C15H20O |
详情 |
详情
|
(XV) |
31869 |
1-cyclohexyl-2-methyl-2-phenyl-4-penten-1-one
|
|
C18H24O |
详情 |
详情
|
合成路线68
该中间体在本合成路线中的序号:
(VII) Commercially available Corey aldehyde benzoate (I) was oxidized to carboxylic acid (II) by Jones reagent at 0 C. Subsequent chlorination of (II) with SOCl2 afforded acid chloride (III). The crude acid chloride (III) was condensed with 3-hydroxy-4-methylthiazole-2-thione (IV) to yield the thiohydroxamate ester (V). Decarboxylation of (V) by means of tris(phenylthio)antimony in a flask open to air furnished alcohol (VI). Alkylation of alcohol (VI) with allyl bromide (VII) afforded allyl ether (VIII), which by epoxidation using m-chloroperbenzoic acid provided the epoxide (IX). Regiospecific epoxide opening with the Grignard reagent (X) gave alcohol (XI) as a diastereomeric mixture. The hydroxyl groups of (XI) were then protected as the bis-tetrahydropyranyl ether (XII) using dihydropyran and p-toluenesulfonic acid. Lactone reduction with DIBAL in toluene at -78 C gave the lactol (XIII).
【1】
Feng, Z.; et al.; Design and synthesis of 13-oxa prostaglandin analogs as antiglaucoma agents. 222nd ACS Natl Meet (Aug 26 2001, Chicago) 2001, Abst MEDI 236.
|
【2】
Feng, Z.; Hellberg, M.R. (Alcon Laboratories, Inc.); 13-Oxa prostaglandins for the treatment of glaucoma and ocular hypertension. US 6232344; WO 9932441 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
35585 |
(3aR,4R,5R,6aS)-4-formyl-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
39746-01-5 |
C15H14O5 |
详情 | 详情
|
(II) |
50695 |
(3aR,4R,5R,6aS)-5-(benzoyloxy)-2-oxohexahydro-2H-cyclopenta[b]furan-4-carboxylic acid
|
|
C15H14O6 |
详情 |
详情
|
(III) |
50696 |
(3aR,4R,5R,6aS)-4-(chlorocarbonyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
|
C15H13ClO5 |
详情 |
详情
|
(IV) |
50697 |
3-Hydroxy-4-methyl-2(3H)thiazolethione; N-Hydroxy-4-methyl-2-thiazolethione; 2-Mercapto-4-methylthiazole 3-oxide
|
49762-08-5 |
C4H5NOS2 |
详情 | 详情
|
(V) |
50698 |
(3aR,4R,5R,6aS)-4-([[4-methyl-2-thioxo-1,3-thiazol-3(2H)-yl]oxy]carbonyl)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
|
C19H17NO6S2 |
详情 |
详情
|
(VI) |
50699 |
(3aR,4R,5R,6aS)-4-hydroxy-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
|
C14H14O5 |
详情 |
详情
|
(VII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VIII) |
50700 |
(3aR,4R,5R,6aS)-4-(allyloxy)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
|
C17H18O5 |
详情 |
详情
|
(IX) |
50701 |
(3aR,4R,5R,6aS)-4-(2-oxiranylmethoxy)-2-oxohexahydro-2H-cyclopenta[b]furan-5-yl benzoate
|
|
C17H18O6 |
详情 |
详情
|
(X) |
50702 |
bromo[3-(trifluoromethyl)benzyl]magnesium
|
|
C8H6BrF3Mg |
详情 |
详情
|
(XI) |
50703 |
(3aR,4R,5R,6aS)-5-hydroxy-4-[2-hydroxy-4-[3-(trifluoromethyl)phenyl]butoxy]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C18H21F3O5 |
详情 |
详情
|
(XII) |
50704 |
(3aR,4R,5R,6aS)-5-(tetrahydro-2H-pyran-2-yloxy)-4-[2-(tetrahydro-2H-pyran-2-yloxy)-4-[3-(trifluoromethyl)phenyl]butoxy]hexahydro-2H-cyclopenta[b]furan-2-one
|
|
C28H37F3O7 |
详情 |
详情
|
(XIII) |
50705 |
(3aR,4R,5R,6aS)-5-(tetrahydro-2H-pyran-2-yloxy)-4-[2-(tetrahydro-2H-pyran-2-yloxy)-4-[3-(trifluoromethyl)phenyl]butoxy]hexahydro-2H-cyclopenta[b]furan-2-ol
|
|
C28H39F3O7 |
详情 |
详情
|
合成路线69
该中间体在本合成路线中的序号:
(II) The title compound was prepared by two related ways from 3-iodo-8-methoxy-4-(2-methylphenyl)aminoquinoline (I). Alkylationof (I) with allyl bromide (II) and NaH afforded the N-allyl amine (III). Subsequent intramolecular palladium-catalyzed Heck reaction in (III) produced the title pyrroloquinoline. In an alternative procedure, the intermolecular palladium-catalyzed heteroannulation of (I) with 1-trimethylsilylpropyne (IV) gave the silyl pyrroloquinoline (V), which was finally desilylated by means of trifluoroacetic acid.
【1】
Yum, E.K.; et al.; Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolones. Bioorg Med Chem Lett 1999, 9, 19, 2819.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34558 |
3-iodo-8-methoxy-N-(2-methylphenyl)-4-quinolinamine; N-(3-iodo-8-methoxy-4-quinolinyl)-N-(2-methylphenyl)amine
|
|
C17H15IN2O |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
34559 |
N-allyl-3-iodo-8-methoxy-N-(2-methylphenyl)-4-quinolinamine; N-allyl-N-(3-iodo-8-methoxy-4-quinolinyl)-N-(2-methylphenyl)amine
|
|
C20H19IN2O |
详情 |
详情
|
(IV) |
34560 |
trimethyl(1-propynyl)silane
|
6224-91-5 |
C6H12Si |
详情 | 详情
|
合成路线70
该中间体在本合成路线中的序号:
(VI) Condensation of 4-methylpentanoyl chloride (I) with (S)-4-benzyl-2-oxazolidinone using n-BuLi afforded the N-acyloxazolidinone (III). Asymmetric alkylation of (III) with tert-butyl bromoacetate and LDA gave (IV), and subsequent removal of the chiral auxiliary by hydrolysis with lithium peroxide yielded (R)-2-isobutylsuccinic acid mono tert-butyl ester (V). This was further alkylated with allyl bromide (VI) and LDA to provide the (R,R)-2,3-disubstituted succinate (VII). Epimerization of (VII) to the required (2R,3S)-isomer (VIII) was accomplished by treatment with LDA and Et2AlCl. Benzyl ester (IX) was then prepared by reaction of (VIII) with benzyl bromide and DBU. Hydroboration of the olefinic double bond of (IX) by means of 9-borabicyclononane, followed by oxidative treatment with H2O2 gave rise to the primary alcohol (X). This was converted to carbonate (XI) upon reaction with p-nitrophenyl chloroformate and N-methylmorpholine (NMM). Coupling of (XI) with lysine derivative (XII) then yielded carbamate (XIII).
【1】
Xue, C.-B.; Cherney, R.J.; DeCicco, C.P.; Degrado, W.F.; He, X.; Hodge, C.N.; Jacobson, I.C.; Magolda, R.L.; Arner, E.C.; Duan, J.; Nelson, D.J. (DuPont Pharmaceuticals Co.); Novel macrocyclic cpds. as metalloprotease inhibitors. EP 0863885; JP 2000502050; WO 9718207 . |
【2】
Nelson, D.; Magolda, R.L.; Jacobson, I.C.; He, X.; Arner, E.; Cherney, R.J.; Duan, J.; Xue, C.-B.; Decicco, C.P.; Degrado, W.F. (DuPont Pharmaceuticals Co.); Novel macrocyclic cpds. as metalloprotease inhibitors. EP 0981521; WO 9851665 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
|
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
|
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(I) |
25390 |
4-methylpentanoyl chloride
|
38136-29-7 |
C6H11ClO |
详情 | 详情
|
(II) |
14694 |
(S)-4-Benzyl-2-oxazolidinone; (4S)-4-Benzyl-1,3-oxazolan-2-one; (S)-(-)-4-Benzyl-2-oxazolidinone
|
90719-32-7 |
C10H11NO2 |
详情 | 详情
|
(III) |
25391 |
(4S)-4-benzyl-3-(4-methylpentanoyl)-1,3-oxazolidin-2-one
|
|
C16H21NO3 |
详情 |
详情
|
(IV) |
25392 |
tert-butyl (3R)-3-[[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]carbonyl]-5-methylhexanoate
|
|
C22H31NO5 |
详情 |
详情
|
(V) |
25393 |
(2R)-2-[2-(tert-butoxy)-2-oxoethyl]-4-methylpentanoic acid
|
|
C12H22O4 |
详情 |
详情
|
(VI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VII) |
35082 |
(2R,3R)-3-(tert-butoxycarbonyl)-2-isobutyl-5-hexenoic acid
|
|
C15H26O4 |
详情 |
详情
|
(VIII) |
35083 |
(2R,3S)-3-(tert-butoxycarbonyl)-2-isobutyl-5-hexenoic acid
|
|
C15H26O4 |
详情 |
详情
|
(IX) |
35084 |
4-benzyl 1-(tert-butyl) (2S,3R)-2-allyl-3-isobutylbutanedioate
|
|
C22H32O4 |
详情 |
详情
|
(X) |
35085 |
4-benzyl 1-(tert-butyl) (2S,3R)-2-(3-hydroxypropyl)-3-isobutylbutanedioate
|
|
C22H34O5 |
详情 |
详情
|
(XI) |
35086 |
1-benzyl 4-(tert-butyl) (2R,3S)-2-isobutyl-3-(3-[[(4-nitrophenoxy)carbonyl]oxy]propyl)butanedioate
|
|
C29H37NO9 |
详情 |
详情
|
(XII) |
35087 |
methyl (2S)-6-amino-2-[[(benzyloxy)carbonyl]amino]hexanoate
|
|
C15H22N2O4 |
详情 |
详情
|
(XIII) |
35088 |
17-benzyl 16-(tert-butyl) 5-methyl (5S,16S,17R)-19-methyl-3,11-dioxo-1-phenyl-2,12-dioxa-4,10-diazaicosane-5,16,17-tricarboxylate
|
|
C38H54N2O10 |
详情 |
详情
|
合成路线71
该中间体在本合成路线中的序号:
(I) The preparation of the intermediate aminoboronate (VII) is shown in Scheme 27968701a. Addition of catecholborane (II) to allyl bromide (I) provided boronic ester (III). Subsequent exchange with (+)-alpha-pinanediol (IV) afforded the chiral borane (V). Insertion of dichloromethyllithium in (V) produced the alpha-chloroboronic ester (VI). The required amino compound was then obtained by displacement of the halogen with lithium hexamethyldisilazide, followed by acid-catalyzed desilylation.
【1】
Verbeuren, T.; Rupin, A.; De Nanteuil, G.; Gloanec, P.; New dicarbonyl cycloalkyl based thrombin inhibitors with improved activity and selectivity compared to (D)-Phe-Pro-boroArg derivatives
. 218th ACS Natl Meet (Aug 22 1999, New Orleans) 1999, Abst MEDI 201. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(II) |
32533 |
1,3,2-benzodioxaborole
|
274-07-7 |
C6H5BO2 |
详情 | 详情
|
(III) |
35558 |
2-(3-bromopropyl)-1,3,2-benzodioxaborole
|
|
C9H10BBrO2 |
详情 |
详情
|
(IV) |
32535 |
(1R,2S,3R,5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-2,3-diol |
|
C10H18O2 |
详情 |
详情
|
(V) |
35559 |
(1R,2S,6R,8R)-4-(3-bromopropyl)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane
|
|
C13H22BBrO2 |
详情 |
详情
|
(VI) |
35560 |
(1R,2S,6R,8R)-4-[(1S)-4-bromo-1-chlorobutyl]-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]decane
|
|
C14H23BBrClO2 |
详情 |
详情
|
(VII) |
35561 |
(1R)-4-bromo-1-[(1R,2S,6R,8R)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]-1-butanamine; (1R)-4-bromo-1-[(1R,2S,6R,8R)-2,9,9-trimethyl-3,5-dioxa-4-boratricyclo[6.1.1.0(2,6)]dec-4-yl]butylamine
|
|
C14H25BBrNO2 |
详情 |
详情
|
合成路线72
该中间体在本合成路线中的序号:
(XIII) The dihydroxylation of 2-[3-(tert-butyldimethylsilyloxy)-1-propenyl]furan (I) with OsO4 and NMO gives the racemic diol (II), which is oxidized with MCPBA to yield the dhydropyranone (III). The cyclization of (III) by means of Ts-OH affords the racemic bicyclic enone (IV), which is reduced with NaBH4 to the racemic alcohol (V). The reaction of (V) with Ac2O and pyridine provides the racemic acetate (VI), which is treated with Lipase PS and vinyl acetate, furnishing a mixture of unreacted chiral acetate (-)-(VI) and the chiral alcohol (+)-(VII), which are easily separated. The reduction of (-)-(VII) with H2 over PtO2 gives the bicyclic alcohol (VIII), which is treated with Ms-Cl and TEA to yield the mesylate (IX). The reaction of (IX) with sodium azide in THF affords the azido derivative (X), which is reduced with LiAlH4 in THF to provide the bicyclic amine (XI). The protection of (XI) with benzyl chloroformate gives the carbamate (XII), which is alkylated with allyl bromide (XIII) and NaH in DMF to yield the N-allyl carbamate (XIV). The desilylation of (XIV) with TBAF, followed by a treatment with Ms-Cl and TEA, affords the mesylate (XV). The reaction of (XV) with LiI, and then reaction of the intermediate iodide with Zn/HOAc, provides the hemiacetal (XVI), which is further reduced with NaBH4 in ethanol to give the dihydroxydiene (XVII). The ring-closing metathesis reaction of (XVII) by means of Grubbs' catalyst yields the tetrahydropyridine (XVIII), which is reduced with H2 over PtO2 to afford the chiral dihydroxy piperidine (XIX). The reaction of (XIX) with diphenyl disulfide and tributyl phosphine provides the thioether (XX), which is treated with benzyl bromide and NaH to give the piperidin benzyl ether (XXI).
【1】
Taniguchi, T.; et al.; Lipase-mediated preparation of sugar building blocks. Synthesis 1999, 8, 1325.
|
【2】
Taniguchi, T.; Ofasawara, K.; A diastereocontrolled synthesis of (+)-febrifugine: A potent antimalarial piperidine alkaloid. Org Lett 2000, 2, 20, 3193.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(rac)-(VI) |
51249 |
(rac)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-3-en-2-yl acetate
|
|
C15H26O5Si |
详情 |
详情
|
(-)-(VI) |
51263 |
(-)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-3-en-2-yl acetate
|
|
C15H26O5Si |
详情 |
详情
|
(+)(VII) |
65206 |
(+)-7-({[(1,1-dimethylethyl)(dimethyl)silyl]oxy}methyl)-6,8-dioxabicyclo[3.2.1]oct-3-en-2-ol
|
|
C13H24O4Si |
详情 |
详情
|
(I) |
51244 |
tert-butyl(dimethyl)silyl (E)-3-(2-furyl)-2-propenyl ether; tert-butyl[[(E)-3-(2-furyl)-2-propenyl]oxy]dimethylsilane
|
|
C13H22O2Si |
详情 |
详情
|
(II) |
51245 |
(1S,2R)-3-[[tert-butyl(dimethyl)silyl]oxy]-1-(2-furyl)-1,2-propanediol
|
|
C13H24O4Si |
详情 |
详情
|
(III) |
51246 |
(2S)-2-((1R)-2-[[tert-butyl(dimethyl)silyl]oxy]-1-hydroxyethyl)-6-hydroxy-2H-pyran-3(6H)-one
|
|
C13H24O5Si |
详情 |
详情
|
(IV) |
51247 |
7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-3-en-2-one
|
|
C13H22O4Si |
详情 |
详情
|
(V) |
51248 |
(rac)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-3-en-2-ol
|
|
C13H24O4Si |
详情 |
详情
|
(VIII) |
51250 |
7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]octan-2-ol
|
|
C13H26O4Si |
详情 |
详情
|
(IX) |
51251 |
7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-2-yl methanesulfonate
|
|
C14H28O6SSi |
详情 |
详情
|
(X) |
51252 |
[[(2S)-2-azido-6,8-dioxabicyclo[3.2.1]oct-7-yl]methoxy](tert-butyl)dimethylsilane; [(2S)-2-azido-6,8-dioxabicyclo[3.2.1]oct-7-yl]methyl tert-butyl(dimethyl)silyl ether
|
|
C13H25N3O3Si |
详情 |
详情
|
(XI) |
51253 |
(2S)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-2-ylamine; (2S)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]octan-2-amine
|
|
C13H27NO3Si |
详情 |
详情
|
(XII) |
51254 |
benzyl (2S)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-2-ylcarbamate
|
|
C21H33NO5Si |
详情 |
详情
|
(XIII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XIV) |
51255 |
benzyl allyl[(2S)-7-([[tert-butyl(dimethyl)silyl]oxy]methyl)-6,8-dioxabicyclo[3.2.1]oct-2-yl]carbamate
|
|
C24H37NO5Si |
详情 |
详情
|
(XV) |
51256 |
((2S)-2-[allyl[(benzyloxy)carbonyl]amino]-6,8-dioxabicyclo[3.2.1]oct-7-yl)methyl methanesulfonate
|
|
C19H25NO7S |
详情 |
详情
|
(XVI) |
51257 |
benzyl allyl[(2S,3R)-6-hydroxy-2-vinyltetrahydro-2H-pyran-3-yl]carbamate
|
|
C18H23NO4 |
详情 |
详情
|
(XVII) |
51258 |
benzyl allyl[(1R,2S)-2-hydroxy-1-(3-hydroxypropyl)-3-butenyl]carbamate
|
|
C18H25NO4 |
详情 |
详情
|
(XVIII) |
51259 |
benzyl (2R,3S)-3-hydroxy-2-(3-hydroxypropyl)-3,6-dihydro-1(2H)-pyridinecarboxylate
|
|
C16H21NO4 |
详情 |
详情
|
(XIX) |
51260 |
benzyl (2R,3S)-3-hydroxy-2-(3-hydroxypropyl)-1-piperidinecarboxylate
|
|
C16H23NO4 |
详情 |
详情
|
(XX) |
51261 |
benzyl (2R,3S)-3-hydroxy-2-[3-(phenylsulfanyl)propyl]-1-piperidinecarboxylate
|
|
C22H27NO3S |
详情 |
详情
|
(XXI) |
51262 |
benzyl (2R,3S)-3-(benzyloxy)-2-[3-(phenylsulfanyl)propyl]-1-piperidinecarboxylate
|
|
C29H33NO3S |
详情 |
详情
|
合成路线73
该中间体在本合成路线中的序号:
(III) Intermediate (VII) is first synthesized by following one of two different routes:
1. Esterification of vanillic acid (I) by treatment with refluxing H2SO4/MeOH affords ester (II), which is then O-alkylated with NaH and allyl bromide (III) in THF to provide allyloxy derivative (IV). Nitration of (IV) by treatment either with SnCl4/HNO3 in dichloromethane or simply with HNO3 yields nitro derivative (V), which is finally hydrolyzed with aqueous NaOH in THF.
2. Alternatively, acid (I) is directly alkylated with NaH and allyl bromide (III) in THF, affording allyloxy derivative (VI), which is then nitrated by means of HNO3 and SnCl4 in dichloromethane to provide (VII).
Once intermediate (VII) is obtained, the synthesis of the target product can be accomplished as follows:
Coupling of carboxylic acid (VII) with diethyl thioacetal derivative (VIII) by means of DCC in dichloromethane gives nitro thioacetal (IX), whose nitro group is then reduced with SnCl2 in refluxing MeOH to provide amino thioacetal (X). Protection of the amino group of (X) with Fmoc-Cl and Na2CO3 in dioxane yields derivative (XI), which is then subjected to ring closure by treatment with HgCl2 and CaCO3 in acetonitrile to afford the tricyclic compound (XII). Epoxidation of the allyloxy group of (XII) with m-chloroperbenzoic acid (m-CPBA) in dichloromethane furnishes epoxide (XIII), whose Fmoc group is finally removed by treatment with tetrabutylammonium fluoride (TBAF) in DMF.
【2】
Wilson, S.C.; et al.; Design and synthesis of a novel epoxide-containing pyrrolo[2,1-c][1,4]benzodiazepine (PBD) via a new cyclization procedure. Tetrahedron Lett 1995, 36, 35, 6333.
|
【1】
Adams, L.J.; Thurston, D.E.; Jenkins, T.C.; Wilson, S.C.; Hartley, J.A.; Howard, P.W.; Kelland, L.R.; Forrow, S.M.; Design and synthesis and evaluation of a novel sequence-selective epoxide-containing DNA cross-linking agent based on the pyrrolo[2,1-c][1,4]benzodiazepine system. J Med Chem 1999, 42, 20, 4028. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17786 |
4-hydroxy-3-methoxybenzoic acid; Vanillic acid
|
121-34-6 |
C8H8O4 |
详情 | 详情
|
(II) |
29176 |
methyl 4-hydroxy-3-methoxybenzoate
|
3943-74-6 |
C9H10O4 |
详情 | 详情
|
(III) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IV) |
47620 |
methyl 4-(allyloxy)-3-methoxybenzoate
|
|
C12H14O4 |
详情 |
详情
|
(V) |
47621 |
methyl 4-(allyloxy)-5-methoxy-2-nitrobenzoate
|
|
C12H13NO6 |
详情 |
详情
|
(VI) |
47622 |
4-(allyloxy)-3-methoxybenzoic acid
|
|
C11H12O4 |
详情 |
详情
|
(VII) |
47623 |
4-(allyloxy)-5-methoxy-2-nitrobenzoic acid
|
|
C11H11NO6 |
详情 |
详情
|
(VIII) |
47624 |
(2S)-2-[bis(propylsulfanyl)methyl]pyrrolidine; propyl (propylsulfanyl)[(2S)pyrrolidinyl]methyl sulfide
|
|
C11H23NS2 |
详情 |
详情
|
(IX) |
47625 |
[4-(allyloxy)-5-methoxy-2-nitrophenyl][(2S)-2-[bis(propylsulfanyl)methyl]pyrrolidinyl]methanone
|
|
C22H32N2O5S2 |
详情 |
详情
|
(X) |
47626 |
[4-(allyloxy)-2-amino-5-methoxyphenyl][(2S)-2-[bis(propylsulfanyl)methyl]pyrrolidinyl]methanone
|
|
C22H34N2O3S2 |
详情 |
详情
|
(XI) |
47627 |
9H-fluoren-9-ylmethyl 5-(allyloxy)-2-([(2S)-2-[bis(propylsulfanyl)methyl]pyrrolidinyl]carbonyl)-4-methoxyphenylcarbamate
|
|
C37H44N2O5S2 |
详情 |
详情
|
(XII) |
47628 |
9H-fluoren-9-ylmethyl (11aS)-8-(allyloxy)-11-hydroxy-7-methoxy-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate
|
|
C31H30N2O6 |
详情 |
详情
|
(XIII) |
47629 |
9H-fluoren-9-ylmethyl (11aS)-11-hydroxy-7-methoxy-8-(2-oxiranylmethoxy)-5-oxo-2,3,11,11a-tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-10(5H)-carboxylate
|
|
C31H30N2O7 |
详情 |
详情
|
合成路线74
该中间体在本合成路线中的序号:
(XII) The reductocondensation of 3-methyl-4-oxopiperidine-1-carboxylic acid methyl ester (I) with aniline (II) by means of TsOH and NaBH4 in refluxing toluene gives 3-methyl-4-(phenylamino)piperidine-1-carboxylic acid methyl ester (III), which is acylated with propionyl anhydride yielding the corresponding propionamide as a mixture of cis and trans isomers, from which the racemic cis isomer (rac)-(IV) is isolated by crystallization. The optical resolution of (rac)-(IV) with d-tartaric acid followed by treatment with NaOH affords (3S.4R)-3-methyl-4-(phenylamino)piperidine (3S,4R)-(V), which is methylated with methyl iodide and K2CO3 to provide (3S,4R)-1,3-dimethyl-4-(phenylamino)piperidine (VI) (1). The condensation of (VI) with the 4-fluorobenzoate (VII) by means of BuLi in THF furnishes the corresponding tertiary amine (VIII), which is transesterified with NaOMe and hydrolyzed with ethanol/water to give the free benzoic acid (IX). The condensation of (IX) with diethylamine by means of BOP and TEA yields the corresponding diethylamide (X), which is demethylated by acylation with phenyl chloroformate and cleavage with KOH to afford the free piperidine NH compound (XI). Finally this piperidine derivative is allylated with allyl bromide (XII) and K2CO3 in ethanol.
【1】
Niemegeers, C.J.E.; Van Bever, W.F.M.; Janssen, P.A.J.; Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide and N-[3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl]-N-phenylpropanamide. J Med Chem 1974, 17, 10, 1047-1051. |
【2】
Carroll, F.I.; Thomas, J.B.; Dersch, C.M.; Rothman, R.B.; Mascarella, S.W.; Burges, J.P.; Xu, H.; Herault, X.M.; Horel, R.B.; (±)-4-[(N-Allyl-cis-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding for the delta opioid receptor. Bioorg Med Chem Lett 1999, 9, 20, 3053. |
【3】
Carroll, F.I.; Horel, R.B.; Rothman, R.B.; Mascarella, S.W.; Dersch, C.M.; Atkinson, R.N.; Xu, H.; Herault, X.M.; Thomas, J.B.; Optically pure (-)-4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide displays selective binding and full agonist activity for the delta opioid receptor. Bioorg Med Chem Lett 1999, 9, 23, 3347. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
41454 |
methyl 3-methyl-4-oxo-1-piperidinecarboxylate
|
|
C8H13NO3 |
详情 |
详情
|
(II) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(III) |
41455 |
methyl 4-anilino-3-methyl-1-piperidinecarboxylate
|
|
C14H20N2O2 |
详情 |
详情
|
(IV) |
41456 |
methyl (3S,4R)-3-methyl-4-(propionylanilino)-1-piperidinecarboxylate
|
|
C17H24N2O3 |
详情 |
详情
|
(V) |
41457 |
N-[(3S,4R)-3-methylpiperidinyl]-N-phenylamine; (3S,4R)-3-methyl-N-phenyl-4-piperidinamine
|
|
C12H18N2 |
详情 |
详情
|
(VI) |
41459 |
N-[(3S,4R)-1,3-dimethylpiperidinyl]-N-phenylamine; (3S,4R)-1,3-dimethyl-N-phenyl-4-piperidinamine
|
|
C13H20N2 |
详情 |
详情
|
(VII) |
41458 |
2,6-di(tert-butyl)-4-methoxyphenyl 4-fluorobenzoate
|
|
C22H27FO3 |
详情 |
详情
|
(VIII) |
41460 |
2,6-di(tert-butyl)-4-methoxyphenyl 4-[[(3S,4R)-1,3-dimethylpiperidinyl]anilino]benzoate
|
|
C35H46N2O3 |
详情 |
详情
|
(IX) |
41461 |
4-[[(3S,4R)-1,3-dimethylpiperidinyl]anilino]benzoic acid
|
|
C20H24N2O2 |
详情 |
详情
|
(X) |
41462 |
4-[[(3S,4R)-1,3-dimethylpiperidinyl]anilino]-N,N-diethylbenzamide
|
|
C24H33N3O |
详情 |
详情
|
(XI) |
41463 |
N,N-diethyl-4-[[(3S,4R)-3-methylpiperidinyl]anilino]benzamide
|
|
C23H31N3O |
详情 |
详情
|
(XII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
合成路线75
该中间体在本合成路线中的序号:
(S)-2-Hydroxyisovaleric acid (IX) was obtained from L-valine (VIII) by diazotization in the presence of sulfuric acid. After protection as the allyl ester (X), coupling with isostatine derivative (VII) using DCC and DMAP afforded (XI). Then, removal of the allyl group of (XI) by means of Pd(PPh3)4 gave acid (XIII), which was activated as the pentafluorophenyl ester (XIII).
【1】
Liang, B.; et al.; The first total synthesis of (-)-tamadarin A. Org Lett 1999, 1, 8, 1319.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VII) |
37827 |
(3S,4S,5S)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]heptanoic acid
|
|
C25H43NO5Si |
详情 |
详情
|
(VIII) |
37828 |
L-2-Amino-3-methylbutyric acid; L-2-Aminoisovaleric acid; 2-Aminoisovaleric acid; L-2-Amino-3-methylbutyric acid; L-alpha-Aminoisovaleric acid; L-valine; (S)-(+)-Valine; (S)-alpha-Aminoisovaleric acid
|
72-18-4 |
C5H11NO2 |
详情 | 详情
|
(IX) |
37829 |
(2S)-2-hydroxy-3-methylbutyric acid
|
|
C5H10O3 |
详情 |
详情
|
(X) |
37830 |
allyl (2S)-2-hydroxy-3-methylbutanoate
|
|
C8H14O3 |
详情 |
详情
|
(XI) |
37831 |
(1S)-1-[(allyloxy)carbonyl]-2-methylpropyl (3S,4S,5S)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]heptanoate
|
|
C33H55NO7Si |
详情 |
详情
|
(XII) |
37832 |
(2S)-2-([(3S,4S,5S)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]heptanoyl]oxy)-3-methylbutyric acid
|
|
C30H51NO7Si |
详情 |
详情
|
(XIII) |
37833 |
(1S)-2-methyl-1-[(2,3,4,5,6-pentafluorophenoxy)carbonyl]propyl (3S,4S,5S)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]heptanoate
|
|
C36H50F5NO7Si |
详情 |
详情
|
合成路线76
该中间体在本合成路线中的序号:
(XI) The synthesis of the carboxylic acid intermediate (VIII) has been performed as follows: The reaction of D-valine (I) with benzyl chloroformate and NaHCO3 gives the protected valine (II), which is esterified with pentafluorophenol and EDAC to yield the activated ester (III). The condensation of (III) with the lithium enolate of methyl acetate (IV) affords the beta ketoester (V), which is stereoselectively reduced with KBH4 and crystallized to afford the desired enantiomeric beta hydroxyester (VI). The silylation of (VI) with Tips-OTf and lutidine provides the silyl ether (VII), which is hydrolyzed with NaOH to give the desired carboxylic acid intermediate (VIII).
The synthesis of the activated ester intermediate (XV) has been performed as follows: The reaction of L-valine (IX) with NaNO2 and H2SO4 gives the hydroxyacid (X), which is esterified with allyl bromide (XI) and K2CO3 to yield the allyl ester (XII). The condensation of (XII) with the intermediate (VIII) by means of EDAC and DMAP affords the adduct (XIII), which is treated with Pd(PPh3)4 to provide the carboxylic acid (XIV). Finally, this compound is esterified with C6F5-OTf to give the activated ester intermediate (XV).
【1】
Liang, B.; et al.; Total syntheses and biological investigations of tamandarins A and B and tamandarin A analogs. J Am Chem Soc 2001, 123, 19, 4469.
|
【2】
Joullie, M.M.; et al.; Total synthesis of (-)-tamandarin B. Tetrahedron Lett 2000, 41, 49, 9373.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
21056 |
(R)-(-)-Valine; D-Valine; (R)-alpha-Aminoisovaleric acid
|
640-68-6 |
C5H11NO2 |
详情 | 详情
|
(II) |
49332 |
(2R)-2-[[(benzyloxy)carbonyl]amino]-3-methylbutyric acid
|
|
C13H17NO4 |
详情 |
详情
|
(III) |
49323 |
2,3,4,5,6-pentafluorophenyl (2R)-2-[[(benzyloxy)carbonyl]amino]-3-methylbutanoate
|
|
C19H16F5NO4 |
详情 |
详情
|
(IV) |
49324 |
|
|
C3H5LiO2 |
详情 |
详情
|
(V) |
49325 |
methyl (4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-oxohexanoate
|
|
C16H21NO5 |
详情 |
详情
|
(VI) |
49326 |
methyl (3S,4R)-4-[[(benzyloxy)carbonyl]amino]-3-hydroxy-5-methylhexanoate
|
|
C16H23NO5 |
详情 |
详情
|
(VII) |
49327 |
methyl (3S,4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]hexanoate
|
|
C25H43NO5Si |
详情 |
详情
|
(VIII) |
49328 |
(3S,4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]hexanoic acid
|
|
C24H41NO5Si |
详情 |
详情
|
(IX) |
37828 |
L-2-Amino-3-methylbutyric acid; L-2-Aminoisovaleric acid; 2-Aminoisovaleric acid; L-2-Amino-3-methylbutyric acid; L-alpha-Aminoisovaleric acid; L-valine; (S)-(+)-Valine; (S)-alpha-Aminoisovaleric acid
|
72-18-4 |
C5H11NO2 |
详情 | 详情
|
(X) |
37829 |
(2S)-2-hydroxy-3-methylbutyric acid
|
|
C5H10O3 |
详情 |
详情
|
(XI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XII) |
37830 |
allyl (2S)-2-hydroxy-3-methylbutanoate
|
|
C8H14O3 |
详情 |
详情
|
(XIII) |
49329 |
(1S)-1-[(allyloxy)carbonyl]-2-methylpropyl (3S,4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]hexanoate
|
|
C32H53NO7Si |
详情 |
详情
|
(XIV) |
49330 |
(2S)-2-([(3S,4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]hexanoyl]oxy)-3-methylbutyric acid
|
|
C29H49NO7Si |
详情 |
详情
|
(XV) |
49331 |
(1S)-2-methyl-1-[(2,3,4,5,6-pentafluorophenoxy)carbonyl]propyl (3S,4R)-4-[[(benzyloxy)carbonyl]amino]-5-methyl-3-[(triisopropylsilyl)oxy]hexanoate
|
|
C35H48F5NO7Si |
详情 |
详情
|
合成路线77
该中间体在本合成路线中的序号:
(V) Condensation of 4-fluorophenylacetyl chloride (I) with ethylene in the presence of AlCl3 provided the beta-tetralone (II). After conversion of (III) into enamine (IV) upon reaction with pyrrolidine (III) in MeOH, alkylation with allyl bromide (V) afforded iminium salt (VI). Acid hydrolysis of (VI) generated the allyl tetralone (VII), which was subjected to reductive amination with ammonium acetate and sodium cyanoborohydride to produce the cis-1-allyl-2-aminotetralin (VIII) as the major isomer. Coupling of (VIII) with carboxylic acid (IX) using 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU) gave amide (X), which was finally reduced to the target aminotetralin derivative with LiAlH4.
【1】
Lovenberg, T.W.; McNally, J.J.; Youngman, M.A.; et al.; alpha-Substituted N-(sulfonamido)alkyl-beta-aminotetralins: Potent and selective neuropeptide Y Y5 receptor antagonists. J Med Chem 2000, 43, 3, 346.
|
【2】
Reitz, A.B.; Lovenberg, T.W.; Dax, S.L.; Youngman, M.A.; McNally, J.J. (Ortho-McNeil Pharmaceutical, Inc.); N-Substd. aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders. WO 9955667 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
37014 |
2-(4-fluorophenyl)acetyl chloride
|
459-04-1 |
C8H6ClFO |
详情 | 详情
|
(II) |
37015 |
6-fluoro-3,4-dihydro-2(1H)-naphthalenone
|
|
C10H9FO |
详情 |
详情
|
(III) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(IV) |
37016 |
1-(6-fluoro-3,4-dihydro-2-naphthalenyl)pyrrolidine
|
|
C14H16FN |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
37017 |
1-[1-allyl-6-fluoro-3,4-dihydro-2(1H)-naphthalenylidene]pyrrolidinium bromide
|
|
C17H21BrFN |
详情 |
详情
|
(VII) |
37018 |
1-allyl-6-fluoro-3,4-dihydro-2(1H)-naphthalenone
|
|
C13H13FO |
详情 |
详情
|
(VIII) |
37019 |
(1S,2R)-1-allyl-6-fluoro-1,2,3,4-tetrahydro-2-naphthalenamine; (1S,2R)-1-allyl-6-fluoro-1,2,3,4-tetrahydro-2-naphthalenylamine
|
|
C13H16FN |
详情 |
详情
|
(IX) |
37020 |
4-[[(phenylsulfonyl)amino]methyl]cyclohexanecarboxylic acid
|
|
C14H19NO4S |
详情 |
详情
|
(X) |
37021 |
N-[(1S,2R)-1-allyl-6-fluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-4-[[(phenylsulfonyl)amino]methyl]cyclohexanecarboxamide
|
|
C27H33FN2O3S |
详情 |
详情
|
合成路线78
该中间体在本合成路线中的序号:
(II) Alkylation of 3-chlorophenylacetic acid (I) with allyl bromide (II) using lithium hexamethyldisilazide provided racemic (III), which was resolved by recrystallization of the corresponding diastereoisomeric salts with (S)-alpha-methylbenzylamine. The desired (S)-carboxylic acid (IV) was converted to acid chloride and then treated with methylamine yielding amide (V). Reduction of (V) with LiAlH4 gave amine (VI), which was acylated with benzenesulfonyl chloride to afford sulfonamide (VII). A two-step oxidation of the allyl group of (VII) with osmium tetroxide and N-methylmorpholine N-oxide, followed by sodium periodate cleavage of the resulting diol produced aldehyde (VIII). Reductive condensation of (VIII) with spiro piperidine (IX) using NaBH(OAc)3 furnished adduct (X). Final oxidation of the sulfide group of (X) with one equivalent of Oxone(r) afforded the title sulfoxide.
【1】
Meurer, L.C.; Oates, B.; Finke, P.E.; et al.; Discovery of potent human CCR5 antagonists for the treatment of HIV-1 infection. 219th ACS Natl Meet (March 26 2000, San Francisco) 2000, Abst MEDI 118.
|
【2】
Mills, S.G.; MacCoss, M.; Springer, M.S. (Merck & Co., Inc.); Spiro-substd. azacycles as modulators of chemokine receptor activity. US 5962462; WO 9825605 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
39705 |
2-(3-chlorophenyl)acetic acid; 3-chlorophenylacetic acid
|
1878-65-5 |
C8H7ClO2 |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
39706 |
2-(3-chlorophenyl)-4-pentenoic acid
|
|
C11H11ClO2 |
详情 |
详情
|
(IV) |
39707 |
(2S)-2-(3-chlorophenyl)-4-pentenoic acid
|
|
C11H11ClO2 |
详情 |
详情
|
(V) |
39708 |
(2S)-2-(3-chlorophenyl)-N-methyl-4-pentenamide
|
|
C12H14ClNO |
详情 |
详情
|
(VI) |
39709 |
N-[(2S)-2-(3-chlorophenyl)-4-pentenyl]-N-methylamine; (2S)-2-(3-chlorophenyl)-N-methyl-4-penten-1-amine
|
|
C12H16ClN |
详情 |
详情
|
(VII) |
39710 |
N-[(2S)-2-(3-chlorophenyl)-4-pentenyl]-N-methylbenzenesulfonamide
|
|
C18H20ClNO2S |
详情 |
详情
|
(VIII) |
39711 |
N-[(2S)-2-(3-chlorophenyl)-4-oxobutyl]-N-methylbenzenesulfonamide
|
|
C17H18ClNO3S |
详情 |
详情
|
(IX) |
39712 |
|
|
C12H15NS |
详情 |
详情
|
(X) |
39713 |
|
|
C29H33ClN2O2S2 |
详情 |
详情
|
合成路线79
该中间体在本合成路线中的序号:
(V) Treatment of 4-phenoxyphenol (I) with N,N-dimethylthiocarbamoyl chloride afforded the O-aryl thiocarbamate (II), which was thermally rearranged to the S-aryl thiocarbamate (III). Basic hydrolysis of (III) provided 4-phenoxythiophenol (IV). Subsequent alkylation of (IV) with allyl bromide (V) led to the allyl thioether (VI). Further oxidation of (VI) with m-chloroperbenzoic acid (MCPBA) gave rise to the epoxisulfone (VII). This was finally converted to the target thiirane derivative upon treatment with ammonium thiocyanate.
【1】
Kotra, L.P.; Brown, S.; Bernardo, M.M.; Tanaka, Y.; Li, Z.-H.; Fridman, R.; Mobashery, S.; Potent and selective mechanism-based inhibition of gelatinases. J Am Chem Soc 2000, 122, 28, 6799.
|
【2】
Mobashery, S.; Fridman, R. (Wayne State University); Inhibitors of matrix metalloproteinases. WO 0192244 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27080 |
4-Phenoxyphenol
|
831-82-3 |
C12H10O2 |
详情 | 详情
|
(II) |
27081 |
O-(4-phenoxyphenyl) dimethylcarbamothioate
|
|
C15H15NO2S |
详情 |
详情
|
(III) |
46031 |
S-(4-phenoxyphenyl) dimethylcarbamothioate
|
|
C15H15NO2S |
详情 |
详情
|
(IV) |
26254 |
4-phenoxybenzenethiol; 4-phenoxyphenylhydrosulfide
|
|
C12H10OS |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
46032 |
1-(allylsulfanyl)-4-phenoxybenzene; 4-(allylsulfanyl)phenyl phenyl ether
|
|
C15H14OS |
详情 |
详情
|
(VII) |
46033 |
2-[[(4-phenoxyphenyl)sulfonyl]methyl]oxirane; 2-oxiranylmethyl 4-phenoxyphenyl sulfone
|
|
C15H14O4S |
详情 |
详情
|
合成路线80
该中间体在本合成路线中的序号:
(VIII) Alkylation of phenylacetic acid (VII) with allyl bromide (VIII) using lithium bis(trimethylsilyl)amide furnished 2-phenyl-4-pentenoic acid (IX). Reduction of the carboxylate group of (IX) by means of LiAlH4 and AlCl3 gave rise to alcohol (X), which was subsequently converted to triflate (XI). The triflate group of (XI) was then displaced with benzimidazole (XII) to produce adduct (XIII). Dihydroxylation of the double bond of (XIII) with N-methylmorpholine-N-oxide in the presence of OsO4, followed by oxidative cleavage with NaIO4, yielded aldehyde (XIV). Finally, aldehyde (XIV) was reductively condensed with piperidine (VI) in the presence of sodium triacetoxyborohydride.
【1】
Kim, D.; Wang, L.; Caldwell, C.G.; et al.; Design, synthesis, and SAR of heterocycle-containing human CCR5 antagonists for the treatment of HIV-1 infection. 220th ACS Natl Meet (Aug 20 2000, Washington DC) 2000, Abst MEDI 84.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(VI) |
43905 |
4-nitrobenzyl allyl(4-piperidinyl)carbamate
|
|
C16H21N3O4 |
详情 |
详情
|
(VII) |
16148 |
Benzeneacetic acid; 2-Phenylacetic acid; Phenyl Acetic Acid
|
103-82-2 |
C8H8O2 |
详情 | 详情
|
(VIII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IX) |
44294 |
2-phenyl-4-pentenoic acid
|
|
C11H12O2 |
详情 |
详情
|
(X) |
44295 |
2-phenyl-4-penten-1-ol
|
|
C11H14O |
详情 |
详情
|
(XI) |
44296 |
2-phenyl-4-pentenyl trifluoromethanesulfonate
|
|
C12H13F3O3S |
详情 |
详情
|
(XII) |
44297 |
1H-benzimidazole
|
51-17-2 |
C7H6N2 |
详情 | 详情
|
(XIII) |
44298 |
1-(2-phenyl-4-pentenyl)-1H-benzimidazole
|
|
C18H18N2 |
详情 |
详情
|
(XIV) |
44299 |
4-(1H-benzimidazol-1-yl)-3-phenylbutanal
|
|
C17H16N2O |
详情 |
详情
|
合成路线81
该中间体在本合成路线中的序号:
(II) Isovanillin (I) was protected as the allyl ether (III) by treatment with allyl bromide (II) and K2CO3. Aldehyde reduction of (III) with NaBH4 gave alcohol (IV), which was converted to chloride (V) using SOCl2. Condensation of chloride (V) with the sodium salt of 3,4,5-trimethoxyphenol (VI) produced the corresponding ether (VII). Finally, deprotection of the allyl group of (VII) was achieved by treatment with Wilkinson’s catalyst and DABCO.
【1】
McGown, A.T.; Hadfield, J.A.; Rennison, D.; Woo, M.; Lawrence, N.J.; Antimitotic and cell growth inhibitory properties of combrestastatin A-4-like ethers. Bioorg Med Chem Lett 2001, 11, 1, 51.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
18455 |
3-hydroxy-4-methoxybenzaldehyde; Isovanillin
|
621-59-0 |
C8H8O3 |
详情 | 详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
48348 |
3-Allyloxy-4-methoxybenzaldehyde
|
|
C11H12O3 |
详情 |
详情
|
(IV) |
48349 |
[3-(allyloxy)-4-methoxyphenyl]methanol
|
|
C11H14O3 |
详情 |
详情
|
(V) |
48350 |
allyl 5-(chloromethyl)-2-methoxyphenyl ether; 2-(allyloxy)-4-(chloromethyl)-1-methoxybenzene
|
|
C11H13ClO2 |
详情 |
详情
|
(VI) |
37163 |
3,4,5-trimethoxyphenol
|
|
C9H12O4 |
详情 |
详情
|
(VII) |
48351 |
allyl 2-methoxy-5-[(3,4,5-trimethoxyphenoxy)methyl]phenyl ether; 5-[[3-(allyloxy)-4-methoxybenzyl]oxy]-1,2,3-trimethoxybenzene
|
|
C20H24O6 |
详情 |
详情
|
合成路线82
该中间体在本合成路线中的序号:
Swern oxidation of derivative (I) by means of oxalyl chloride and DMSO in CH2Cl2 followed by Wittig reaction with MePPh3Br and BuLi in THF yields alkene (II), which is then converted into alcohol (III) by hydroboration with 9-BBN in EtOH and oxidation with NaOH and H2O2 in THF followed by isomer separation. Benzylation of (III) by means of NaH and BnBr (IV) in DMF, followed by hydrolysis with acetyl chloride (V) in CH2Cl2/MeOH, affords derivative (VI), which is further benzylated with BnBr (IV) and NaH in DMF and then hydrolyzed with HCl in MeOH to provide diol (VII). Derivative (VII) is O-stannylated by means of Bu2SnO in refluxing toluene and selectively allylated with allyl bromide and CsF to furnish compound (VIII), which is then benzylated with BnBr (IV) and NaH in DMF to give completely protected derivative (IX). Removal of the allyl group of (IX) is then performed by catalytic treatment with RhCl(PPh3)3 and DABCO in refluxing EtOH, and subsequent hydrolysis with HCl in refluxing acetone yields inositol derivative (X). Conversion of (X) into protected phosphatidylinositol (XII) is then performed by a standard phosphitylation protocol with BnOP(N-i-Pr2)2 and diisopropylamine-tetrazole, followed by treatment with the imidazolyl derivative (XI) in the presence of tetrazole and final adjustment of the oxidation state of the P atom by means of tert-BuOOH. Finally, hydrogenolysis of the benzyl groups of compound (XII) with Pd(OH)2/C in tert-butanol gives the desired phosphate.
【1】
Hu, Y.; et al.; 3-(Hydroxymethyl)-bearing phosphatidylinositol ether lipid analogues and carbonate surrogates block PI3-K, Akt, and cancer cell growth. J Med Chem 2000, 43, 16, 3045.
|
【2】
Meuillet, E.J.; Kozikowski, A.P.; Hu, Y.; Berggren, M.; Powis, G.; 3-Deoxy-3-substituted-D-myo-inositol imidazolyl ether lipid phosphates and carbonate as inhibitors of the phosphatidylinositol 3-kinase pathway and cancer cell growth. Bioorg Med Chem Lett 2001, 11, 2, 173. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
|
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(I) |
48135 |
(3aR,4aR,7aR,8aS)-8-(benzyloxy)-2,2,6,6-tetramethylhexahydro[1,3]dioxolo[4,5-f][1,3]benzodioxol-4-ol
|
|
C19H26O6 |
详情 |
详情
|
(II) |
48136 |
(3aR,4aS,7aR,8aR)-4-(benzyloxy)-2,2,6,6-tetramethyl-8-methylenehexahydro[1,3]dioxolo[4,5-f][1,3]benzodioxole; (3aR,4aS,7aR,8aR)-2,2,6,6-tetramethyl-8-methylenehexahydro[1,3]dioxolo[4,5-f][1,3]benzodioxol-4-yl benzyl ether
|
|
C20H26O5 |
详情 |
详情
|
(III) |
48137 |
[(3aR,4aR,7aR,8aS)-8-(benzyloxy)-2,2,6,6-tetramethylhexahydro[1,3]dioxolo[4,5-f][1,3]benzodioxol-4-yl]methanol
|
|
C20H28O6 |
详情 |
详情
|
(IV) |
12912 |
1-(Bromomethyl)benzene; Alpha-bromotoluene
|
100-39-0 |
C7H7Br |
详情 | 详情
|
(V) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
(VI) |
48138 |
(3aS,4R,5S,6R,7S,7aR)-4-(benzyloxy)-7-[(benzyloxy)methyl]-2,2-dimethylhexahydro-1,3-benzodioxole-5,6-diol
|
|
C24H30O6 |
详情 |
详情
|
(VII) |
48139 |
(1R,2R,3S,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]-1,2-cyclohexanediol
|
|
C35H38O6 |
详情 |
详情
|
(VIII) |
48140 |
(1R,2R,3S,4S,5R,6R)-2-(allyloxy)-3,4,5-tris(benzyloxy)-6-[(benzyloxy)methyl]cyclohexanol
|
|
C38H42O6 |
详情 |
详情
|
(IX) |
48141 |
1-[([(1S,2R,3R,4R,5R,6S)-2-(allyloxy)-3,5,6-tris(benzyloxy)-4-[(benzyloxy)methyl]cyclohexyl]oxy)methyl]benzene; allyl (1R,2S,3S,4R,5R,6R)-2,3,4,6-tetrakis(benzyloxy)-5-[(benzyloxy)methyl]cyclohexyl ether
|
|
C45H48O6 |
详情 |
详情
|
(X) |
48142 |
(1R,2S,3S,4R,5R,6R)-2,3,4,6-tetrakis(benzyloxy)-5-[(benzyloxy)methyl]cyclohexanol
|
|
C42H44O6 |
详情 |
详情
|
(XI) |
48143 |
(2R)-2-(1H-imidazol-1-yl)-3-(octadecyloxy)-1-propanol
|
|
C24H46N2O2 |
详情 |
详情
|
(XII) |
48144 |
benzyl (2S)-2-(1H-imidazol-1-yl)-3-(octadecyloxy)propyl (1R,2R,3S,4R,5S,6R)-2,3,4,6-tetrakis(benzyloxy)-5-[(benzyloxy)methyl]cyclohexyl phosphate
|
|
C73H95N2O10P |
详情 |
详情
|
合成路线83
该中间体在本合成路线中的序号:
(IV) Reaction of betulin (I) and 2,2-dimethylsuccinic acid (II) in refluxing pyridine, followed by HPLC separation of the two products obtained, affords derivative (III). Protection of the carboxylic group of (III) is then performed by formation of the corresponding allyl ester derivative (V) by reaction with allyl bromide (IV) and K2CO3 in acetone.
Separately, 2,2-dimethylsuccinic acid (II) is treated with allyl alcohol (VI) in refluxing pyridine to give an isomeric mixture of compounds from which allyl succinate derivative (VII) is chromatographically isolated. Formation of the corresponding acid chloride (VIII) is finally performed by treatment of (VII) with (COCl)2 in refluxing benzene. Condensation between alcohol (V) and acid chloride (VIII) by means of DMAP in CH2Cl2 provides compound (IX), which is finally converted into the target product by removal of the allyl protecting groups by means of Pd(Ph3P)4 and morpholine.
【1】
Chiyo, J.; Ikeshiro, Y.; Cosentino, L.M.; Kashiwada, Y.; Fowke, K.; Lee, K.H.; Okabe, H.; Nagao, T.; 3,28-Di-O-(dimethylsuccinyl)-betulin isomers as anti-HIV agents. Bioorg Med Chem Lett 2001, 11, 2, 183.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
50064 |
(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-(hydroxymethyl)-1-isopropenyl-5a,5b,8,8,11a-pentamethylicosahydro-1H-cyclopenta[a]chrysen-9-ol
|
|
C30H50O2 |
详情 |
详情
|
(II) |
46622 |
2,2-dimethylsuccinic acid
|
|
C6H10O4 |
详情 |
详情
|
(III) |
50065 |
4-[[(1R,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethylicosahydro-3aH-cyclopenta[a]chrysen-3-yl]methoxy]-3,3-dimethyl-4-oxobutyric acid
|
|
C36H58O5 |
详情 |
详情
|
(IV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(V) |
50066 |
1-[[(1R,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethylicosahydro-3aH-cyclopenta[a]chrysen-3-yl]methyl] 4-allyl 2,2-dimethylsuccinate
|
|
C39H62O5 |
详情 |
详情
|
(VI) |
12234 |
2-Propen-1-ol; Allyl alcohol
|
107-18-6 |
C3H6O |
详情 | 详情
|
(VII) |
50067 |
4-(allyloxy)-3,3-dimethyl-4-oxobutyric acid
|
|
C9H14O4 |
详情 |
详情
|
(VIII) |
50068 |
allyl 4-chloro-2,2-dimethyl-4-oxobutanoate
|
|
C9H13ClO3 |
详情 |
详情
|
(IX) |
50069 |
4-[(1R,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-([[4-(allyloxy)-2,2-dimethyl-4-oxobutanoyl]oxy]methyl)-1-isopropenyl-5a,5b,8,8,11a-pentamethylicosahydro-3aH-cyclopenta[a]chrysen-9-yl] 1-allyl 2,2-dimethylsuccinate
|
|
C48H74O8 |
详情 |
详情
|
合成路线84
该中间体在本合成路线中的序号:
(VII) In an alternative procedure, diol (II) was selectively protected as the 14-allyl ether (VIII) by O-alkylation with allyl bromide (VII) in the presence of K2CO3. Displacement of the 16-hydroxyl of (VIII) with diethylaminosulfur trifluoride provided fluoride (IX). The O-allyl protecting group of (IX) was finally removed employing p-toluenesulfonic acid and palladium tetrakis(triphenylphosphine).
【1】
Barriere, J.-C.; Achard, D.; Grisoni, S.; Bacque, E.; Ribeill, Y.; Bouquerel, J.; Desmazeau, P.; Leconte, J.-P.; Ronan, B. (Aventis Pharma SA); Streptogramin derivs., preparation and compsns. containing them. EP 1187847; FR 2795733; WO 0102427 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
59396 |
(7R,10R,11R,21S,23S)-21,23-dihydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0~3,7~]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14-trione
|
|
C28H39N3O7 |
详情 |
详情
|
(VII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VIII) |
59397 |
(7R,10R,11R,21S,23S)-21-{[tert-butyl(diphenyl)silyl]oxy}-23-hydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0~3,7~]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14-trione
|
|
C44H57N3O7Si |
详情 |
详情
|
(IX) |
59398 |
(7R,10R,11R,21S,23R)-21-{[tert-butyl(diphenyl)silyl]oxy}-23-fluoro-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0~3,7~]octacosa-1(27),12,17,19,25(28)-pentaene-2,8,14-trione
|
|
C44H56FN3O6Si |
详情 |
详情
|
合成路线85
该中间体在本合成路线中的序号:
(X) Synthesis of undecenoic ester intermediate (XXI): The reaction of 2,2-dimethylpropane-1,3-diol (I) with benzaldehyde, Ts-OH and DIBAL gives the monobenzyl ether (II), which is oxidized with SO3/pyridine in dichloromethane, yielding the propionaldehyde (III). The condensation of (III) with butanone (IV) by means of LDA and TFAA affords the heptenone (V), which is epoxidated with H2O2 and NaOH in aq. methanol to provide the racemic epoxide (rac)-(VI). The reaction of ketone (VI) with O-methylhydroxylamine and NaOAc in methanol gives the corresponding oxime (rac)-(VII), which is treated with CuCN and Me-Li in ethyl ether to yield the beta-hydroxy oxime (rac)-(VIII). The treatment of (VIII) with H2 and RaNi in acetone/THF affords the corresponding beta-hydroxy ketone (rac)-(IX), which is allylated with allyl bromide (X) and LHMDS in the presence of 1,3-dimethylperhydropyrimidin-2-one to give the beta-hydroxynonen-5-one (rac)-(XI). The reduction of (XI) with Me4NBH(OAc)3 and HOAc in acetonitrile yields the diol (rac)-(XII), which is protected with 2-methoxypropene (XIII) and Ts-OH, affording the 1,3-dioxane (rac)-(XIV). The reaction of (XIV) with Li in liquid ammonia, tert-butanol and THF provides the debenzylated primary alcohol (rac)-(XV), which is oxidized with tetrapropylammonium perrhuthenate in dichloromethane, giving the corresponding aldehyde (rac)-(XVI).
【1】
Sawada, D.; et al.; Enantioselective total synthesis of epothilones A and B using multifunctional asymmetric catalysis. J Am Chem Soc 2000, 122, 43, 10521.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12641 |
Neopentyl glycol; 2,2-Dimethyl-1,3-propanediol
|
126-30-7 |
C5H12O2 |
详情 | 详情
|
(II) |
44529 |
3-(benzyloxy)-2,2-dimethyl-1-propanol
|
|
C12H18O2 |
详情 |
详情
|
(III) |
44504 |
3-(benzyloxy)-2,2-dimethylpropanal
|
|
C12H16O2 |
详情 |
详情
|
(IV) |
33891 |
Methyl ethyl ketone; 2-Butanone
|
78-93-3 |
C4H8O |
详情 | 详情
|
(V) |
44505 |
(E)-7-(benzyloxy)-6,6-dimethyl-4-hepten-3-one
|
|
C16H22O2 |
详情 |
详情
|
(VI) |
44506 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone
|
|
C16H22O3 |
详情 |
详情
|
(VII) |
44507 |
1-[3-[2-(benzyloxy)-1,1-dimethylethyl]-2-oxiranyl]-1-propanone O-methyloxime
|
|
C17H25NO3 |
详情 |
详情
|
(VIII) |
44508 |
(4R,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone O-methyloxime
|
|
C18H29NO3 |
详情 |
详情
|
(IX) |
44509 |
(4S,5R)-7-(benzyloxy)-5-hydroxy-4,6,6-trimethyl-3-heptanone
|
|
C17H26O3 |
详情 |
详情
|
(X) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XI) |
44510 |
(4S,6S,7R)-9-(benzyloxy)-7-hydroxy-4,6,8,8-tetramethyl-1-nonen-5-one
|
|
C20H30O3 |
详情 |
详情
|
(XII) |
44511 |
(3R,4R,5S,6S)-1-(benzyloxy)-2,2,4,6-tetramethyl-8-nonene-3,5-diol
|
|
C20H32O3 |
详情 |
详情
|
(XIII) |
17354 |
isopropenyl methyl ether; 2-methoxy-1-propene
|
116-11-0 |
C4H8O |
详情 | 详情
|
(XIV) |
44512 |
benzyl 2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propyl ether; (4R,5S,6S)-4-[2-(benzyloxy)-1,1-dimethylethyl]-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxane
|
|
C23H36O3 |
详情 |
详情
|
(XV) |
44513 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]-1-propanol
|
|
C16H30O3 |
详情 |
详情
|
(XVI) |
44514 |
2-methyl-2-[(4R,5S,6S)-2,2,5-trimethyl-6-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-4-yl]propanal
|
|
C16H28O3 |
详情 |
详情
|
合成路线86
该中间体在本合成路线中的序号:
(XV) The oxidation of the lactol (XIII) with Br2 and BaCO3 gives the lactone (XIV), which is stereoselectively alkylated with allyl bromide (XV) by means of LDA in HMPA to yield lactone (XVI). The opening of the lactone ring of (XVI) with MeONa affords the dihydroxyester (XVII), which is protected by reaction with anisaldehyde dimethylacetal (XVIII) and CSA to provide the benzylidene derivative (XIX). The reduction of the ester group of (XIX) with LiAlH4 gives the corresponding carbinol (XX), which is acylated with Ms-Cl and TEA to yield the mesylate (XXI). The reduction of the mesyloxy group of (XXI) with LiAlH4 affords the dimethyl compound (XXII), which is submitted to a regioselective cleavage of the Pmp protecting group by means of DIBAL in toluene to provide the primary alcohol (XXIII). The oxidation of (XXIII) with DMP gives the corresponding aldehyde (XXIV), which is condensed with tert-butyl isobutyrylacetate (XXV) by means of NaH and BuLi to yield the unsaturated ketoester (XXVI). Stereoselective reduction of the beta-oxo group of (XXVI) by means of Me4NBH(OAc)3 affords the desired diol (XXVII), which is regioselectively silylated at the beta-hydroxy group by means of Tbdms-OTf to provide the monosilyl ether (XXVIII). The oxidation of the remaining hydroxy group of (XXVIII) by means of DMP gives the unsaturated ketoester (XXIX).
【1】
Wong, C.-H.; Liu, J.; Aldolase-catalyzed asymmetric synthesis of novel pyranose synthons as a new entry to heterocycles and epothilones. Angew Chem. Int Ed 2002, 41, 8, 1404.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
54267 |
(4S,5S)-5-methyltetrahydro-2H-pyran-2,4-diol
|
|
C6H12O3 |
详情 |
详情
|
(XIV) |
54268 |
(4S,5S)-4-hydroxy-5-methyltetrahydro-2H-pyran-2-one
|
|
C6H10O3 |
详情 |
详情
|
(XV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVI) |
54269 |
(3S,4R,5S)-3-allyl-4-hydroxy-5-methyltetrahydro-2H-pyran-2-one
|
|
C9H14O3 |
详情 |
详情
|
(XVII) |
54270 |
methyl (2S)-2-[(1R,2S)-1,3-dihydroxy-2-methylpropyl]-4-pentenoate
|
|
C10H18O4 |
详情 |
详情
|
(XVIII) |
26485 |
1-(dimethoxymethyl)-4-methoxybenzene
|
2186-92-7 |
C10H14O3 |
详情 | 详情
|
(XIX) |
54271 |
methyl (2S)-2-[(4R,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-pentenoate
|
n/a |
C18H24O5 |
详情 | 详情
|
(XX) |
54272 |
(2R)-2-[(4S,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-penten-1-ol
|
n/a |
C17H24O4 |
详情 | 详情
|
(XXI) |
54273 |
(2R)-2-[(4R,5S)-2-(4-methoxyphenyl)-5-methyl-1,3-dioxan-4-yl]-4-pentenyl methanesulfonate
|
n/a |
C18H26O6S |
详情 | 详情
|
(XXII) |
54274 |
(4S,5S)-2-(4-methoxyphenyl)-5-methyl-4-[(1S)-1-methyl-3-butenyl]-1,3-dioxane; methyl 4-{(4S,5S)-5-methyl-4-[(1S)-1-methyl-3-butenyl]-1,3-dioxan-2-yl}phenyl ether
|
n/a |
C17H24O3 |
详情 | 详情
|
(XXIII) |
54275 |
(2S,3S,4S)-3-[(4-methoxybenzyl)oxy]-2,4-dimethyl-6-hepten-1-ol
|
n/a |
C17H26O3 |
详情 | 详情
|
(XXIV) |
54276 |
(2R,3S,4S)-3-[(4-methoxybenzyl)oxy]-2,4-dimethyl-6-heptenal
|
n/a |
C17H24O3 |
详情 | 详情
|
(XXV) |
54277 |
tert-butyl 4-methyl-3-oxopentanoate
|
94250-54-1 |
C10H18O3 |
详情 | 详情
|
(XXVI) |
54278 |
tert-butyl (5S,6S,7S,8S)-5-hydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-3-oxo-10-undecenoate
|
n/a |
C27H42O6 |
详情 | 详情
|
(XXVII) |
54279 |
tert-butyl (3S,5S,6S,7S,8S)-3,5-dihydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-10-undecenoate
|
n/a |
C27H44O6 |
详情 | 详情
|
(XXVIII) |
54280 |
tert-butyl (3S,5S,6S,7S,8S)-3-{[tert-butyl(dimethyl)silyl]oxy}-5-hydroxy-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-10-undecenoate
|
n/a |
C33H58O6Si |
详情 | 详情
|
(XXIX) |
54281 |
tert-butyl (3S,6R,7S,8S)-3-{[tert-butyl(dimethyl)silyl]oxy}-7-[(4-methoxybenzyl)oxy]-4,4,6,8-tetramethyl-5-oxo-10-undecenoate
|
n/a |
C33H56O6Si |
详情 | 详情
|
合成路线87
该中间体在本合成路线中的序号:
(XXII) Bromochromanone (XVI) was prepared by bromination of 4-chromanone (XV). Subsequent reduction of (XVI) with NaBH4 provided bromohydrin (XVII). Ritter reaction of (XVII) with acetonitrile and sulfuric acid, followed by acidic hydrolysis, led to racemic cis-3-bromo-4-chromanol, which was then resolved by means of (S)-(+)-mandelic acid. The desired (S,S)-isomer (XVIII) was coupled with hydrocinnamic acid (XIX) giving amide (XX). After protection of hydroxy amide (XX) as the acetonide (XXI), the lithium enolate of amide (XXI) was alkylated with allyl bromide (XXII) to furnish the (S)-2-benzyl-4-pentenamide (XXIII) as the main diastereoisomer. Halogenation of (XXIII) with N-iodosuccinimide in H2O-EtOAc afforded iodohydrin (XXIV), which was cyclized to epoxide (XXV) in the presence of NaOMe.
【1】
gamma-Hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as HIV protease inhibitors. EP 1242426; WO 0138332 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XV) |
14461 |
2,3-Dihydro-4H-chromen-4-one; 4-Chromanone
|
491-37-2 |
C9H8O2 |
详情 | 详情
|
(XVI) |
56263 |
3-bromo-2,3-dihydro-4H-chromen-4-one
|
|
C9H7BrO2 |
详情 |
详情
|
(XVII) |
56264 |
3-bromo-4-chromanol
|
|
C9H9BrO2 |
详情 |
详情
|
(XVIII) |
56265 |
(3S,4S)-4-amino-3,4-dihydro-2H-chromen-3-ol
|
|
C9H11NO2 |
详情 |
详情
|
(XIX) |
49181 |
Hydrocinnamic acid; 3-Phenylpropionic acid; Benzylacetic acid
|
501-52-0 |
C9H10O2 |
详情 | 详情
|
(XX) |
56266 |
N-[(3S,4S)-3-hydroxy-3,4-dihydro-2H-chromen-4-yl]-3-phenylpropanamide
|
|
C18H19NO3 |
详情 |
详情
|
(XXI) |
56267 |
1-[(3aS,9bS)-2,2-dimethyl-3a,9b-dihydro-2H-chromeno[4,3-d][1,3]oxazol-1(4H)-yl]-3-phenyl-1-propanone
|
|
C21H23NO3 |
详情 |
详情
|
(XXII) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XXIII) |
56268 |
(2S)-1-[(3aS,9bS)-2,2-dimethyl-3a,9b-dihydro-2H-chromeno[4,3-d][1,3]oxazol-1(4H)-yl]-2-benzyl-4-penten-1-one
|
|
C24H27NO3 |
详情 |
详情
|
(XXIV) |
56269 |
(2R,4S)-1-[(3aS,9bS)-2,2-dimethyl-3a,9b-dihydro-2H-chromeno[4,3-d][1,3]oxazol-1(4H)-yl]-2-benzyl-4-hydroxy-5-iodo-1-pentanone
|
|
C24H28INO4 |
详情 |
详情
|
(XXV) |
56270 |
(2R)-1-[(3aS,9bS)-2,2-dimethyl-3a,9b-dihydro-2H-chromeno[4,3-d][1,3]oxazol-1(4H)-yl]-2-benzyl-3-[(2S)oxiranyl]-1-propanone
|
|
C24H27NO4 |
详情 |
详情
|
合成路线88
该中间体在本合成路线中的序号:
(III) The esterification of 3,4-dichlorophenylacetic acid (I) with methanol and ClH gives the methyl ester (II), which is alkylated with allyl bromide and LDA in THF to yield 2-(3,4-dichlorophenyl)-4-pentenoic acid methyl ester (IV). The hydrolysis of (IV) with LiOH in MeOH/water affords the corresponding free acid (V), which is epoxidated with MCPBA in refluxing chloroform to provide epoxide (VI), which, without isolation, is treated in acid medium, giving the tetrahydrofuranone (VII). The silylation of the OH group of (VII) with Tbdms-Cl and imidazole in DMF yields the protected silyl ether (VIII), which is treated with LDA in THF to afford the lithium enolate (IX). The reaction of (IX) with phenylselenyl chloride in THF provides the phenylselenyl derivative (X), which is oxidized with MCPBA to the corresponding selenoxide. This nonisolated compound undergoes spontaneous syn elimination to give, after hydrolysis of the silyl ether with AcOH, 3-(3,4-dichlorophenyl)-5-(hydroxymethyl)furan-2(5H)-one (XI). Finally, this compound is esterified with pivaloyl chloride and pyridine in dichloromethane to afford the target ester.
【1】
Pour, M.; et al.; 3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: Synthesis and biological activity of a novel group of potential antifungal drugs. J Med Chem 2001, 44, 17, 2701.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30414 |
2-(3,4-dichlorophenyl)acetic acid;2-(3,4-Dichlorophenyl)acetic acid |
5807-30-7 |
C8H6Cl2O2 |
详情 | 详情
|
(II) |
47947 |
methyl 2-(3,4-dichlorophenyl)acetate
|
|
C9H8Cl2O2 |
详情 |
详情
|
(III) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IV) |
50420 |
methyl 2-(3,4-dichlorophenyl)-4-pentenoate
|
|
C12H12Cl2O2 |
详情 |
详情
|
(V) |
50421 |
2-(3,4-dichlorophenyl)-4-pentenoic acid
|
|
C11H10Cl2O2 |
详情 |
详情
|
(VI) |
50422 |
2-(3,4-dichlorophenyl)-3-(2-oxiranyl)propionic acid
|
|
C11H10Cl2O3 |
详情 |
详情
|
(VII) |
50423 |
3-(3,4-dichlorophenyl)-5-(hydroxymethyl)dihydro-2(3H)-furanone
|
|
C11H10Cl2O3 |
详情 |
详情
|
(VIII) |
50424 |
5-([[tert-butyl(dimethyl)silyl]oxy]methyl)-3-(3,4-dichlorophenyl)dihydro-2(3H)-furanone
|
|
C17H24Cl2O3Si |
详情 |
详情
|
(IX) |
50425 |
|
|
C17H23Cl2LiO3Si |
详情 |
详情
|
(X) |
50426 |
5-([[tert-butyl(dimethyl)silyl]oxy]methyl)-3-(3,4-dichlorophenyl)-3-(phenylselanyl)dihydro-2(3H)-furanone
|
|
C23H28Cl2O3SeSi |
详情 |
详情
|
(XI) |
50427 |
3-(3,4-dichlorophenyl)-5-(hydroxymethyl)-2(5H)-furanone
|
|
C11H8Cl2O3 |
详情 |
详情
|
(XII) |
44281 |
pivalic acid
|
75-98-9 |
C5H10O2 |
详情 | 详情
|
合成路线89
该中间体在本合成路线中的序号:
(XVI) The intermediate phosphonate (XXI) has been obtained as follows: The reaction of tert-butyl mercaptan (XV) with allyl bromide (XVI) by means of NaOH in ethanol gives the sulfide (XVII), which is oxidized with Oxone in methanol/water to yield the sulfone (XVIII). The bromination of (XVIII) with Br2 in CCl4 followed by dehydrobromination with TEA affords the bromosulfone (XIX), which is finally condensed with tributyl phosphite (XX) by heating at 130 C to provide the target intermediate phosphonate (XXI).
The silylation of the known diol (XXII) (obtained by degradation of vitamin D2) with Tes-OTf and lutidine gives the bis silyl ether (XXIII), which is submitted to a Swern oxidation ((COCl)2), yielding the carbaldehyde (XXIV). The Wadsworth-Emmons condensation of aldehyde (XXIV) with the intermediate phosphonate (XXI) by means of tBu-OLi affords the diinsaturated sulfone (XXV), which is desilylated with HF in THF to provide the alcohol (XXVI). The oxidation of (XXVI) with TPAP and NMO furnishes the ketone (XXVII), which is submitted to a Wittig-Horner condensation with the intermediate phosphine oxide (XIV) by means of PhLi, giving the silylated precursor (XXVIII). Finally, this compound is desilylated with HF in ethanol to afford the target vitamin D3 analogue.
【1】
Posner, G.H.; et al.; A non-calcemic sulfone version of the vitamin D3 analogue seocalcitol (EB 1089): Chemical synthesis, biological evaluation and potency enhancement of the anticancer drug adriamycin. Bioorg Med Chem 2001, 9, 9, 2365.
|
【2】
Fall, Y.; A new approach to the synthesis of the 25-hydroxy-22-oxa-vitamin D3 side chain. Tetrahedron Lett 1997, 38, 27, 4909.
|
【3】
Lee, J.K.; Crawford, K.R.; Wang, Q.; Posner, G.H.; Han, G. (Johns Hopkins University); Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1alpha,25-dihydroxyvitamin D3. US 6380408; WO 0059513 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIV) |
42574 |
[2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethyl](oxo)diphenylphosphorane; 2-((3S,5R)-3,5-bis[[tert-butyl(dimethyl)silyl]oxy]-2-methylenecyclohexylidene)ethyl(diphenyl)phosphine oxide
|
|
C33H51O3PSi2 |
详情 |
详情
|
(XV) |
52551 |
tert-Butyl mercaptan; 2-Methyl-2-propanethiol
|
75-66-1 |
C4H10S |
详情 | 详情
|
(XVI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVII) |
52552 |
1,1-dimethylethyl 2-propenyl sulfide; 3-[(1,1-dimethylethyl)sulfanyl]-1-propene
|
|
C7H14S |
详情 |
详情
|
(XVIII) |
52553 |
(1,1-dimethylethyl)(dioxo)2-propenyl-lambda~6~-sulfane; 1,1-dimethylethyl 2-propenyl sulfone
|
|
C7H14O2S |
详情 |
详情
|
(XIX) |
52554 |
(3-bromo-1-propenyl)(1,1-dimethylethyl)dioxo-lambda~6~-sulfane; 3-bromo-1-propenyl 1,1-dimethylethyl sulfone
|
|
C7H13BrO2S |
详情 |
详情
|
(XX) |
52555 |
Tri-n-butylphosphite; Tributyl phosphite; Phosphorous acid Tri-N-butyl ester
|
102-85-2 |
C12H27O3P |
详情 | 详情
|
(XXI) |
52556 |
dibutyl 3-[(1,1-dimethylethyl)sulfonyl]-2-propenylphosphonate
|
|
C15H31O5PS |
详情 |
详情
|
(XXII) |
52151 |
(1R,3aR,4S,7aR)-1-[(1S)-2-hydroxy-1-methylethyl]-7a-methyloctahydro-1H-inden-4-ol
|
|
C13H24O2 |
详情 |
详情
|
(XXIII) |
52557 |
7a-methyl-1-{1-methyl-2-[(triethylsilyl)oxy]ethyl}octahydro-1H-inden-4-yl triethylsilyl ether; [(7a-methyl-1-{1-methyl-2-[(triethylsilyl)oxy]ethyl}octahydro-1H-inden-4-yl)oxy](triethyl)silane
|
|
C25H52O2Si2 |
详情 |
详情
|
(XXIV) |
52558 |
2-{7a-methyl-4-[(triethylsilyl)oxy]octahydro-1H-inden-1-yl}propanal
|
|
C19H36O2Si |
详情 |
详情
|
(XXV) |
52559 |
[(1-{5-[(1,1-dimethylethyl)sulfonyl]-1-methyl-2,4-pentadienyl}-7a-methyloctahydro-1H-inden-4-yl)oxy](triethyl)silane; 5-{7a-methyl-4-[(triethylsilyl)oxy]octahydro-1H-inden-1-yl}-1,3-hexadienyl 1,1-dimethylethyl sulfone
|
|
C26H48O3SSi |
详情 |
详情
|
(XXVI) |
52560 |
1-{5-[(1,1-dimethylethyl)sulfonyl]-1-methyl-2,4-pentadienyl}-7a-methyloctahydro-1H-inden-4-ol
|
|
C20H34O3S |
详情 |
详情
|
(XXVII) |
52561 |
1-{5-[(1,1-dimethylethyl)sulfonyl]-1-methyl-2,4-pentadienyl}-7a-methyloctahydro-4H-inden-4-one
|
|
C20H32O3S |
详情 |
详情
|
(XXVIII) |
52562 |
(1,1-dimethylethyl)({3-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}-5-[2-(1-{5-[(1,1-dimethylethyl)sulfonyl]-1-methyl-2,4-pentadienyl}-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene]-4-methylidenecyclohexyl}oxy)dimethylsilane; 5-{4-[2-(3,5-bis{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}-2-methylidenecyclohexylidene)ethylidene]-7a-methyloctahydro-4H-inden-1-yl}-1,3-hexadienyl 1,1-dimethylethyl sulfone |
|
C41H72O4SSi2 |
详情 |
详情
|
合成路线90
该中间体在本合成路线中的序号:
(IX) Esterification of 3-(4-hydroxyphenyl)propionic acid (I), followed by alkylation of the phenolic hydroxyl, provided methyl 3-(4-benzyloxyphenyl)propionate (II), which was hydrolyzed to the corresponding carboxylic acid (III) by means of LiOH. Coupling of carboxylic acid (III) with the chiral auxiliary (S)-4-benzyl-2-oxazolidinone (IV) gave the oxazolide (V), which was subjected to diastereoselective alkylation with tert-butyl bromoacetate (VI), yielding (VII). Subsequent removal of the chiral auxiliary group of (VII) using lithium hydroperoxide afforded the (R)-acid (VIII). Alkylation of the dianion of acid (VIII) with allyl bromide (IX) and further epimerization in the presence of LDA and Et2AlCl furnished the anti-dialkylated succinate (X). The carboxyl group of (X) was then alkylated using benzyl bromide and DBU to produce the corresponding benzyl ester (XI). Olefin (XI) hydroboration followed by oxidative work-up gave rise to the primary alcohol (XII). This was acylated with 4-nitrophenyl chloroformate (XIII) to provide the activated carbonate (XIV).
【1】
Xue, C.-B.; et al.; Discovery of macrocyclic hydroxamic acids containing biphenylmethyl derivatives at P1', a series of selective TNF-alpha converting enzyme inhibitors with potent cellular activity in the inhibition of TNF-alpha release. J Med Chem 2001, 44, 21, 3351. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25691 |
3-(4-hydroxyphenyl)propionic acid
|
501-97-3 |
C9H10O3 |
详情 | 详情
|
(II) |
53167 |
methyl 3-[4-(benzyloxy)phenyl]propanoate
|
n/a |
C17H18O3 |
详情 | 详情
|
(III) |
53168 |
3-[4-(benzyloxy)phenyl]propanoic acid
|
50463-48-4 |
C16H16O3 |
详情 | 详情
|
(IV) |
14694 |
(S)-4-Benzyl-2-oxazolidinone; (4S)-4-Benzyl-1,3-oxazolan-2-one; (S)-(-)-4-Benzyl-2-oxazolidinone
|
90719-32-7 |
C10H11NO2 |
详情 | 详情
|
(V) |
53169 |
(4S)-4-benzyl-3-{3-[4-(benzyloxy)phenyl]propanoyl}-1,3-oxazolidin-2-one
|
n/a |
C26H25NO4 |
详情 | 详情
|
(VI) |
17430 |
2-Bromoacetic acid tert-butyl ester; tert-butyl 2-bromoacetate; tert-Butyl bromoacetate
|
5292-43-3 |
C6H11BrO2 |
详情 | 详情
|
(VII) |
53170 |
tert-butyl (3R)-4-[(4S)-4-benzyl-2-oxo-1,3-oxazolidin-3-yl]-3-[4-(benzyloxy)benzyl]-4-oxobutanoate
|
n/a |
C32H35NO6 |
详情 | 详情
|
(VIII) |
53171 |
(2R)-2-[4-(benzyloxy)benzyl]-4-(tert-butoxy)-4-oxobutanoic acid
|
n/a |
C22H26O5 |
详情 | 详情
|
(IX) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(X) |
53172 |
(2R,3S)-2-[4-(benzyloxy)benzyl]-3-(tert-butoxycarbonyl)-5-hexenoic acid
|
n/a |
C25H30O5 |
详情 | 详情
|
(XI) |
53173 |
4-benzyl 1-(tert-butyl) (2S,3R)-2-allyl-3-[4-(benzyloxy)benzyl]butanedioate
|
n/a |
C32H36O5 |
详情 | 详情
|
(XII) |
53174 |
1-benzyl 4-(tert-butyl) (2R,3S)-2-[4-(benzyloxy)benzyl]-3-(3-hydroxypropyl)butanedioate
|
n/a |
C32H38O6 |
详情 | 详情
|
(XIII) |
16605 |
4-Nitrophenyl chloroformate; 1-[(Chlorocarbonyl)oxy]-4-nitrobenzene
|
7693-46-1 |
C7H4ClNO4 |
详情 | 详情
|
(XIV) |
53175 |
1-benzyl 4-(tert-butyl) (2R,3S)-2-[4-(benzyloxy)benzyl]-3-(3-{[(4-nitrophenoxy)carbonyl]oxy}propyl)butanedioate
|
n/a |
C39H41NO10 |
详情 | 详情
|
合成路线91
该中间体在本合成路线中的序号:
(V) The reaction of 15-methylerythromycin A (I) with hydroxylamine, cyclohexanone di-isopropylacetal (II) and PPTS gives the substituted oxime (III), which is regioselectively silylated with Tms-Cl and imidazole to yield the disilylated compound (IV). The alkylation of (IV) with allyl bromide (V) and tBu-OK affords the 6-O-allyl derivative (VI),which is treated with HOAc and HCOOH to cleave the oxime group and furnish the 6-O-allyl-15-methylerythromycin A (VII). The cleavage of the 3-O-carbohydrate moiety of (VII) by means of aq. HCl, followed by benzoylation with Bz2O, gives the benzoyl intermediate (VIII), which is oxidized with NCS and Me2S and dehydrated with Ms-Cl, pyridine and DBU to yield the ketolide (IX). The fluorination of (IX) by means of (PhSO2)2N-F and tBu-OK affords the 2-fluoro derivative (X).
【1】
Macielag, M.; et al.; Structure-antibacterial activty relationships of ketolides derived from 15-methylerythromycin A. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1174.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54474 |
(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7,12,13-trihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione |
|
C38H69NO13 |
详情 |
详情
|
(II) |
45909 |
1-isopropoxycyclohexyl isopropyl ether; 1,1-diisopropoxycyclohexane
|
1132-95-2 |
C12H24O2 |
详情 | 详情
|
(III) |
54475 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7,12,13-trihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C47H86N2O14 |
详情 |
详情
|
(IV) |
54476 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7,12,13-trihydroxy-6-({(2S,3S,6R)-4-isopropyl-6-methyl-3-[(trimethylsilyl)oxy]morpholinyl}oxy)-4-({(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C53H102N2O14Si2 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
54477 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7-(allyloxy)-12,13-dihydroxy-6-({(2S,3S,6R)-4-isopropyl-6-methyl-3-[(trimethylsilyl)oxy]morpholinyl}oxy)-4-({(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C56H106N2O14Si2 |
详情 |
详情
|
(VII) |
54478 |
(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-12,13-dihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione |
|
C41H73NO13 |
详情 |
详情
|
(VIII) |
54479 |
(2S,3S,6R)-2-{[(3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-14-propyloxacyclotetradecanyl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H63NO11 |
详情 |
详情
|
(IX) |
54480 |
(2S,3S,6R)-2-{[(3R,5R,6R,7S,9R,13S,14R)-7-(allyloxy)-13-hydroxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxo-14-propyloxa-11-cyclotetradecen-6-yl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H59NO10 |
详情 |
详情
|
(X) |
54481 |
(2S,3S,6R)-2-{[(3S,5S,6R,7S,9R,13S,14R)-7-(allyloxy)-3-fluoro-4,13-dihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-14-propyloxa-11-cyclotetradecen-6-yl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H60FNO10 |
详情 |
详情
|
合成路线92
该中间体在本合成路线中的序号:
(V) The reaction of 15-methylerythromycin A (I) with hydroxylamine, cyclohexanone di-isopropylacetal (II) and PPTS gives the substituted oxime (III), which is regioselectively silylated with Tms-Cl and imidazole to yield the disilylated compound (IV). The alkylation of (IV) with allyl bromide (V) and tBu-OK affords the 6-O-allyl derivative (VI),which is treated with HOAc and HCOOH to cleave the oxime group and furnish the 6-O-allyl-15-methylerythromycin A (VII). The cleavage of the 3-O-carbohydrate moiety of (VII) by means of aq. HCl, followed by benzoylation with Bz2O, gives the benzoyl intermediate (VIII), which is oxidized with NCS and Me2S and dehydrated with Ms-Cl, pyridine and DBU to yield the ketolide (IX). The fluorination of (IX) by means of (PhSO2)2N-F and tBu-OK affords the 2-fluoro derivative (X).
【1】
Macielag, M.; et al.; Structure-antibacterial activty relationships of ketolides derived from 15-methylerythromycin A. 41st Intersci Conf Antimicrob Agents Chemother (Dec 16 2001, Chicago) 2001, Abst F-1174.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
54474 |
(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7,12,13-trihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione |
|
C38H69NO13 |
详情 |
详情
|
(II) |
45909 |
1-isopropoxycyclohexyl isopropyl ether; 1,1-diisopropoxycyclohexane
|
1132-95-2 |
C12H24O2 |
详情 | 详情
|
(III) |
54475 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7,12,13-trihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C47H86N2O14 |
详情 |
详情
|
(IV) |
54476 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7,12,13-trihydroxy-6-({(2S,3S,6R)-4-isopropyl-6-methyl-3-[(trimethylsilyl)oxy]morpholinyl}oxy)-4-({(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C53H102N2O14Si2 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
54477 |
(3R,4S,5R,6R,7S,9R,11S,12R,13S,14R)-7-(allyloxy)-12,13-dihydroxy-6-({(2S,3S,6R)-4-isopropyl-6-methyl-3-[(trimethylsilyl)oxy]morpholinyl}oxy)-4-({(2R,4R,5S,6S)-4-methoxy-4,6-dimethyl-5-[(trimethylsilyl)oxy]tetrahydro-2H-pyran-2-yl}oxy)-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione 10-[O-(1-isopropoxycyclohexyl)oxime] |
|
C56H106N2O14Si2 |
详情 |
详情
|
(VII) |
54478 |
(3R,4S,5R,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-12,13-dihydroxy-6-{[(2S,3S,6R)-3-hydroxy-4-isopropyl-6-methylmorpholinyl]oxy}-4-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl]oxy}-3,5,7,9,11,13-hexamethyl-14-propyl-2,10-oxacyclotetradecanedione |
|
C41H73NO13 |
详情 |
详情
|
(VIII) |
54479 |
(2S,3S,6R)-2-{[(3R,4S,5S,6R,7S,9R,11R,12R,13S,14R)-7-(allyloxy)-4,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-14-propyloxacyclotetradecanyl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H63NO11 |
详情 |
详情
|
(IX) |
54480 |
(2S,3S,6R)-2-{[(3R,5R,6R,7S,9R,13S,14R)-7-(allyloxy)-13-hydroxy-3,5,7,9,11,13-hexamethyl-2,4,10-trioxo-14-propyloxa-11-cyclotetradecen-6-yl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H59NO10 |
详情 |
详情
|
(X) |
54481 |
(2S,3S,6R)-2-{[(3S,5S,6R,7S,9R,13S,14R)-7-(allyloxy)-3-fluoro-4,13-dihydroxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-14-propyloxa-11-cyclotetradecen-6-yl]oxy}-4-isopropyl-6-methylmorpholinyl benzoate
|
|
C40H60FNO10 |
详情 |
详情
|
合成路线93
该中间体在本合成路线中的序号:
(III) Direct amination of veratrole (I) with lithium dimethylamide produces 2-methoxy-N,N-dimethylaniline (II). The title ammonium salt is then prepared by quaternization of the tertiary amine (II) with allyl bromide (III).
【1】
Tarver, G.J.; Kaur, J.; Zhang, M.-Q.; Pow, E.; Muir, A.W.; Grove, S.J.A.; Oxyaniliniums as acetylcholinesterase inhibitors for the reversal of neuromuscular block. Bioorg Med Chem Lett 2002, 12, 2, 193.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17398 |
2-methoxyphenyl methyl ether; Veratrole; 1,2-dimethoxybenzene
|
91-16-7 |
C8H10O2 |
详情 | 详情
|
(II) |
59068 |
N-(2-methoxyphenyl)-N,N-dimethylamine; 2-methoxy-N,N-dimethylaniline
|
|
C9H13NO |
详情 |
详情
|
(III) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
合成路线94
该中间体在本合成路线中的序号:
(V) Condensation of 2,4-diaminotoluene (I) with methyl 4-methoxyacetoacetate (II) produces quinolinone (III). Conversion of the 7-aminoquinolinone (III) into the 7-hydroxy analogue (IV) is achieved by diazotization, followed by hydrolysis in hot sulfuric acid. Alkylation of phenol (IV) with allyl bromide (V) gives allyl ether (VI). Subsequent methylation of (VI) by means of dimethyl sulfate leads to a mixture of the desired N-methyl quinoline (VII) along with minor amounts of the O-methyl isomer (VIII), which are separated by column chromatography. Claisen rearrangement of the allyl ether (VII) in refluxing N,N-dimethylaniline affords the 7-hydroxy-8-allyl quinolone (IX), which is further acetylated to (X) by means of acetic anhydride and sodium acetate. Bromination of the allyl group of (X) in HOAc yields the dibromo compound (XI).
【1】
Chilin, A.; et al.; Synthesis and biological evaluation of a new furo(2,3-h)quinolin-2(1H)-one. J Med Chem 2002, 45, 5, 1146.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
57682 |
4-methyl-1,3-benzenediamine; 3-amino-4-methylphenylamine
|
|
C7H10N2 |
详情 |
详情
|
(II) |
57683 |
ethyl 4-methoxy-3-oxobutanoate
|
|
C7H12O4 |
详情 |
详情
|
(III) |
57684 |
7-amino-4-(methoxymethyl)-6-methyl-2(1H)-quinolinone
|
|
C12H14N2O2 |
详情 |
详情
|
(IV) |
57685 |
7-hydroxy-4-(methoxymethyl)-6-methyl-2(1H)-quinolinone
|
|
C12H13NO3 |
详情 |
详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
57686 |
7-(allyloxy)-4-(methoxymethyl)-6-methyl-2(1H)-quinolinone
|
|
C15H17NO3 |
详情 |
详情
|
(VII) |
57687 |
7-(allyloxy)-4-(methoxymethyl)-1,6-dimethyl-2(1H)-quinolinone
|
|
C16H19NO3 |
详情 |
详情
|
(VIII) |
57688 |
7-(allyloxy)-2-methoxy-4-(methoxymethyl)-6-methylquinoline; allyl 2-methoxy-4-(methoxymethyl)-6-methyl-7-quinolinyl ether
|
|
C16H19NO3 |
详情 |
详情
|
(IX) |
57689 |
8-allyl-7-hydroxy-4-(methoxymethyl)-1,6-dimethyl-2(1H)-quinolinone
|
|
C16H19NO3 |
详情 |
详情
|
(X) |
57690 |
8-allyl-4-(methoxymethyl)-1,6-dimethyl-2-oxo-1,2-dihydro-7-quinolinyl acetate
|
|
C18H21NO4 |
详情 |
详情
|
(XI) |
57691 |
8-(2,3-dibromopropyl)-4-(methoxymethyl)-1,6-dimethyl-2-oxo-1,2-dihydro-7-quinolinyl acetate
|
|
C18H21Br2NO4 |
详情 |
详情
|
合成路线95
该中间体在本合成路线中的序号:
(XV) Alkylation of the enolate derived from N-Boc ethyl isonipecotate (XIV) with allyl bromide (XV) gives the alpha-allyl ester (XVI). Double bond ozonolysis in (XIV) with reductive work-up in the presence of NaBH4 leads to lactone (XVII). Reductive ring-opening of lactone (XVII) by means of DIBAL affords diol (XVIII). This is then cyclized under Mitsunobu conditions to the spirocyclic amine (XIX). Acidic Boc group cleavage in (XIX) provides 2-oxa-8-azaspiro[4.5]decane (XX). Finally, reductive amination of cyclohexanone (XIII) with the bicyclic amine (XX) gives rise to a cis/trans mixture of diamino cyclohexanes, from which the desired trans isomer is isolated by chromatography.
【1】
Cooper, L.C.; et al.; 4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II. Bioorg Med Chem Lett 2002, 12, 13, 1759.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(XIII) |
57089 |
2-[3,5-bis(trifluoromethyl)phenyl]-N-(4-oxo-1-phenylcyclohexyl)propanamide
|
|
C23H21F6NO2 |
详情 |
详情
|
(XIV) |
49847 |
1-(tert-butyl) 4-ethyl-1,4-piperidinedicarboxylate; N-Boc-4-Carbethoxypiperidine
|
142851-03-4 |
C13H23NO4 |
详情 | 详情
|
(XV) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(XVI) |
57090 |
1-(tert-butyl) 4-ethyl 4-allyl-1,4-piperidinedicarboxylate
|
|
C16H27NO4 |
详情 |
详情
|
(XVII) |
57091 |
tert-butyl 1-oxo-2-oxa-8-azaspiro[4.5]decane-8-carboxylate
|
|
C13H21NO4 |
详情 |
详情
|
(XVIII) |
57092 |
tert-butyl 4-(2-hydroxyethyl)-4-(hydroxymethyl)-1-piperidinecarboxylate
|
|
C13H25NO4 |
详情 |
详情
|
(XIX) |
57093 |
tert-butyl 2-oxa-8-azaspiro[4.5]decane-8-carboxylate
|
|
C13H23NO3 |
详情 |
详情
|
(XX) |
57094 |
2-oxa-8-azaspiro[4.5]decane
|
|
C8H15NO |
详情 |
详情
|
合成路线96
该中间体在本合成路线中的序号:
(III) 5,5-Dimethylthiazolidine-4-carboxylic acid (I) is protected as the N-Boc derivative (II), and subsequently treated with allyl bromide (III) and triethylamine to form the allyl ester (IV). Acidic Boc group cleavage in (IV) provides amino ester (V), which is further coupled to the lactone acid (VI) to furnish amide (VII). The allyl ester group of (VII) is then removed by treatment with morpholine and Pd(PPh3)4, yielding acid (VIII). This is then coupled to (3,5-dimethylisothiazol-4-yl)methyl amine (IX) employing EDC/HOAt to afford the corresponding amide (X). Lactone ring opening in (X) by hydrolysis with LiOH gives rise to the hydroxy acid (XI), which is further protected as the silyl ether (XII) employing t-butyldimethylsilyl triflate.
【1】
Bohn, J.; Lu, Z.; Raghavan, S.; Charest, M.; Stahlhut, M.; Rutkowski, C.A.; Himmelberger, A.L.; Olsen, D.B.; Scheleif, W.A.; Carella, A.; Gabryelski, L.; Jin, L.; Lin, J.H.; Tata, J.R.; Chapman, K.; Synthesis of highly potent HIV protease inhibitors with activity against protease resistant virus. 224th ACS Natl Meet (Aug 18 2002, Boston) 2002, Abst MEDI 205. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
34776 |
(4R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
|
72778-00-8 |
C6H11NO2S |
详情 | 详情
|
(II) |
34777 |
(4R)-3-(tert-butoxycarbonyl)-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
|
|
C11H19NO4S |
详情 |
详情
|
(III) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(IV) |
65046 |
4-allyl 3-(tert-butyl) (4R)-5,5-dimethyl-1,3-thiazolidine-3,4-dicarboxylate
|
|
C14H23NO4S |
详情 |
详情
|
(V) |
65047 |
allyl (4R)-5,5-dimethyl-1,3-thiazolidine-4-carboxylate
|
|
C9H15NO2S |
详情 |
详情
|
(VI) |
65048 |
(2S,4R)-4-benzyl-5-oxotetrahydro-2-furancarboxylic acid
|
|
C12H12O4 |
详情 |
详情
|
(VII) |
65049 |
allyl (4R)-3-{[(2S,4R)-4-benzyl-5-oxotetrahydro-2-furanyl]carbonyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylate
|
|
C21H25NO5S |
详情 |
详情
|
(VIII) |
65050 |
(4R)-3-{[(2S,4R)-4-benzyl-5-oxotetrahydro-2-furanyl]carbonyl}-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
|
|
C18H21NO5S |
详情 |
详情
|
(IX) |
65059 |
(3,5-dimethyl-4-isothiazolyl)methanamine; (3,5-dimethyl-4-isothiazolyl)methylamine
|
|
C6H10N2S |
详情 |
详情
|
(X) |
65060 |
(4R)-3-{[(2S,4R)-4-benzyl-5-oxotetrahydro-2-furanyl]carbonyl}-N-[(3,5-dimethyl-4-isothiazolyl)methyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxamide
|
|
C24H29N3O4S2 |
详情 |
详情
|
(XI) |
65061 |
(2R,4S)-2-benzyl-5-[(4R)-4-({[(3,5-dimethyl-4-isothiazolyl)methyl]amino}carbonyl)-5,5-dimethyl-1,3-thiazolidin-3-yl]-4-hydroxy-5-oxopentanoic acid
|
|
C24H31N3O5S2 |
详情 |
详情
|
(XII) |
65062 |
(2R,4S)-2-benzyl-4-{[tert-butyl(dimethyl)silyl]oxy}-5-[(4R)-4-({[(3,5-dimethyl-4-isothiazolyl)methyl]amino}carbonyl)-5,5-dimethyl-1,3-thiazolidin-3-yl]-5-oxopentanoic acid
|
|
C30H45N3O5S2Si |
详情 |
详情
|
合成路线97
该中间体在本合成路线中的序号:
(II) Benzazepinone (I) is alkylated by allyl bromide (II) in the presence of NaH to furnish (III). Ozonolysis of the N-allyl group of (III) in cold CH2Cl2 then produces aldehyde (IV). This is then reductively aminated with 5-fluoro-1-(piperidin-4-yl)-2,3-dihydro-1H-benzimidazol-2-one (V) employing NaBH(OAc)3 in 1,2-dichloroethane to yield the title compound.
【1】
Forbes, I.T.; Cooper, D.G.; Dodds, E.K.; Douglas, S.E.; Gribble, A.D.; Ife, R.J.; Lightfoot, A.P.; Meeson, M.; Campbell, L.P.; Coleman, T.; Riley, G.J.; Thomas, D.R.; Identification of a novel series of selective 5-HT7 receptor antagonists. Bioorg Med Chem Lett 2003, 13, 6, 1055. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
63710 |
2,3,4,5-tetrahydro-1H-2-benzazepin-1-one
|
|
C10H11NO |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
63711 |
2-(2-propenyl)-2,3,4,5-tetrahydro-1H-2-benzazepin-1-one
|
|
C13H15NO |
详情 |
详情
|
(IV) |
63712 |
2-(1-oxo-1,3,4,5-tetrahydro-2H-2-benzazepin-2-yl)acetaldehyde
|
|
C12H13NO2 |
详情 |
详情
|
(V) |
63713 |
5-fluoro-1-(4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one
|
|
C12H14FN3O |
详情 |
详情
|
合成路线98
该中间体在本合成路线中的序号:
(VI) Alkylation of 14-hydroxycodeinone (I) with cinnamyl bromide (II) in the presence of NaH in DMF gives 14-cinnamyloxycodeinone (III). Catalytic hydrogenation of (III) over Pd/C catalyst affords the corresponding 7,8-dihydro-14-phenylpropoxy derivative (IV). N-Demethylation of (IV) is accomplished by treatment with 1-chloroethyl chloroformate, followed by cleavage of the intermediate chloroethyl carbamate in refluxing MeOH. The resulting N-nor derivative (V) is then alkylated with allyl bromide (VI) using K2CO3 in DMF to provide the N-allyl amine (VII). O-Demethylation of (VII) with boiling 48% HBr yields phenol (VIII). Finally, catalytic hydrogenation of the N-allyl group of (VIII) in the presence of Pd/C affords the title N-propyl derivative.
【1】
Greiner, E.; Spetea, M.; Krassnig, R.; Schullner, F.; Aceto, M.; Harris, L.S.; Traynor, J.R.; Woods, J.H.; Coop, A.; Schmidhammer, H.; Synthesis and biological evaluation of 14-alkoxymorphinans. 18.(1) N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: Extending the scope of common structure-activity relationships. J Med Chem 2003, 46, 9, 1758. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
64962 |
17-hydroxy-4-methyl-10-(methyloxy)-12-oxa-4-azapentacyclo[9.6.1.0~1,13~.0~5,17~.0~7,18~]octadeca-7(18),8,10,15-tetraen-14-one
|
|
C18H19NO4 |
详情 |
详情
|
(II) |
21131 |
1-[(E)-3-bromo-1-propenyl]benzene
|
4392-24-9 |
C9H9Br |
详情 | 详情
|
(III) |
64963 |
|
|
C27H27NO4 |
详情 |
详情
|
(IV) |
64964 |
|
|
C27H31NO4 |
详情 |
详情
|
(V) |
64965 |
|
|
C26H29NO4 |
详情 |
详情
|
(VI) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VII) |
64966 |
|
|
C29H33NO4 |
详情 |
详情
|
(VIII) |
64967 |
|
|
C28H31NO4 |
详情 |
详情
|
合成路线99
该中间体在本合成路线中的序号:
(II) Synthesis of the perhydroindole intermediate (XIII): The alkylation of the N-protected glutamate (I) with allyl bromide (II) by means of LiHMDS in THF gives the protected chiral allyl glutamate (III) (1), which is cyclized by means of TFA in dichloromethane to yield the pyroglutamate (IV). The reduction of (IV) with LiHBEt3 in THF affords the hydroxy compound (V), which is treated with Ac2O and DMAP in dichloromethane to provide the expected hemiaminal derivative (VI). The reaction of (VI) with allyl tributylstannane (VII) by means of BF3/Et2O in toluene gives the diallyl pyrrolidine (VIII), which is submitted to a ring closure by olefin metathesis using a Grubbs Ru catalyst in dichloromethane to yield the hexahydroindole derivative (IX). The reaction of (IX) with mCPBA in dichloromethane affords the epoxide (X), which is hydrolyzed with TFA to yield the dihydroxy compound (XI). The reaction of (XI) with Mom-Cl and DIEA in dichloromethane provides the bis mom ether (XII), which is treated with H2 over Pd/C in methanol to yield the desired perhydroindole intermediate (XIII) (2).
【1】
Hanessian, S.; Margarita, R.; 1,3-Asymmetric induction in dianionic allylation reactions of amino acid derivatives-synthesis of functionally useful enantiopure glutamates, pipecolates and pyroglutamates. Tetrahedron Lett 1998, 39, 33, 5887.
|
【2】
Hanessian, S.; Margarita, R.; Hall, A.; Johnstone, S.; Tremblay, M.; Parlanti, L.; Total synthesis and structural confirmation of the marine natural product Dysinosin A: A novel inhibitor of thrombin and Factor VIIa. J Am Chem Soc 2002, 124, 45, 13342. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
64903 |
dimethyl 2-({[(phenylmethyl)oxy]carbonyl}amino)pentanedioate
|
|
C15H19NO6 |
详情 |
详情
|
(II) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(III) |
64904 |
dimethyl 2-({[(phenylmethyl)oxy]carbonyl}amino)-4-(2-propenyl)pentanedioate
|
|
C18H23NO6 |
详情 |
详情
|
(IV) |
64905 |
2-methyl 1-(phenylmethyl) 5-oxo-4-(2-propenyl)-1,2-pyrrolidinedicarboxylate
|
|
C17H19NO5 |
详情 |
详情
|
(V) |
64906 |
2-methyl 1-(phenylmethyl) 5-hydroxy-4-(2-propenyl)-1,2-pyrrolidinedicarboxylate
|
|
C17H21NO5 |
详情 |
详情
|
(VI) |
64907 |
2-methyl 1-(phenylmethyl) 5-(acetyloxy)-4-(2-propenyl)-1,2-pyrrolidinedicarboxylate
|
|
C19H23NO6 |
详情 |
详情
|
(VII) |
40599 |
Allyltributyltin; Tributyl-2-propenylstannane |
24850-33-7 |
C15H32Sn |
详情 | 详情
|
(VIII) |
64908 |
2-methyl 1-(phenylmethyl) 4,5-di(2-propenyl)-1,2-pyrrolidinedicarboxylate
|
|
C20H25NO4 |
详情 |
详情
|
(IX) |
64909 |
2-methyl 1-(phenylmethyl) 2,3,3a,4,7,7a-hexahydro-1H-indole-1,2-dicarboxylate
|
|
C18H21NO4 |
详情 |
详情
|
(X) |
64910 |
4-methyl 3-(phenylmethyl) octahydro-3H-oxireno[2,3-f]indole-3,4-dicarboxylate
|
|
C18H21NO5 |
详情 |
详情
|
(XI) |
64911 |
2-methyl 1-(phenylmethyl) 5,6-dihydroxyoctahydro-1H-indole-1,2-dicarboxylate
|
|
C18H23NO6 |
详情 |
详情
|
(XII) |
64912 |
2-methyl 1-(phenylmethyl) 5,6-bis{[(methyloxy)methyl]oxy}octahydro-1H-indole-1,2-dicarboxylate
|
|
C22H31NO8 |
详情 |
详情
|
(XIII) |
64913 |
methyl 5,6-bis{[(methyloxy)methyl]oxy}octahydro-1H-indole-2-carboxylate
|
|
C14H25NO6 |
详情 |
详情
|
合成路线100
该中间体在本合成路线中的序号:
(V) O-Alkylation of 5-nitrosalicylaldehyde (I) with 1,2-dichloroethane (IIa) or 1-bromo-2-chloroethane (IIb) (3) by means of K2CO3 in DMF at 100-5 °c or 60 °c affords 2-(2-chloroethoxy)-5-nitrobenzaldehyde (III), which by reduction with nabH4 in THF or MeoH yields the corresponding alcohol (IV). O-Alkylation of alcohol (IV) with allyl bromide (V) and KoH and Bu4NHSo4 or Bu4Ni at 40 °c gives 2-(allyloxymethyl)-1-(2-chloroethoxy)-4-nitrobenzene (VI), which is then reduced with Fe in the presence of nH4cl in EtoH to yield the corresponding aniline (VII). condensation of amine (VII) with 4-[3-(allyloxymethyl)phenyl]-2-chloropyrimidine (VIII) by means of Hcl in buoH at 80 °c affords the 2-anilinopyrimidine derivative (IX), which then undergoes ring-closing metathesis in the presence of Grubbs’ second-generation catalyst and HCl in CH2Cl2 at 40-45 °c to yield macrocycle (X). Finally, compound (X) is submitted to microwave-assisted condensation with pyrrolidine (XI) in dimethylacetamide at 80 °c .
intermediate (VIII) can be prepared by Suzuki coupling of 2,4-dichloropyrimidine (XII) with 3-(hydroxymethyl)phenylboronic acid (XIII) in the presence of Pd(OAc)2, PPh3 and na2co3 in THF at 70 °c or Pd(PPh3)4 and Na2CO3 in DME at 80-5 °c to give [3-(2-chloropyrimidin-4-yl)phenyl]methanol (XIV), which is finally O-alkylated with allyl bromide (V) and KOH and Bu4NHSO4 or Cs2CO3 in DMF at 40 °c .
【1】
William, A.D., Lee, A.c., blanchard, S. et al. Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma. J Med chem 2011, 54(13): 4638-58. |
【2】
Lee, A., William, A., Poulsen, A. et al. Design, synthesis and SAR studies leading to SB1518, a novel macrocyclic JAK2/FLT3 inhibitor in phase 2 clinical trials for myelofibrosis and lymphoma. 102nd Annu Meet Am Assoc cancer Res (AAcR) (April 2-6, orlando) 2011, Abst 3564. |
【3】
blanchard, S., Lee, c.H.A., nagaraj, H.K.M., Poulsen, A., Sun, E.t., tan, Y.L.E., William, A.D. (S*bio Pte. Ltd.). EP 1951729, JP 2009515954, US 8153632, Wo 2007058627. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(IIa) |
16170 |
1,2-dichloroethane
|
107-06-2 |
C2H4Cl2 |
详情 | 详情
|
(IIb) |
24271 |
1-bromo-2-chloroethane
|
107-04-0 |
C2H4BrCl |
详情 | 详情
|
(IX) |
68053 |
N-(3-((allyloxy)methyl)-4-(2-chloroethoxy)phenyl)-4-(3-((allyloxy)methyl)phenyl)pyrimidin-2-amine |
|
C26H28ClN3O3 |
详情 | 详情
|
(I) |
42307 |
2-hydroxy-5-nitrobenzaldehyde;5-nitrosalicylaldehyde |
97-51-8 |
C7H5NO4 |
详情 | 详情
|
(III) |
68048 |
2-(2-chloroethoxy)-5-nitrobenzaldehyde |
|
C9H8ClNO4 |
详情 | 详情
|
(IV) |
68049 |
(2-(2-chloroethoxy)-5-nitrophenyl)methanol |
|
C9H10ClNO4 |
详情 | 详情
|
(V) |
11463 |
3-Bromo-1-propene; 3-Bromopropene;allyl bromide |
106-95-6 |
C3H5Br |
详情 | 详情
|
(VI) |
68050 |
2-((allyloxy)methyl)-1-(2-chloroethoxy)-4-nitrobenzene |
|
C12H14ClNO4 |
详情 | 详情
|
(VII) |
68051 |
3-((allyloxy)methyl)-4-(2-chloroethoxy)aniline |
|
C12H16ClNO2 |
详情 | 详情
|
(VIII) |
68052 |
4-[3-(allyloxymethyl)phenyl]-2-chloropyrimidine |
|
C14H13ClN2O |
详情 | 详情
|
(X) |
68054 |
|
|
C24H24ClN3O3 |
详情 | 详情
|
(XI) |
11376 |
Pyrrolidine
|
123-75-1 |
C4H9N |
详情 | 详情
|
(XII) |
54377 |
2,4-Dichloropyrimidine
|
3934-20-1 |
C4H2Cl2N2 |
详情 | 详情
|
(XIII) |
68055 |
3-(hydroxymethyl)phenylboronic acid;(3-Hydroxymethyl)phenylboronic acid;(m-Hydroxymethyl)phenylboronic acid;3-Hydroxymethylbenzeneboronic acid |
87199-15-3 |
C7H9BO3 |
详情 | 详情
|
(XIV) |
68056 |
[3-(2-chloropyrimidin-4-yl)phenyl]methanol |
|
C11H9ClN2O |
详情 | 详情
|